Morgan Creek Energy Corp. (the "Company") (OTC Bulletin Board: MCKE; M6C1-Frankfurt) has taken control of the exploration of the Frio Draw prospect in Curry County, New Mexico. The Company had previously entered an agreement with FormCap, which was to act as a joint-venture partner on the project, but could not meet the requirements as set forth under the agreement.

Morgan Creek Energy will now retain a 100% interest in the 13,252-acre Frio Draw Prospect and intends to fund exploration drilling on the prospect through alternative sources.

Company President Peter Wilson states, "We have seen a tremendous upswing in the energy markets while drilling costs have gone down drastically. This gives Morgan Creek Energy the opportunity to fund its own drilling initiatives and therefore control the entire process."

Following a planned initial well drilling and completion, Morgan Creek Energy's management team expects to establish a set of drilling initiatives on the Frio Draw based on technical data and drill results.

About Morgan Creek Energy Corp.:

Morgan Creek Energy Corp. is a natural resource exploration company engaged in the acquisition and development of strategic oil and natural gas properties. For further information see: www.morgancreekenergy.com

Symbol: OTCBB - MCKE; Frankfurt/Berlin Symbol - M6C1, WKN No.: A0QYTM; ISIN: 61732R 206

SAFE HARBOR STATEMENT

THIS NEWS RELEASE CONTAINS "FORWARD-LOOKING STATEMENTS", AS THAT TERM IS DEFINED IN SECTION 27A OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE UNITED STATES SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. STATEMENTS IN THIS NEWS RELEASE, WHICH ARE NOT PURELY HISTORICAL, ARE FORWARD-LOOKING STATEMENTS AND INCLUDE ANY STATEMENTS REGARDING BELIEFS, PLANS, EXPECTATIONS OR INTENTIONS REGARDING THE FUTURE.

EXCEPT FOR THE HISTORICAL INFORMATION PRESENTED HEREIN, MATTERS DISCUSSED IN THIS NEWS RELEASE CONTAIN FORWARD-LOOKING STATEMENTS THAT ARE SUBJECT TO CERTAIN RISKS AND UNCERTAINTIES THAT COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM ANY FUTURE RESULTS, PERFORMANCE OR ACHIEVEMENTS EXPRESSED OR IMPLIED BY SUCH STATEMENTS. STATEMENTS THAT ARE NOT HISTORICAL FACTS, INCLUDING STATEMENTS THAT ARE PRECEDED BY, FOLLOWED BY, OR THAT INCLUDE SUCH WORDS AS "ESTIMATE," "ANTICIPATE," "BELIEVE," "PLAN" OR "EXPECT" OR SIMILAR STATEMENTS ARE FORWARD-LOOKING STATEMENTS. RISKS AND UNCERTAINTIES FOR THE COMPANY INCLUDE, BUT ARE NOT LIMITED TO, THE RISKS ASSOCIATED WITH PROPERTY DEVELOPMENT AND FUNDING AS WELL AS THE RISKS SHOWN IN THE COMPANY'S MOST RECENT ANNUAL REPORT ON FORM 10-KSB AND ON FORM 10-QSB AND FROM TIME-TO-TIME IN OTHER PUBLICLY AVAILABLE INFORMATION REGARDING THE COMPANY. OTHER RISKS INCLUDE RISKS ASSOCIATED WITH THE REGULATORY APPROVAL PROCESS, COMPETITIVE COMPANIES, FUTURE CAPITAL REQUIREMENTS AND THE COMPANY'S ABILITY AND LEVEL OF SUPPORT FOR ITS EXPLORATION AND DEVELOPMENT ACTIVITIES. THERE CAN BE NO ASSURANCE THAT THE COMPANY'S DEVELOPMENT EFFORTS WILL SUCCEED AND THE COMPANY WILL ULTIMATELY ACHIEVE COMMERCIAL SUCCESS. THESE FORWARD-LOOKING STATEMENTS ARE MADE AS OF THE DATE OF THIS NEWS RELEASE, AND THE COMPANY ASSUMES NO OBLIGATION TO UPDATE THE FORWARD-LOOKING STATEMENTS, OR TO UPDATE THE REASONS WHY ACTUAL RESULTS COULD DIFFER FROM THOSE PROJECTED IN THE FORWARD-LOOKING STATEMENTS. ALTHOUGH THE COMPANY BELIEVES THAT THE BELIEFS, PLANS, EXPECTATIONS AND INTENTIONS CONTAINED IN THIS NEWS RELEASE ARE REASONABLE, THERE CAN BE NO ASSURANCE THOSE BELIEFS, PLANS, EXPECTATIONS OR INTENTIONS WILL PROVE TO BE ACCURATE. INVESTORS SHOULD CONSIDER ALL OF THE INFORMATION SET FORTH HEREIN AND SHOULD ALSO REFER TO THE RISK FACTORS DISCLOSED IN THE COMPANY'S PERIODIC REPORTS FILED FROM TIME-TO-TIME WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION.

THIS NEWS RELEASE HAS BEEN PREPARED BY MANAGEMENT OF THE COMPANY WHO TAKES FULL RESPONSIBILITY FOR ITS CONTENTS. EACH OF THE NASD, THE SEC AND THE OTCBB NEITHER APPROVES NOR DISAPPROVES OF THE CONTENTS OF THIS NEWS RELEASE. THIS NEWS RELEASE SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE SECURITIES IN ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION.

ActionView International, Inc. (Pink Sheets: AVEW) and its wholly owned MatchFights, LLC subsidiary has announced a special discounted sign-up promotion for the inaugural BKB Fight Club pay-per-view event. Anyone who pre-registers today at the BKB Fight Club website, www.bkbfightclub.com, from 6:00 pm to 7:00 pm Pacific Daylight Time will receive the discounted price of $4.99. The live BKB Fight Club pay-per-view broadcast will begin at 7:00 pm Pacific Daylight Time on September 25th.

"We have offered a number of special promotions for our inaugural MatchFights event, and we hope that this deeply discounted price will provide the opportunity for a wider range of fight fans to view the September 25th bouts," said Gary Nerison, chairman of ActionView International.

"In addition to attracting more subscribers, we will also use the anticipated increase in traffic on the BKB Fight Club website to test some of its load capabilities. We want to ensure that all aspects of the site work flawlessly so that our customers have the best experience possible as they sign up, review and vote on the fight cards, and, ultimately, tune in to view the event," added Mr. Nerison.

The September 25, 2009 MatchFights event, which features sixteen fighters from broad fight backgrounds including MMA, Muay Thai, boxing and street fighting, will take place in Evanston, Wyoming and will be broadcast live in high definition around the world over the Internet. A pre-event party, which will include appearances by ActionView International Director and 3-time world boxing champion Tony "The Tiger" Lopez and several of the BKB Fight Club ring girls, will be held tonight at Suds Brothers Brewery located at 1012 Main Street in Evanston.

The company encourages shareholders and anyone interested in following the progress of ActionView International and its wholly owned MatchFights, LLC subsidiary to subscribe to the mailing list at www.matchfights.com.

About ActionView International, Inc.

ActionView International has completed its acquisition of MatchFights, LLC, which is now the focus of the company's operations. MatchFights, LLC and its BKB Fight Club property deliver live, high definition, pay-per-view events, including no-holds-barred, full contact fights, in an interactive venue over the Internet to a global audience. The live events will have broad appeal and include elements of fighting, music, ring girl contests, and other live entertainment as part of the broadcast. For additional information about MatchFights and its BKB Fight Club, please visit www.matchfights.com or www.bkbfightclub.com.

    Contact:
    ActionView International, Inc.
    Investor Relations
    951-200-4107
    media@matchfights.com

Syndication Inc., (Pink Sheets: SYNJ), reports that McCutcheon Marshall Jr., President and Chairman of the Board for Sentinel Renewable Energy S.C. Inc. and Pinnacle Energy Inc., the wholly owned energy subsidiary of Syndication Inc., is considering a number of candidates for the engineering supervisory position for the Companies 75,000 sq. ft. warehouse project.

The Company is considering a number of project managers that would be qualified to operate the Denami 600 series Bio Diesel manufacturing processor. Those qualifications are best articulated by the listed specs below:

Denami 600 Turnkey Production Line:

Includes:

• Two (2) Denami 600 Biodiesel Processors
• One (1) Environmental Checklist
• On-site installation and commissioning for up to Five (5) days
• On-site training for up to Five (5) days. SAID training may, or will be done after Installation but during or after Commissioning.
  

Additional Major components (these components are based on a typical site as shown in Methes's facility in Mississauga and there may be changes or adjustments that will be reflected in the total price):

    Major Component Detail Description Qty
    Insulated Tanks Insulated Storage Tank

    7 15,000 gallon vertical storage tank (11.5 x 19 feet)
    4 Insulation  2" insulation with cladding
    4 Heating coil
    4 Level Sensor Level Sensor - Ultra Sonic
    4 Fire Rated Valves
    3 C.S. Full Port 150 lb. FLGD Ball Valve; Fire Safe
    4 Teflon Gasket 1/16 Teflon Gasket
    4 Blind Valve STD WELD BLIND FLANG
    4 Custom Pipe Weld Assembly's
    4 3" ball valves
    3 C.S. Full Port 150 lb. FLGD Ball Valves
    4 1" ball valves
    1 in C.S. 3 PC Full Port Ball Valves
    4 Sample Ports
    3 Sample Ports (Top, Middle and Bottom)

    4 Non-Insulated Tanks

    Non Insulated Storage Tanks 15,000 gallon vertical storage tank
    (11.5 x 19 feet)
    7 Heating coils
    7 Level Sensor Level Sensor - Ultra Sonic
    7 Fire Rated Valves
    3 C.S. Full Port 150 lb. FLGD Ball Valve Fire Safe
    7 Teflon Gasket 1/16 Teflon Gaskets
    7 Blind Valve STD WELD BLIND FLANGE
    7 Custom Pipe Weld Assembly's
    7 3" ball valves
    3 C.S. Full Port 150 lb. FLGD Ball Valves
    7 1" ball valves
    1 in C.S. 3 PC Full Port Ball Valve
    7 Sample Ports
    3 Sample Ports (Top, Middle and Bottom)

    7 Methanol Tank Flammable Storage Tank 12,000 gallon Double Wall vertical
    storage tank (11 x 15 feet)
    1 Level Sensor Level Sensor - Ultra Sonic
    1 Level Sensor Level Sensor - Tuning Fork
    1 Habonim Ball Valve 2" Fire Safe Type Stainless Ball Valve
    1 Habonim Ball Valve
    1 Fire Safe Type Stainless Ball Valve
    1 12" Vent
    1 2" Emergency Pressure

    Vent 1
    2" Working Vent End of line Blanketing Valve
    1 Blanketing Valve Nitrogen Blanketing Valve

    1 Tank Farm Piping

    1 Loading and Unloading
    3 Blackpipes, 1" Blackpipes (Victaulic)
    3 Heat Trace Heat Cable, 20 Watts per ft. with Jacket 160 Power
    Connection Kit 110 V Power Connection Kit
    4 Temperature Switch Temperature Regulator
    2 Insulation 1" Fibreglass insulation 160

    Tank Farm Piping

    2 Methanol Line 2" Stainless Steel

    2 Service Lines

    Hot water, cooling water and Nitrogen Service lines to the
    biodiesel processor

    5 Containment wall Concrete Block Wall to hold 110% by volume of the
    largest tank
    1 Seal Containment Wall proxy seal
    1 Wall Cap Stainless steel Cap
    1 Ladder For access into the containment wall

    Fire Rated Room
    2 hr. fire-rated room
    30 ft. to the steel deck plus one double steel frame and doors (subject
    to permitting)

    1 Loading Rack; Rack Frame Stainless Stain Frame
    1 Pump 7 1/2 HP Centrifugal Pump
    3 Filters Filter Bag housing, gooseneck style
    3 Truck Hoses 2 Tank Truck Hoses 15 ft. 30; Truck Sample Probe For sample
    collection from truck before loading
    1 Composite Hose 2" x 25
    1 Composite Hose 2" x 40

    Tote Containment;

    Tote Containment for Catalyst

    2 Boiler 500,000 BTU/hr

    1 Air Compressor 7.5 HP, with Air Dryer
    1 Material Handling Equipment
    1 Booster Pump; To bring feedstock into the machine at a set PSI

    1 Nitrogen Generator
    1 CFM Nitrogen Generator
    1 10 CFM Air Dryer
    1 Parker Filter
    1 Parker Autodrain
    1 Safety Equipment; Eye Wash Station
    1 LEL Meter Lower Explosive Limit Meter
    1 Safety Glasses
    1 First Aid Kit
    2 MSDS Binder
    3 Supplies Spill containment booms 15 ft., 8" Thick
    5 Shovels
    2 Brooms
    2 Mops
    2 Dry/Wet Vacuum
    1 Work Bench

    2 Construction and Installation; Epoxy Floor Up to 3500 square feet
    1 Erect and install tanks

    1 Feedstock Chemical Kit Wet Chemistry Kit to test for FFA Level 15
    Centrifuge to Test for Water and Sediment

"Mac is looking for a pro. This is not a light weight project and his pick would have to be one of the best in the Bio-Diesel production industry. The Denami 600 is arguably the most advanced Bio Diesel manufacturing system on the Globe because, it is able to produce Bio-Fuel from wet or dry feed stock based on the price of the futures markets, (soybean, corn, beef skin, poultry skin or pork skin and the price per gallon at the pump). I stay out of Mac's Office because, he is better at this than I am. He is running the program and he is the best at it," said Brian Sorrentino the CEO of Syndication Inc.

The CEO would like to remind and reinforce the shareholders of the pending RECORD DATE of the 2% dividend that is to be paid on all shares owned as of the record date 'October 19th 2009'. "The dividend policy of the Company is designed to increase equity valuation, enhance the potential for equity investment, discourage short trading activity and, most importantly, foster a longer term investor attitude. As the growth in valuation of the Company becomes realized the dividends will become a strong attraction to new shareholders," said Sorrentino. The Company indicates that additional announcements are pending.

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products, which we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets.

Contact Information: Syndication Inc, Brian Sorrentino Phone # 888-422-5515

For all mail correspondence: Box 503, Damascus, MD 20872

American DG Energy Inc. (OTC Bulletin Board: ADGE), a leading On-Site Utility offering clean electricity, heat, hot water and cooling solutions to hospitality, healthcare, housing and athletic facilities, announced that its installed base consists of 59 energy systems and has under construction an additional 13 systems under signed agreements. In addition, as announced on August 12, 2009, all twenty-seven Combined Heat and Power (CHP) energy projects, representing 38 energy systems, which the Company submitted for Federal stimulus funds through the American Recovery and Reinvestment Act of 2009, allocated for efficient energy projects under Funding Opportunity Announcement (FOA) DE-FOA-0000044, have passed the first stage in the selection process by being approved at the State level. The company has also sent over 100 proposals for new installations.

"In addition to our current successful activities, we are very excited about our future growth for 2010 and beyond," said John N. Hatsopoulos, CEO of American DG Energy. "The introduction and UL approval of the InVerde, inverter-based, 100-kilowatt CHP system for both base load and back-up generation and its integration with solar or other renewable energy sources make our energy systems very desirable, both in the United States and in Europe. With the InVerde system available, we will now pursue expansion of our company into Europe. Furthermore, our growth will be augmented by the creation of Ilios Dynamics Inc. that is developing a Hybrid Heat System based on a highly efficient natural gas heat pump."

About American DG Energy

American DG Energy supplies low-cost energy to its customers through distributed power generating systems. The Company is committed to providing institutional, commercial and small industrial facilities with clean, reliable power, cooling, heat and hot water at lower costs than charged by local utilities -- without any capital or start-up costs to the energy user. American DG Energy is headquartered in Waltham, Massachusetts. More information can be found at www.americandg.com.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements under the Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. Important factors could cause actual results to differ materially from those indicated by such forward-looking statements, as disclosed on the Company's website and in Securities and Exchange Commission filings. This press release does not constitute an offer to buy or sell securities by the Company, its subsidiaries or any associated party and is meant purely for informational purposes. The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

China Education Alliance, Inc. (NYSE Amex: CEU) announced today that it intends to offer, subject to market and other conditions, $17,391,304 of shares of its common stock. In connection with this offering, China Education will grant the underwriters an option to purchase an additional $2,608,696 of shares of common stock to cover any over-allotments.

China Education intends to use the proceeds from this offering to fund its operations and for general corporate purposes, such as additions to working capital, expansion of its business through internal growth or acquisitions, although it has no current commitments or agreements with respect to any such investments or acquisitions as of the date of this press release. Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (Nasdaq: RODM) will act as the sole book-running manager for the offering. The offering will be made under China Education's effective shelf registration statement previously filed with the Securities and Exchange Commission (the "SEC"). Prospective investors should read the preliminary prospectus supplement and the shelf registration statement for more complete information about China Education and the offering. Copies of the preliminary prospectus supplement and the accompanying prospectus and, when available, copies of the final prospectus supplement will be available on the SEC's website, http://www.sec.gov , and by contacting Rodman & Renshaw LLC, at 1251 Avenue of the Americas, 20th Floor, New York, NY 10020, or by telephone at (212) 430- 1710.

This news release does not constitute an offer to sell or solicitation of an offer to buy any security, nor will there be any sale of such security in any jurisdiction in which such offer, sale or solicitation would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The offering may be made only by means of a prospectus supplement and related base prospectus.

About the Company

China Education Alliance, Inc. (NYSE Amex: CEU) is a fast growing, leading China-based company offering high-quality education resources and services to students ages 6 to 18 and adults ages 18+ (University students and professionals). For students ages 6 to 18, China Education Alliance, Inc. offers supplemental, online exam-oriented training materials and on-site exam- oriented training and tutoring services. The company is providing on-line, downloadable, famous teachers resources and on-site face-to-face instructions. All resources and tutoring services are provided by famous teachers within mainland China. The purpose of online exam-orientated resources and on-site tutoring is to help Chinese students ages 6 to 18 to pass the two most important and highly competitive exams in their educational career: senior high school entrance exam and college entrance exam. For graduates and professionals age 18+, China Education Alliance provides vocational training including IT and several professional training programs. For more information about China Education Alliance, please visit http://www.chinaeducationalliance.com .

Forward-Looking Statements

This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected.

Among those risks, trends and uncertainties include, without limitation, its dependence on the PRC government's educational policies and programs, PRC rules and regulations in a planned economy, seasonality of business, dependence on senior officers to expand its business, ability to protect its intellectual property rights, inflation, success of acquisitions, the impact of price controls, the lack of sufficient business insurance, and fluctuations of exchange rates. In particular, careful consideration should be given to cautionary statements made in the various reports that China Education has filed with the SEC. China Education undertakes no duty to update or revise these forward-looking statements.

    For further information, please contact:

    Investor Relations:
     RedChip Companies, Inc.
     Dave Gentry, Investor Relations
     Tel:   +1-800-733-2447, x104
     Email: info@redchip.com
     Web:  http://www.RedChip.com

orycontent>

SAN MATEO, CA, Sept. 22 /PRNewswire-FirstCall/ - China Armco Metals, Inc. (OTC.BB:CNAM), a distributor of imported metal ore with plans to launch a new state of the art scrap metal recycling facility in China, today announced that Armco Metawise, Ltd. the Company's wholly owned subsidiary, has completed delivery of iron ore to a China based steel company pursuant to a contract that will generate sales of approximately $15.98 million in the third quarter of 2009.

Commenting on the contract, Mr. Kexuan Yao, CEO and Chairman of China Armco Metals, Inc., stated, "We are pleased to deliver larger sized orders to the steel industry as we look to build on the strong sales efforts we are making in the third quarter. We are carrying strong momentum into the busiest sales period of the year for our industry and remain very optimistic about our prospects for the remainder of this year and into 2010. We believe the environment for our customers remains strong and our anticipated metals recycling business launch places the company in a position to experience record performance in the coming years."

About China Armco Metals, Inc.

China Armco Metals, Inc. is engaged in the sale and distribution of metal ore and non-ferrous metals throughout the PRC and has entered the recycling business with the Company's acquisition of 22 acres of land for the construction and operation of a one million ton per year shredder and recycler of metals. The Company maintains customers throughout China which include the fastest growing steel producing mills and foundries in the PRC. Raw materials are supplied from global suppliers in India, Hong Kong, Nigeria, Brazil, Turkey, the Philippines and Libya. The Company's product lines include ferrous and non-ferrous ore; iron ore, chrome ore, nickel ore, copper ore, manganese ore and steel billet. Beginning in the fourth quarter 2009, the Company expects to begin operations in its steel recycling and scrap metal supply. The recycling facility is expected to be capable of recycling one million metric tons of scrap metal per year which will position the Company as one of the top 10 largest recyclers of scrap metal in China. ARMCO estimates the recycled metal market as 70 million metric tons.

Safe Harbor Statement

In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, China Armco Metals, Inc., is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as "will likely result," "are expected to," "will continue," "is anticipated," "estimated," "intends," "plans," "believes" and "projects") may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our guidance and expectations regarding revenues, net income and earnings.

We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. This press release is qualified in its entirety by the cautionary statements and risk factor disclosure contained in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the year ended December 31, 2008.

Anpath Group, Inc. (OTC Bulletin Board: ANPG), reported today that its wholly-owned subsidiary, EnviroSystems, Inc. (ESI) has made steady progress in the Japanese market through its collaboration and distribution agreement with Minntech Japan. Minntech Japan is a division of Minntech Corporation, ESI's manufacturing partner.

Anpath announced the Minntech Japan relationship in November 2008 and has since reported the joint strategy to penetrate the Japan healthcare market. Minntech Japan intends to expand its current dialysis focus and has plans to introduce EnviroTru(R) Disinfectant & Deodorizing Cleaner at several influential facilities and professional meetings during the near future. Mr. Mike Kitamura, Managing Director, Minntech Japan Corporation, provided examples of the expansion effort. "We are honored to present EnviroTru(R) to the Okinawa-Daiichi Hospital where EnviroTru(R) will be considered as a control agent for potential pandemic. In addition, EnviroTru(R) will be introduced and displayed at the Japanese Society of Blood Purification in Critical Care, the Japanese Society of Hemodiafiltration (HDF) Therapy meeting and the Kyushu Society of Hemodiafiltration (HDF) meeting."

J. Lloyd Breedlove, Anpath Group, Inc, President & CEO stated, "Our relationship with Minntech continues to be positive for our company on multiple levels. We are very pleased with the success to date in Japan. Mr. Kitamura and his staff continue to make good progress in what is a large progressive healthcare market in Japan."

EnviroTru(R) is a multi-purpose disinfectant, sanitizer and deodorizing cleaner effective against numerous organisms, including MRSA. EnviroTru(R) is registered by the Environmental Protection Agency (EPA) and meets requirements for Toxicity Category IV (minimal effects noted, no precautionary or first aid statements required; no harmful dermal, ocular, inhalation or ingestion effects), which is the lowest toxicity level available on the market today. EnviroTru(R) does not require protective clothing, gloves or special ventilation.

About Anpath Group, Incorporated:

Anpath Group, Inc. (Anpath), through its wholly-owned subsidiary EnviroSystems, Inc., produces cleaning and disinfecting products that it believes will help prevent the spread of infectious microorganisms while minimizing the harmful effects to people, equipment or the environment. Visit www.anpathgroup.com for more information.

EnviroSystems, Inc. is focused on safe infection prevention technologies that the company believes will position the company in the forefront of the industry at a time when there is rapidly growing awareness of the critical need to prevent biological risks -- both natural and man-made. Visit www.envirosi.com for more information.

Forward Looking Statements:

This release may contain forward-looking statements, which reflect expectation or belief by Anpath Group, Inc. concerning future events that involve risks and uncertainties. Anpath Group can give no assurance that the expectations reflected in forward looking statements will prove correct and various factors could cause results to differ materially from Anpath Group expectations, including, but not limited to U.S. EPA and state registration of Anpath Group's products, foreign registration of its products, its ability to carry out its business plan, successful development and commercial acceptance of its products, ability to fund development of its technology, the risk that products may not result from development activities, protection of its intellectual property, need for regulatory approvals, and other factors discussed in periodic Anpath Group, Inc. filings with the Securities and Exchange Commission. Forward-looking statements are qualified in their entirety by the above cautionary statement. Anpath Group assumes no duty to update its outlook or other forward-looking statements as of any future date.

Halberd Corporation (OTC: HALB), a Michigan-based management company, announced today it has entered into confidential discussions with a possible acquisition candidate.

Mark Lundquist, Halberd CEO states, "We have begun discussions with an acquisition candidate that fits very well within our corporate strategy and can build value for both of our companies."

Lundquist continues, "Halberd Corporation is focused on building its core structure within the business and media products and services. We want to create a strong value for our shareholders by organically growing our launch entity, SellMyBusiness.com(R), and by making strategic acquisitions of high margin businesses that can grow our revenue and assets.

About Halberd Corporation

Halberd Corporation (OTC: HALB) is a management company focused on shareholder value, asset development and long term strength in the marketplace through the development of specific business units and the creation and acquisition of high margin business-related products and services. Halberd Corporation is a Nevada public corporation headquartered in Southeastern Michigan and is the parent company of SellMyBusinessNow.com. For more information, visit www.halberdcorp.com

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Except for historical information, the forward-looking matters discussed in this news release are subject to certain risks and uncertainties which could cause the Company's actual results and financial condition to differ materially from those anticipated by the forward-looking statements. For a complete Safe Harbor Statement visit www.halberdcorp.com.

Environmental Tectonics Corporation's (OTC Bulletin Board: ETCC) ("ETC" or the "Company") BioMedical Systems today announced the sale of an additional BARA-MED((R)) XD Monoplace Hyperbaric Chamber to Comprehensive Healthcare Solutions, Inc.

Comprehensive Healthcare Solutions is a growing company who focuses solely on initiating and operating wound healing institutes throughout the United States. This sale represents the ongoing commitment that Comprehensive Healthcare Solutions has with ETC chambers. They have purchased directly a total of six (6) BARA-MED((R)) XD chambers and additionally have recommended ETC's chambers to other hospitals which has generated additional sales.

Mario Caruso, CHT, DMT-A, Technical Director, Hyperbaric Services for Comprehensive Healthcare Solutions, remarked, "We strive to be at the cutting edge of advances in wound care and hyperbaric medicine. ETC's BARA-MED((R)) XD monoplace chamber's advanced component features such as computer control, programmable curvilinear descent, and more, make it the hyperbaric chamber of choice for us."

ETC is the manufacturer of a 4th generation, time-honored computerized monoplace hyperbaric chamber. The BARA-MED((R)) XD includes ETC's automated chamber Operating System for Control And Recordkeeping (O.S.C.A.R.(TM)).

O.S.C.A.R.(TM) produces a comprehensive documentation of the treatment, thereby diminishing the need for operator dive time management and paper recordkeeping. These features enable technicians to focus their attention on patient care and management.

We are proud to be the manufacturer of the industry's most technically advanced hyperbaric chamber. ETC chambers remain the leader in providing a patient friendly pressurization alternative (Smooth Ride(TM)) that minimizes complications due to middle ear and sinus barotraumas without increasing compression time.

Dave Mitchell, Vice President of ETC's Control Systems Group, commented, "We are very satisfied to continue our long-standing relationship with Comprehensive Healthcare Solutions. We appreciate their continued confidence in our ability to deliver a world-class system."

ETC was incorporated in 1969 in Pennsylvania and this year we will celebrate our 40(th) anniversary. Our core technologies include the design, manufacture and sale of Training Services (TSG) which includes (1) software driven products and services used to create and monitor the physiological effects of flight; (2) high performance jet tactical flight simulation, and; (3) driving and disaster simulation systems, and Control Systems (CSG) which includes: (1) steam and gas sterilization; (2) testing and simulation devices for the automotive industry, and; (3) hyperbaric and hypobaric chambers. Product categories included in TSG are Aircrew Training Systems (ATS) and flight simulators, disaster management systems and entertainment applications. CSG includes sterilizers, environmental control devices and hyperbaric chambers along with parts and service support.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on ETC's current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about ETC and its subsidiaries that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

These forward-looking statements include statements with respect to the Company's vision, mission, strategies, goals, beliefs, plans, objectives, expectations, anticipations, estimates, intentions, financial condition, results of operations, future performance and business of the company, including but not limited to, (i) potential additional funding by H.F. Lenfest, a member of our Board of Directors and a significant shareholder, and PNC Bank, (ii) the trading of the Company's common stock on the Over-the-Counter Bulletin Board (iii) projections of revenues, costs of materials, income or loss, earnings or loss per share, capital expenditures, growth prospects, dividends, capital structure, other financial items and the effects of currency fluctuations, (iv) statements of our plans and objectives of the Company or its management or Board of Directors, including the introduction of new products, or estimates or predictions of actions of customers, suppliers, competitors or regulatory authorities, (v) statements of future economic performance, (vi) statements of assumptions and other statements about the Company or its business, (vii) statements made about the possible outcomes of litigation involving the Company, (viii) statements regarding the Company's ability to obtain financing to support its operations and other expenses, and (ix) statements preceded by, followed by or that include the words, "may," "could," "should," "looking forward," "would," "believe," "expect," "anticipate," "estimate," "intend," "plan," or the negative of such terms or similar expressions. These forward-looking statements involve risks and uncertainties which are subject to change based on various important factors. Some of these risks and uncertainties, in whole or in part, are beyond the Company's control. Factors that might cause or contribute to such a material difference include, but are not limited to, those discussed in the Company's Annual Report on Form 10K for the fiscal year ended February 27, 2009, in the section entitled "Risks Particular to Our Business." Shareholders are urged to review these risks carefully prior to making an investment in the Company's common stock.

The Company cautions that the foregoing list of important factors is not exclusive. Except as required by federal securities law, the Company does not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by or on behalf of the Company.

    Contact: Duane D. Deaner, CFO
    Tel: 215-355-9100 (ext. 1203)
    Fax: 215-357-4000
    ETC - Internet Home Page: http://www.etcusa.com

Emissary Capital Group, Inc. has initiated investment research coverage on Sinobiopharma, Inc. (OTC Bulletin Board: SNBP) with a Buy rating and target price of $1.00-$1.25. Jiangsu, China-based SNBP, known domestically as Dong Ying Pharmaceutical Co. Ltd., is a fully integrated and high growth company engaged in the R&D, manufacture and distribution of biopharmaceutical products. The company focuses primarily on the development of anesthesia-assisted agents as well as antibiotics for penicillin-allergic patients and cardiovascular-related products related to high blood pressure (commercial in October 2009). KuTai, SNBP's flagship product is a first-to-market Cisatracurium Besylate injectable that serves as a low cost skeletal muscle relaxant used during pre-surgical and surgical procedures. The company holds five patents in Chiral Pharmaceutical Ingredient Synthesis and Purification, and Molecular Packaging Formulation (see proprietary technology section) and has the longer-term ability to expand both the breadth of its product line and market share through R&D partnerships with Cornell University, Nanjing University, China Pharmaceutical University, and Nanjing Medical University.

About Emissary Capital Group

Emissary Capital Group, Inc. is a New York City-based company that provides strategic consulting and research services to emerging growth companies primarily based in India and China. The firm provides a diversified array of services to small and medium sized private companies, generally defined as those with annual revenues under $200 million, in order to assist them to become publicly traded companies in the U.S. For more information, please visit www.emissarycapital.com

    Contact:
    Albert Lee
    Emissary Capital Group, LLC
    1-212-297-6218

The Beard Company (OTC Bulletin Board: BRCO) today announced that Geohedral LLC, a private company in which Beard has a 23.16% equity interest, has expanded its holdings of mining claims in the Yakutat Forelands district of southeastern Alaska to encompass 521 new claims (10,420 acres). The additional claims are located in the Tanis Mesa area and are contiguous to the 48,000-acre block that Geohedral staked and claimed last year (the "BlackSands Area").

Dr. P. Jan Cannon, Manager and President of Geohedral, reported: "At least 400 of the new claims are considered to be potential 'pay dirt,' and are underlain with an unconsolidated placer deposit that averages more than six feet in thickness and may average more than 12 feet in thickness. Thirty holes were dug or drilled across a widely spaced grid of points, with a spacing of one-half mile, across the central part of the staked area. Depth of the holes ranged from 2.5 feet to 27.1 feet below the surface. The 171 samples from these holes were assayed for gold, silver, platinum and palladium."

"An additional 30 shallow holes, mostly three to six feet in depth, were dug with a closer spacing of points in two selected parts of the widely spaced grid north and south of Tanis Mesa. These holes produced an additional 71 samples that were also assayed for gold, silver, platinum and palladium. Ten samples from the 30 holes were assayed for a suite of 14 elements. They provided a test of the previous assay values and an indication of the larger potential of the placer material."

"Two slim core holes were drilled on the south side of Tanis Mesa, one to 12.0 feet and the other to 50.3 feet, that produced 91 samples. All of the 353 samples were acquired, processed and assayed under strict chain-of-custody procedures."

"Preliminary evaluation of the assays indicates that the unconsolidated materials above the bedrock in the Tanis Mesa area contain appreciable amounts of gold and silver, averaging 0.30 oz/ton of gold and 0.75 oz/ton of silver. The 400 claims of primary interest are projected to produce 34,800,000 troy ounces of gold. In our opinion, we have a 'world class' discovery," Dr. Cannon concluded.

Herb Mee, Jr., Beard's President, added: "To put things into perspective, ENGINEERING AND MINING JOURNAL, a leading industry publication, defines a significant gold discovery as one 'containing at least 2 million oz. of gold in total reserves and resources.' So you can see why we are extremely excited about this new development."(A)

"Geohedral is already contacting certain major players in the mining industry to determine whether they would be interested in becoming Geohedral's partner in the Tanis Mesa area. Some preliminary contacts have been made, and two parties have already expressed interest in obtaining additional information. Our goal is to sell a portion of Tanis Mesa to an industry partner, generating a meaningful return on our investment, while leaving Geohedral with sufficient funds to participate in the mining of Tanis Mesa and pursue further development of the BlackSands Area."

"We feel that Geohedral has a unique property to present to potential industry partners. Tanis Mesa is distinctive because of its location on the Gulf of Alaska, its temperate climate, its proximity to markets and ocean transportation, its abundance of water, and the fact that the unconsolidated materials above the bedrock can be extracted by low-cost dredging with minimal environmental impact. The placer material can be recovered without the costly blasting, shoveling, crushing, removal, handling and disposal costs that more expensive hard rock mines are faced with. We believe that operating costs to recover the material at Tanis Mesa will be among the lowest in the mining industry."

(A) See Engineering and MINING JOURNAL, JULY/AUGUST 2009 ISSUE, Page 6.

About The Beard Company

The Beard Company creates, acquires, and/or invests in businesses, primarily related to natural resources, that management believes have high growth and/or above-average profit potential and can enhance shareholder value. The Company is involved in oil and gas activities; coal reclamation activities; and minerals exploration and development through its Geohedral investment.

The Company is headquartered in Oklahoma City and its common stock trades on the OTC Bulletin Board under the symbol "BRCO".

Forward-Looking Statements

This document may include statements that constitute "forward-looking" statements, usually containing the words "believe", "estimate", "project", "expect", "anticipate", or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the ability to negotiate and execute contracts in connection with the Company's coal reclamation activities; future trends in commodities prices; financial, geological or mechanical difficulties affecting Geohedral's or Beard Dilworth's planned geological work programs; uncertainties surrounding estimates of mineralized material; and other risks associated with the Company's business. By making these forward-looking statements, Beard undertakes no obligation to update these statements for revisions or changes in the future.

                    For Additional Information, Please Contact:

                  Herb Mee, Jr., President, at (405) 842-2333 or
                           via email at hmee@beardco.com

                                        or

     RJ Falkner & Company, Inc., Investor Relations Counsel, at (800) 377-9893
                        or via email at info@rjfalkner.com

ActionView International, Inc. (Pink Sheets: AVEW) and its wholly owned MatchFights, LLC subsidiary today announced that fans of MatchFights should follow the company on Twitter. ActionView Director Tony "The Tiger" Lopez, a 3-time world boxing champion, will provide updates on his activities related to Action and MatchFights on his Twitter account, which can be found under the name "1boxer63." MatchFights also has a Twitter account, which can be found under the name "preacherBKB."

Mr. Lopez, who, along with his role as director of ActionView International, is actively involved in the promotion and marketing of MatchFights events, including the premier September 25, 2009 broadcast, has already begun encouraging followers of his Twitter account to visit the event website, www.bkbfightclub.com and register to view the first fight. The first live event, which will be delivered in an interactive venue over the Internet to a global audience, will feature fourteen fighters from a broad fight background including MMA, Muy Thai, boxing and street fighting.

"Twitter and other social networking sites are just one part of MatchFights' comprehensive marketing and promotional strategy," commented Gary Nerison, chairman of ActionView International. "As we grow the brand, there should be no marketing channel that we will not utilize, including print, radio and television. Our core demographic is the fight fan, but there are countless ways to reach that audience as well as other sports fans who are not interested in the more traditional boxing or MMA products, but who will be drawn in by the unique elements of MatchFights events, including contrasting styles of the fighters and the interactive features of our live broadcasts."

Mr. Lopez said, "Having been at the world championship level of professional boxing as a fighter and now as a fight promoter, I understand the importance of effective promotion. I plan to use every appropriate resource at my disposal to bring attention to MatchFights events, and I hope anyone interested in the company or our events will follow my Twitter postings. They will range from updates on the pre-fight planning, updates on the event as they unfold and my thoughts after each event is concluded.

Fight fans interested in watching the MatchFights event live via the Internet can pre-register for $9.95 at www.bkbfightclub.com. Tickets for the event are available by contacting www.bkbfightclub.com and through several local retailers in Evanston. The pre-fight weigh in will be at 12:30 local time on September 25, 2009 at Suds Brothers Brewery located at 1012 Main Street in Evanston.

For this inaugural MatchFights event, all subscribers have their names entered into a drawing, and winners will receive a year of free subscriptions to MatchFights pay-per-view events. MatchFights is planning to hold its events approximately every 45 days, so winners will receive free pay-per-view subscriptions to 8 additional events throughout the year.

The company encourages shareholders and anyone interested in following the progress of ActionView International and its wholly owned MatchFights, LLC subsidiary to subscribe to the mailing list at www.matchfights.com.

About ActionView International, Inc.

ActionView International has completed its acquisition of MatchFights, LLC, which is now the focus of the company's operations. MatchFights, LLC and its BKB Fight Club property deliver live, high definition, pay-per-view events, including no-holds-barred, full contact fights, in an interactive venue over the Internet to a global audience. MatchFights intends to sanction events and ultimately create BKB champions that are recognized worldwide. The live events will have broad appeal and include elements of fighting, music, ring girl contests, and other live entertainment as part of the broadcast. The premier BKB Fight Club event will take place on September 25, 2009. For additional information about MatchFights and its BKB Fight Club, please visit www.matchfights.com or www.bkbfightclub.com.

Forward-Looking Statements

This release contains 'forward-looking statements' within the meaning of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be 'forward-looking statements.' Forward-looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated.

    Contact:
    ActionView International, Inc.
    Investor Relations
    951-200-4107
    media@matchfights.com

The Board of Directors of Farmers & Merchants Bancorp, Inc., (OTC Bulletin Board: FMAO) the holding company of The Farmers & Merchants State Bank, with assets of approximately $800 million, at their last regular meeting on Friday, September 18, 2009 declared a third quarter dividend of eighteen cents ($.18) per share. The third quarter dividend is payable on October 20, 2009 to shareholders of record as of September 18, 2009.

The Farmers & Merchants State Bank is a locally owned and operated community bank that has been serving Northwest Ohio and Northeast Indiana since 1897. The Farmers & Merchants State Bank provides commercial banking, retail banking and other financial services through its 18 office locations in Fulton, Defiance, Henry, Williams, Lucas, and Wood counties of Northwest Ohio. In Northeast Indiana they have offices located in DeKalb and Steuben counties.

SAFE HARBOR STATEMENT

Farmers & Merchants Bancorp, Inc. ("F&M") wishes to take advantage of the Safe Harbor provisions included in the Private Securities Litigation Reform Act of 1995. Statements by F&M, including management's expectations and comments, may not be based on historical facts and are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21B of the Securities Act of 1934, as amended. Actual results could vary materially depending on risks and uncertainties inherent in general and local banking conditions, competitive factors specific to markets in which F&M and its subsidiaries operate, future interest rate levels, legislative and regulatory decisions or capital market conditions. F&M assumes no responsibility to update this information. For more details, please refer to F&M's SEC filing, including its most recent Annual Report on Form 10-K and quarterly reports on Form 10-Q. Such filings can be viewed at the SEC's website, www.sec.gov.

Tidelands Royalty Trust "B" (OTC Bulletin Board: TIRTZ) ("Tidelands"), today declared a quarterly cash distribution to the holders of its units of beneficial interest of $0.409457 per unit, payable on October 15, 2009, to unitholders of record on September 30, 2009. Tidelands' cash distribution history, current and prior year financial reports, a link to filings made with the Securities and Exchange Commission and more can be found on its website at http://www.tirtz-tidelandsroyaltytrust.com/.

The distribution this quarter decreased to $0.409457 this quarter from $0.550126 last quarter, a 26% reduction. Royalties received are down primarily due to lower prices realized for both oil and natural gas and a decrease in production. The price received for oil this quarter was up 36% from the previous quarter, and the price received for natural gas this quarter was down 26% from the previous quarter. Production of oil and natural gas also decreased (mcf equivalent) 3% this quarter from the previous quarter. Further analysis of this distribution may be found in the September 30, 2009 Form 10-Q filing with the Securities and Exchange Commission on or about November 16, 2009.

Tidelands' distributions to unitholders are determined by royalties received up to the date the distribution amount is declared. In general, Tidelands receives royalties two months after oil production and three months after natural gas production. This quarterly distribution is based on production in March, April, May and June of 2009.

    Contact:  Ron E. Hooper
              Senior Vice President
              U.S. Trust, Bank of America Private Wealth Management
              Toll Free - 1.800.985.0794

Pilgrim's Pride Corporation (Pink Sheets: PGPDQ) and six of its subsidiaries that are debtors and debtors in possession in the chapter 11 cases pending in the United States Bankruptcy Court for the Northern District of Texas today announced they have filed a joint plan of reorganization and disclosure statement under chapter 11 of the Bankruptcy Code.

As previously announced, Pilgrim's Pride and JBS have agreed to a transaction representing an enterprise value of approximately $2.8 billion. Under the terms of the plan of reorganization, Pilgrim's Pride has entered into an agreement to sell 64% of the new common stock of the reorganized Pilgrim's Pride to JBS S.A., through its JBS USA Holdings, Inc. subsidiary (JBS U.S.A.), for $800 million in cash.

Proceeds from the sale of the new common stock of the reorganized Pilgrim's Pride to JBS will be used to fund cash distributions to allowed claims under the plan. Under the terms of the plan, all creditors of the Debtors holding allowed claims will be paid in full. All existing Pilgrim's Pride common stock will be cancelled and existing stockholders will receive the same number of new common stock shares, representing 36% of the reorganized Pilgrim's Pride in aggregate. The plan also calls for an exit facility for senior secured financing in an aggregate principal amount of at least $1.65 billion.

The disclosure statement hearing is currently scheduled to take place on October 20, 2009, at 10:30 a.m. CT before the Bankruptcy Court. If the Bankruptcy Court determines that the proposed disclosure statement provides adequate information to vote on the plan, then the proposed disclosure statement and plan, along with the appropriate ballots, will be sent to shareholders to vote on the plan. Since the proposed plan of reorganization represents a "100% plan," with creditors being repaid in full, shareholders represent the only impaired class and will be the only group entitled to vote on the plan of reorganization.

Information about Pilgrim's Pride's restructuring is available at Pilgrim's Pride's website www.pilgrimspride.com or via Pilgrim's Pride's restructuring information line at (888) 830-4659.

This release is not intended to be, and should not in any way be construed as, a solicitation of votes on the plan. The information contained in the proposed disclosure statement should not be relied on for any purpose until a determination by the Bankruptcy Court is made that the proposed disclosure statement contains adequate information.

As previously announced, the Debtors filed voluntary Chapter 11 petitions on December 1, 2008. The Chapter 11 cases are being jointly administered under case number 08-45664. The Company's operations in Mexico and certain operations in the United States were not included in the filing and continue to operate as usual outside of the Chapter 11 process.

About Pilgrim's Pride

Pilgrim's Pride Corporation employs approximately 41,000 people and operates chicken processing plants and prepared-foods facilities in 12 states, Puerto Rico and Mexico. The Company's primary distribution is through retailers and foodservice distributors. For more information, please visit http://www.pilgrimspride.com.

Forward-Looking Statements

Statements contained in this press release that state the intentions, plans, hopes, beliefs, anticipations, expectations or predictions of the future of Pilgrim's Pride Corporation and its management, including expectations as to the Debtors' emergence from Chapter 11, reorganization of the Debtors' business and finances to resolve its operational and liquidity issues, expectations to emerge from Chapter 11 by December 2009 stronger and more competitive, anticipated authorizations being requested of the Bankruptcy Court, the liquidity to be provided by the proposed exit financing, and expectations that the plan should be supported by the Debtors' major constituencies, are forward-looking statements. It is important to note that the actual results could differ materially from those projected in such forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking statements include: the Debtors' ability to obtain court approval with respect to its motions in the Chapter 11 proceedings and the disclosure statement; the ability of the Debtors to obtain confirmation of, and consummate, the Plan; risks associated with third- party motions or objections in the Chapter 11 proceedings, which may interfere with the Company's ability to obtain confirmation of, and consummate, the Plan; the potential adverse effects of the Chapter 11 proceedings on the Debtors' liquidity or results of operations; matters affecting the poultry industry generally; continued compliance with conditions for funding under the debtor-in-possession financing facility and the proposed exit financing; the ability to execute the Debtors' business and restructuring plan to achieve desired cost savings and additional capital to improve liquidity; future pricing for feed ingredients and the Debtors' products; additional outbreaks of avian influenza or other diseases, either in Pilgrim's Pride's flocks or elsewhere, affecting its ability to conduct its operations and/or demand for its poultry products; contamination of Pilgrim's Pride's products, which has previously and can in the future lead to product liability claims and product recalls; exposure to risks related to product liability, product recalls, property damage and injuries to persons, for which insurance coverage is expensive, limited and potentially inadequate; management of cash resources, particularly in light of Pilgrim's Pride's substantial leverage; restrictions imposed by, and as a result of, Pilgrim's Pride's substantial leverage; changes in laws or regulations affecting Pilgrim's Pride's operations or the application thereof; new immigration legislation or increased enforcement efforts in connection with existing immigration legislation that cause the costs of doing business to increase, cause Pilgrim's Pride to change the way in which it does business, or otherwise disrupt its operations; competitive factors and pricing pressures or the loss of one or more of Pilgrim's Pride's largest customers; currency exchange rate fluctuations, trade barriers, exchange controls, expropriation and other risks associated with foreign operations; disruptions in international markets and distribution channels; and the impact of uncertainties of litigation as well as other risks described under "Risk Factors" in the Company's Annual Report on Form 10-K and subsequent filings with the Securities and Exchange Commission. Pilgrim's Pride Corporation undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

    Media Contact:     Ray Atkinson, Pilgrim's Pride
                       (903) 434-1811

    Investor Contact:  Gary Rhodes, Pilgrim's Pride
                       (903) 434-1495

International Isotopes Inc. (OTC Bulletin Board: INIS) announces the successful conclusion of a private placement completed among numerous directors, past investors and major shareholders.

International Isotopes Inc. successfully completed a private placement with certain shareholders on September 18, 2009 for just under $1 million. In this private placement, the Company offered approximately 4 million Units, each Unit consisting of one share of common stock, priced at $0.30 per common share, and one warrant to purchase another share of common stock for $.40. In a related transaction the Company also converted approximately $380,000 of indebtedness owed to a past Chairman of the Board of the Company into units under terms similar to the private placement. All of the issued shares will be unregistered securities. The offering was entirely led by the Company, and there were no selling commissions or fees paid by the Company, other than standard legal expenses for document preparation.

The net proceeds from the private placement will be used to support ongoing engineering design and license application preparation efforts for the Company's planned uranium processing and fluorine extraction facility. The planned facility remains on schedule with the next anticipated major milestone of submitting its license application to the Nuclear Regulatory Commission later this year.

Steve T. Laflin, Chief Executive Officer stated, "We are very pleased with the level and amount of participation of our shareholders in the private placement. We are also satisfied with the continued progress of the engineering design and license application work. The funding from this private placement will see the project through license submittal later this year and efforts are already well underway for the next major round of financing to continue project development well into the future. While there can be no guarantee additional capital will be available, or available under acceptable terms, the Company is currently evaluating several paths for the next financing.

"In parallel with these fundraising efforts, the Company reports continued progress towards putting contract agreements in place with prospective customers for the products and services this project will provide."

About International Isotopes Inc.

International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards, high purity fluoride gases, and a variety of cobalt-60 products such as teletherapy sources. The Company also provides a wide selection of radioisotopes and radiochemical for medical devices, calibration, clinical research, life sciences, and industrial applications and provides a host of analytical, measurement, recycling, and processing services on a contract basis to clients.

International Isotopes Inc. Safe Harbor Statement

Certain statements in this press release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including the statements with respect to the Company's goals with respect to constructing a depleted uranium de-conversion processing and fluorine extraction facility and specifically including statements regarding the licensing schedule, financing the project to the next stage of funding, the availability of additional capital, and contracting with prospective customers. Information contained in such forward-looking statements is based on current expectations and is subject to change. These statements involve a number of risks, uncertainties and other factors that could cause actual results, performance or achievements of International Isotopes Inc. to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Other factors, which could materially affect such forward-looking statements, can be found in International Isotopes Inc.'s filings with the Securities and Exchange Commission at www.sec.gov, including our annual report on Form 10-KSB for the year ending December 31, 2008. Investors, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. Additional factors that could materially affect the results, performance or achievements of the Company include the ability to successfully obtain additional funding necessary to complete its planned de-conversion facility and complete construction and licensing of such facility, which may not occur. Achievement by the Company of the project is substantially dependent on success in securing off-take agreements with commercial enrichment companies for depleted uranium hexafluoride for de-conversion services and supply of the raw material for the production of high quality fluoride gasses. The forward-looking statements made herein are only made as of the date of this press release and International Isotopes, Inc. undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

For more information, visit our web site at www.intisoid.com

    For More Information, Contact:
    Steve Laflin, President and CEO
    (208) 524-5300

Pilgrim's Pride Corporation (Pink Sheets: PGPDQ) and six of its subsidiaries that are debtors and debtors in possession in the chapter 11 cases pending in the United States Bankruptcy Court for the Northern District of Texas today announced they have filed a joint plan of reorganization and disclosure statement under chapter 11 of the Bankruptcy Code.

As previously announced, Pilgrim's Pride and JBS have agreed to a transaction representing an enterprise value of approximately $2.8 billion. Under the terms of the plan of reorganization, Pilgrim's Pride has entered into an agreement to sell 64% of the new common stock of the reorganized Pilgrim's Pride to JBS S.A., through its JBS USA Holdings, Inc. subsidiary (JBS U.S.A.), for $800 million in cash.

Proceeds from the sale of the new common stock of the reorganized Pilgrim's Pride to JBS will be used to fund cash distributions to allowed claims under the plan. Under the terms of the plan, all creditors of the Debtors holding allowed claims will be paid in full. All existing Pilgrim's Pride common stock will be cancelled and existing stockholders will receive the same number of new common stock shares, representing 36% of the reorganized Pilgrim's Pride in aggregate. The plan also calls for an exit facility for senior secured financing in an aggregate principal amount of at least $1.65 billion.

The disclosure statement hearing is currently scheduled to take place on October 20, 2009, at 10:30 a.m. CT before the Bankruptcy Court. If the Bankruptcy Court determines that the proposed disclosure statement provides adequate information to vote on the plan, then the proposed disclosure statement and plan, along with the appropriate ballots, will be sent to shareholders to vote on the plan. Since the proposed plan of reorganization represents a "100% plan," with creditors being repaid in full, shareholders represent the only impaired class and will be the only group entitled to vote on the plan of reorganization.

Information about Pilgrim's Pride's restructuring is available at Pilgrim's Pride's website www.pilgrimspride.com or via Pilgrim's Pride's restructuring information line at (888) 830-4659.

This release is not intended to be, and should not in any way be construed as, a solicitation of votes on the plan. The information contained in the proposed disclosure statement should not be relied on for any purpose until a determination by the Bankruptcy Court is made that the proposed disclosure statement contains adequate information.

As previously announced, the Debtors filed voluntary Chapter 11 petitions on December 1, 2008. The Chapter 11 cases are being jointly administered under case number 08-45664. The Company's operations in Mexico and certain operations in the United States were not included in the filing and continue to operate as usual outside of the Chapter 11 process.

About Pilgrim's Pride

Pilgrim's Pride Corporation employs approximately 41,000 people and operates chicken processing plants and prepared-foods facilities in 12 states, Puerto Rico and Mexico. The Company's primary distribution is through retailers and foodservice distributors. For more information, please visit http://www.pilgrimspride.com.

Forward-Looking Statements

Statements contained in this press release that state the intentions, plans, hopes, beliefs, anticipations, expectations or predictions of the future of Pilgrim's Pride Corporation and its management, including expectations as to the Debtors' emergence from Chapter 11, reorganization of the Debtors' business and finances to resolve its operational and liquidity issues, expectations to emerge from Chapter 11 by December 2009 stronger and more competitive, anticipated authorizations being requested of the Bankruptcy Court, the liquidity to be provided by the proposed exit financing, and expectations that the plan should be supported by the Debtors' major constituencies, are forward-looking statements. It is important to note that the actual results could differ materially from those projected in such forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking statements include: the Debtors' ability to obtain court approval with respect to its motions in the Chapter 11 proceedings and the disclosure statement; the ability of the Debtors to obtain confirmation of, and consummate, the Plan; risks associated with third- party motions or objections in the Chapter 11 proceedings, which may interfere with the Company's ability to obtain confirmation of, and consummate, the Plan; the potential adverse effects of the Chapter 11 proceedings on the Debtors' liquidity or results of operations; matters affecting the poultry industry generally; continued compliance with conditions for funding under the debtor-in-possession financing facility and the proposed exit financing; the ability to execute the Debtors' business and restructuring plan to achieve desired cost savings and additional capital to improve liquidity; future pricing for feed ingredients and the Debtors' products; additional outbreaks of avian influenza or other diseases, either in Pilgrim's Pride's flocks or elsewhere, affecting its ability to conduct its operations and/or demand for its poultry products; contamination of Pilgrim's Pride's products, which has previously and can in the future lead to product liability claims and product recalls; exposure to risks related to product liability, product recalls, property damage and injuries to persons, for which insurance coverage is expensive, limited and potentially inadequate; management of cash resources, particularly in light of Pilgrim's Pride's substantial leverage; restrictions imposed by, and as a result of, Pilgrim's Pride's substantial leverage; changes in laws or regulations affecting Pilgrim's Pride's operations or the application thereof; new immigration legislation or increased enforcement efforts in connection with existing immigration legislation that cause the costs of doing business to increase, cause Pilgrim's Pride to change the way in which it does business, or otherwise disrupt its operations; competitive factors and pricing pressures or the loss of one or more of Pilgrim's Pride's largest customers; currency exchange rate fluctuations, trade barriers, exchange controls, expropriation and other risks associated with foreign operations; disruptions in international markets and distribution channels; and the impact of uncertainties of litigation as well as other risks described under "Risk Factors" in the Company's Annual Report on Form 10-K and subsequent filings with the Securities and Exchange Commission. Pilgrim's Pride Corporation undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

    Media Contact:     Ray Atkinson, Pilgrim's Pride
                       (903) 434-1811

    Investor Contact:  Gary Rhodes, Pilgrim's Pride
                       (903) 434-1495

ActionView International, Inc. (Pink Sheets: AVEW) and its wholly owned MatchFights, LLC subsidiary today announced that fans of MatchFights should follow the company on Twitter. ActionView Director Tony "The Tiger" Lopez, a 3-time world boxing champion, will provide updates on his activities related to Action and MatchFights on his Twitter account, which can be found under the name "1boxer63." MatchFights also has a Twitter account, which can be found under the name "preacherBKB."

Mr. Lopez, who, along with his role as director of ActionView International, is actively involved in the promotion and marketing of MatchFights events, including the premier September 25, 2009 broadcast, has already begun encouraging followers of his Twitter account to visit the event website, www.bkbfightclub.com and register to view the first fight. The first live event, which will be delivered in an interactive venue over the Internet to a global audience, will feature fourteen fighters from a broad fight background including MMA, Muy Thai, boxing and street fighting.

"Twitter and other social networking sites are just one part of MatchFights' comprehensive marketing and promotional strategy," commented Gary Nerison, chairman of ActionView International. "As we grow the brand, there should be no marketing channel that we will not utilize, including print, radio and television. Our core demographic is the fight fan, but there are countless ways to reach that audience as well as other sports fans who are not interested in the more traditional boxing or MMA products, but who will be drawn in by the unique elements of MatchFights events, including contrasting styles of the fighters and the interactive features of our live broadcasts."

Mr. Lopez said, "Having been at the world championship level of professional boxing as a fighter and now as a fight promoter, I understand the importance of effective promotion. I plan to use every appropriate resource at my disposal to bring attention to MatchFights events, and I hope anyone interested in the company or our events will follow my Twitter postings. They will range from updates on the pre-fight planning, updates on the event as they unfold and my thoughts after each event is concluded.

Fight fans interested in watching the MatchFights event live via the Internet can pre-register for $9.95 at www.bkbfightclub.com. Tickets for the event are available by contacting www.bkbfightclub.com and through several local retailers in Evanston. The pre-fight weigh in will be at 12:30 local time on September 25, 2009 at Suds Brothers Brewery located at 1012 Main Street in Evanston.

For this inaugural MatchFights event, all subscribers have their names entered into a drawing, and winners will receive a year of free subscriptions to MatchFights pay-per-view events. MatchFights is planning to hold its events approximately every 45 days, so winners will receive free pay-per-view subscriptions to 8 additional events throughout the year.

The company encourages shareholders and anyone interested in following the progress of ActionView International and its wholly owned MatchFights, LLC subsidiary to subscribe to the mailing list at www.matchfights.com.

About ActionView International, Inc.

ActionView International has completed its acquisition of MatchFights, LLC, which is now the focus of the company's operations. MatchFights, LLC and its BKB Fight Club property deliver live, high definition, pay-per-view events, including no-holds-barred, full contact fights, in an interactive venue over the Internet to a global audience. MatchFights intends to sanction events and ultimately create BKB champions that are recognized worldwide. The live events will have broad appeal and include elements of fighting, music, ring girl contests, and other live entertainment as part of the broadcast. The premier BKB Fight Club event will take place on September 25, 2009. For additional information about MatchFights and its BKB Fight Club, please visit www.matchfights.com or www.bkbfightclub.com.

Forward-Looking Statements

This release contains 'forward-looking statements' within the meaning of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be 'forward-looking statements.' Forward-looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated.

    Contact:
    ActionView International, Inc.
    Investor Relations
    951-200-4107
    media@matchfights.com

orycontent>

Trading on NASDAQ will begin on September 21, 2009 under the symbol "CAGC"

BEIJING, Sept. 18 /PRNewswire-Asia-FirstCall/ China Agritech, Inc. (OTC Bulletin Board: CTEC) ("China Agritech", or the "Company"), a leading national organic fertilizer manufacturer and distributor in China, today announced that it has received approval for listing on the NASDAQ Global Market.

The Company's common stock will begin trading on the NASDAQ Global Market on September 21, 2009 under the symbol "CAGC." Until that time, the Company's shares will continue to trade on the OTC Bulletin Board under the symbol "CTEC."

"We are proud to be listing on the NASDAQ Global Market, which highlights our commitment to meeting the stringent requirements of a senior exchange in the U.S.," said Mr. Yu Chang, Chairman and Chief Executive Officer of China Agritech, "We have made significant progress in achieving our strategic plan to further build the Company with additional geographically diversified production capacity for our new organic granular products, our expanded marketing and sales network, and innovative new fertilizer products based on our proprietary technologies. We believe trading on NASDAQ is another significant milestone in our corporate history as we are joining other top-tier companies on the NASDAQ and raising our visibility within the investment community, which should enhance our stock's marketability especially among institutional investors, to broaden our shareholder base and build value for our shareholders."

About China Agritech, Inc.

China Agritech, Inc. is engaged in the development, manufacture and distribution of liquid and granular organic compound fertilizers and related products in China. The Company has developed proprietary formulas that provide a continuous supply of high-quality agricultural products while maintaining soil fertility. The Company sells its products to farmers located in 28 provinces of China.

For more information about the Company, please visit http://www.chinaagritechinc.com .

Safe Harbor Statement

This release may contain certain "forward-looking statements" relating to the business of China Agritech and its subsidiary companies, which can be identified by the use of forward-looking terminology such as "believes," "expects," "anticipates," "estimates" or similar expressions, including, but not limited to, statements regarding the continued demand for China Agritech's products, China Agritech's ability to sustain growth for the balance of the year and China Agritech's ability to generally meet all of its objectives. Such forward-looking statements involve known and unknown risks and uncertainties, including all business uncertainties relating to product development, marketing, concentration in a single customer, raw material costs, market acceptance, future capital requirements, and competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the SEC. Except as required by law, China Agritech is under no obligation to update or alter its forward-looking statements whether as a result of new information, future events or otherwise. For more information, please contact:

    In China:
     Mr. Gareth Tang
     Chief Financial Officer
     China Agritech, Inc.
     Tel:   +86-10-5962-1220
     Email: gareth@chinaagritech.com

    In the U.S.:
     Mr. Kevin Theiss / Mr. Valentine Ding
     Investor Relations
     Grayling
     Tel:   +1-646-284-9409
     Email: kevin.theiss@us.grayling.com
            valentine.ding@us.grayling.com

Texas Petrochemicals, Inc., (OTC: TXPI.PK) announced today it will release its fiscal 2009 fourth quarter financial results before the market opens on Friday, September 18, 2009. In conjunction with the release, the Company has scheduled a conference call that will be broadcast live over the internet that same day at 9:30 a.m. Eastern Time (8:30 a.m. Central).

    What:   Texas Petrochemicals Fiscal 2009 Fourth Quarter
            Earnings Conference Call
    When:   Friday, September 18, 2009 - 9:30 a.m. Eastern Time
    How:    Live via Conference Call - Dial (480) 629-9692 at least
            10 minutes prior to the start time and ask for the Texas
            Petrochemicals call
            Live via webcast- Log on to the website address below
    Where:  www.txpetrochem.com. The webcast can be accessed from
            the Investor Relations/Presentations & Webcast page

For those unable to listen to the live call, a replay will be available through Friday, October 2, 2009 by calling (303) 590-3030 using pass code 4146923#. Also, an archive of the webcast will be available shortly after the call on the Company's website at www.txpetrochem.com for approximately 90 days.

Headquartered in Houston, Texas, Texas Petrochemicals, Inc. sells products into a wide range of performance, specialty and intermediate markets, including synthetic rubber, fuel additives, plastics and detergents. The Company has manufacturing facilities in the industrial corridor adjacent to the Houston Ship Channel, Port Neches and Baytown, Texas and operates a product terminal in Lake Charles, Louisiana. For more information, visit the Company's web site at http://www.txpetrochem.com.

    Investor Relations
    Contact:  Robert Whitlow
    Email:    robert.whitlow@txpetrochem.com
    Phone:    713-627-7474

    Contact:  Ruth Dreessen
    Email:    ruth.dreessen@txpetrochem.com
    Phone:    713-627-7474

    Media Relations
    Contact:  Sara Cronin
    Email:    sara.cronin@txpetrochem.com
    Phone:    713-627-7474

Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today that it has completed the acquisition of BioPharma Management Technologies, Inc., a privately held biotechnology company with a platform of proprietary and patented technologies for topical pain management and resorbable orthoses.

Under the terms of the agreement, BioPharma is now a wholly owned subsidiary of Wound Management Technologies in exchange for 4,500,000 shares of Wound Management Technologies common stock.

Wound Management Technologies' Chief Executive Officer Scott Haire states, "BioPharma's proprietary technologies and its future products are complementary to our major product CellerateRx(R). BioPharma provides broad new applications across several of the medical markets that we currently serve. Over the past year we have made excellent progress in bringing the science and technology of CellerateRx to the market. Now with the acquisition of BioPharma, we are adding additional science and technology that strengthen Wound Management Technologies' role as a leading global provider of wound care products."

CellerateRx is a collagen hydrolysate polypeptid whose patented collagen fragments, which are a fraction of the size of the native collagen molecules and particles found in other products, deliver the benefits of collagen to the body immediately. CellerateRx is used in the management of pressure ulcers, traumatic wounds, diabetic ulcers, first and second degree burns, venous stasis ulcers, ulcers due to arterial insufficiency and superficial wounds.

About Wound Management Technologies, Inc.:

Wound Management Technologies, through its subsidiary Wound Care Innovations, markets and distributes wound care products to the healthcare market under patented technology licensed to the company. The company is positioned and seeks to be a leading provider of wound care products. The company's corporate headquarters are in Fort Worth, Texas. For more information please visit the company's website at www.celleraterx.com.

An online investor kit including press releases, current price quotes, stock charts and other valuable information for investors may be found at www.hawkassociates.com.

A profile for investors can be accessed at http://www.hawkassociates.com/clients/profile/wnmd.cfm.

To receive free e-mail notification of future releases for Wound Management, sign up at www.hawkassociates.com/about/alert/.

Safe Harbor Statement Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

Contacts:

Product information, contact Cathy Bradshaw at 954-315-9242.

Shareholder relations, contact Lucy Singleton at 817-820-7080.

Investor relations information, contact Frank Hawkins or Julie Marshall, Hawk Associates, at 305-451-1888 or email woundmanagement@hawkassociates.com'>woundmanagement@hawkassociates.com.

James J. Landy, President & CEO of Hudson Valley Bank, has announced that the Bank has relocated its Thornwood Branch to a new larger location right next door at 501 Marble Avenue, Pleasantville.

Although adjacent to the existing branch, the property of the new location is actually located in Pleasantville, necessitating a name change, Mr. Landy explained. "We are pleased to have found such a convenient location to expand our services to the businesses and residents of Thornwood, Pleasantville and surrounding communities."

According to Michael Gilfeather, EVP for Branch Administration and a Pleasantville resident, the new location offers additional space for the comfort and convenience of customers, a 24-hour ATM, and will allow for additional teller and customer service personal in the future.

The new Pleasantville Branch will also feature additional parking, which will be created on the site of the former branch when the building is removed, Mr. Gilfeather said. "Once the parking lot construction is complete, the new branch will reopen its Drive-Thru window service which has been temporarily suspended. We expect the Drive Thru to be functional again by the beginning November."

"The expansion of this branch, despite the current economic climate, is a testament to our strength and to Hudson Valley's continued commitment to local community banking," Mr. Landy said. "We remain financially strong and with our focus on quality products and very personal service, we believe we have a lot to offer our friends and neighbors in the greater Thornwood and Pleasantville area."

Sharon Spina, an experienced local banker who has been the Manager of Hudson Valley's Thornwood Branch for the past two years, remains manager at the new branch location. The Pleasantville branch is open Monday, Tuesday, Wednesday and Friday from 9 a.m. to 4 p.m. and Thursday from 9 a.m. to 6 p.m.

Hudson Valley specializes in banking services for businesses and professional service firms, including attorneys and property managers, as well as not-for-profit organizations. The Bank currently has $2.5 billion in assets and 32 branches in Westchester, Rockland, the Bronx, Manhattan, Queens and Brooklyn, NY, and Fairfield and New Haven counties, CT.

For additional information about Hudson Valley's new Pleasantville Branch, please call Sharon Spina, Branch Manager, at (914) 769-8661.

orycontent>

MONTREAL, Sept. 16 /PRNewswire-FirstCall/ - Global General Technologies' (GLGT:PK) (www.glgt-corporate.com) subsidiary Collagenna Skin Care Products is pleased announce the release of two new products which have been developed in order to offer a more complete product line.

Michael Arnkvarn President of Collagenna http://collagenna-usa.com/1_5 / Co-CEO of GLGT said "We have recently completed testing on a new Botanical Toner which combines marine minerals, essential proteins and botanicals to revive your skin, refine your pores and promote firmness. This product will be ready for release immediately."

Collagenna Skin Care Products is also pleased to announce an agreement in principle to develop and market a Natural Marine Clay Mask containing Marine Collagen with a Quebec Marine Clay Manufacturer.

Both Products were recently sent out to 100 existing commercial clients for evaluation complete with questionnaires. The feedback was very positive with over 85% of the respondents liking the products and feeling that they completed the line.

The products are scheduled for official release in their final packaging on September 25, 2009. Collagenna Skin Care Products is currently working on several other projects which will expand the product line. New products will be released as they become as they become available.

Collagenna Skin Care Products focuses on the development of Natural Source Products which contain active ingredients that nourish, repair and produce anti-aging effects. Our two main ingredients are 100 % Marine Collagen as well as proven Peptide Technology. Our Skin Care Line concept is also supported internally by the use of our supplements for optimal synergetic effects."

The company will, as per its prior announcement, its new policy of communications with its shareholders and its commitment to that task continue to provide its shareholders and followers with timely and frequent updates.

Safe Harbor Statement

Information in this news release may contain statements about future expectations, plans, prospects or performance of Global General Technologies, Inc. that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. Global General Technologies, Inc. cautions you that any forward-looking information provided by or on behalf of Global General Technologies, Inc. is not a guarantee of future performance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. Global General Technologies Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Global General Technologies Inc.'s control. In addition to those discussed in Global General Technologies Inc.'s press releases, public filings, and statements by Global General Technologies, Inc.'s management, including, but not limited to, Global General Technologies, Inc.'s estimate of the sufficiency of its existing capital resources, Global General Technologies Inc.'s ability to raise additional capital to fund future operations, Global General Technologies Inc.'s ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match Global General Technologies Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Global General Technologies, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

CONTACT: www.minamargroup.com/helpdesk

Hudson Valley Holding Corp. (OTC Bulletin Board: HUVL) announced today that in connection with its underwritten public offering of up to $90 million of its common stock, it has received approval to list its common stock on the NASDAQ Global Select Market.

The Company anticipates that its existing shares of common stock will commence trading on NASDAQ on September 21, 2009. When the shares begin trading on NASDAQ, all transfer restrictions on the existing shares of common stock will terminate and the shares will be freely tradeable. Shares of the Company's common stock issued in connection with the offering will commence trading on the day after the offering is priced, which will be announced in a press release.

Also in connection with the listing of our common stock on NASDAQ, the Company has retained American Stock Transfer & Trust Company, LLC to act as its transfer agent. The Company has arranged with American Stock to have both the shares issued in the offering and its existing common stock issued in uncertificated form, meaning that the Company will no longer be issuing shares in certificated form and each share of common stock represented by a share certificate will be converted to a book entry form as soon as the existing certificate is surrendered. The Company will send to each current stockholder instructions as to how to turn in existing share certificates so that share ownership can be recorded under the new uncertificated, unrestricted, book entry format.

The shares will be offered for sale in the offering pursuant to a prospectus supplement filed with the Securities and Exchange Commission (the "SEC") as part of the Company's existing effective shelf registration statement on Form S-3 (File No. 333-161165). Prospective investors should read the prospectus in that registration statement, the preliminary prospectus supplement and other documents the Company has filed with the SEC for more complete information about the Company and the offering. Investors may obtain these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, a copy of the prospectus supplement may be obtained from Fox-Pitt Kelton Cochran Caronia Waller, Attn: Syndicate Department, 420 5th Avenue, 5th Floor, New York, NY 10018 (212-857-6212); or Raymond James & Associates, Inc., Attn: Andrea Borum, 880 Carillon Parkway, St. Petersburg, FL 33716 (727) 567-2108; or Stifel Nicolaus, Attn: Prospectus Department, One South Street, 15th Floor, Baltimore, MD 21202 (443-224-1988).

This announcement does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Hudson Valley Holding Corp. (HUVL), headquartered in Yonkers, NY, is the parent company of two independently owned local banks, Hudson Valley Bank (HVB) and New York National Bank (NYNB). Hudson Valley Bank is a Westchester based bank with more than $2.4 billion in assets, serving the metropolitan area with 32 branches located in Westchester, Rockland, the Bronx, Manhattan, Queens and Brooklyn in New York and Fairfield County and New Haven County, CT. HVB specializes in providing a full range of financial services to businesses, professional services firms, not-for-profit organizations and individuals; and provides investment management services through a subsidiary, A. R. Schmeidler & Co., Inc. NYNB is a Bronx based bank with approximately $140 million in assets serving the local communities of the Bronx and Upper Manhattan with three branches. NYNB provides a full range of financial services to individuals, small businesses and not-for-profit organizations in its local markets. Hudson Valley Holding Corp.'s stock currently is traded under the ticker symbol "HUVL" on the OTC Bulletin Board.

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements refer to future events or our future financial performance. We have attempted to identify forward-looking statements by terminology including "anticipates," "believes," "can," "continue," "expects," "intends," "may," "plans," "potential," "predicts," "should" or "will" or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause our or the banking industry's actual results, level of activity, performance or achievements to be materially different from any future results, level of activity, performance or achievements expressed or implied by these forward-looking statements. Factors that may cause actual results to differ materially from those contemplated by such forward-looking statements include, but are not limited to those factors included in the Company's Form 8-K filed on September 9, 2009 and the preliminary prospsectus supplement. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements.

IceWEB, Inc.(TM) (OTC Bulletin Board: IWEB), www.iceweb.com, today announced that the Company has launched the Iplicity Cloud Storage Appliance (CSA) product line. The Iplicity CSA products can be deployed either as SAN or NAS devices which deliver high performance scalable capabilities that for the first time are easily, rapidly, and securely deployed in a centrally managed Private Storage Cloud or in a Hybrid Public/Private Cloud configuration.

Gary Dunham, Sr. VP. Of Product Development & Engineering for IceWEB described the offering, "Iplicity Cloud Storage Appliance is the first commercially available Cloud Storage device geared toward allowing its users, businesses of any size, to simply attach a pre-configured appliance to their network and immediately begin serving vast amounts of file and data storage space to local, remote, internet or VPN connected users and applications. This appliance allows corporations to gain all of the benefits of Cloud Storage - positioning content closer to the originators, users and applications, control of replication and backup throughout the enterprise, centralized management of geographically dispersed data and much more - without assuming the risks of putting priceless company data in the hands of third party providers. Iplicity CSA customers can also opt to make their content and storage resources available not only to their own users but also to authenticated partners via the internet - while still maintaining private back-links to the corporate IT infrastructure thus ensuring both data security and consistent quality of service."

Iplicity CSA greatly reduces the complexity of use by implementing a straight forward management Graphical User Interface from which network support staff can easily and fully manage the global storage appliance solution with a great deal of granularity. Once difficult tasks such as growing volumes, dragging and dropping space wherever needed (thin provisioning), reconfiguring network connectivity, creating multiple automatic replications of useable data at diverse locations, can all be performed live without impacting overall systems availability.

Iplicity CSA provides unified storage allowing both applications and users to be granted access to their data by the widest range of protocols available (CIFS, NFS, iSCSI, FC, AOE, WEBDAV and RSYNC), affording organizations ultimate flexibility and range in how the data is accessed. The appliances also offer advanced data protection and replication capabilities which allow organizations to drive content to different locations for different uses as dictated by their own unique needs.

Deployment is quick and easy. From un-boxing to live deployment, the pre-configured Cloud Storage Appliances can be configured on the client network, and rendered ready to begin serving data in less than 20 minutes. Management and monitoring of the appliances is also quite intuitive with easy to understand Dashboard interfaces displaying CPU Utilization, Network I/O and Disk I/O, and the capability to 'drill down' as deeply as necessary. Fully automated reporting and 'email-home' capabilities will alert network staff to any pending, system self healed, or pending issues.

The 19-inch rack mountable Iplicity Cloud Storage Appliances are available immediately in three pre-configured models: The CSA-2000, a base level appliance with 8TB of storage and the Iplicity Management Software, the CSA-4000 with 16TB expandable to 192TB, and the CSA-8000 with 24TB expandable to 192TB. Both the CSA-4000 and CSA-8000 are also available in an optional Active/Active High Availability configuration. To download the CSA Brochure: Iplicity CSA Data Sheet

About IceWEB, Inc.

Headquartered just outside of Washington, D.C., IceWEB manufactures and markets storage solutions and on-line cloud computing application services. Its customer base includes U.S. government agencies, enterprise companies, and small to medium sized businesses (SMB). For more information, please visit www.IceWEB.com.

This press release may contain forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases you can identify those so-called "forward looking statements" by words such as "may," "will," "should," "expects," "plans," "targets," "believes," "anticipates," "estimates," "predicts," "potential," or "continue" or the negative of those words and other comparable words. These forward looking statements are subject to risks and uncertainties, product tests, commercialization risks, availability of financing and results of financing efforts that could cause actual results to differ materially from historical results or those anticipated. Further information regarding these and other risks is described from time to time in the Company's filings with the SEC, which are available on its website at:http://www.sec.gov. We assume no obligation to update or alter our forward-looking statements made in this release or in any periodic report filed by us under the Securities Exchange Act of 1934 or any other document, whether as a result of new information, future events or otherwise, except as otherwise required by applicable federal securities laws.

    Contact:
    IceWEB, Inc.
    Investor Relations, 571.287.2400
    investor@iceweb.com or Gary Nash at CEOCast 212.732.4300

Zaldiva, Inc., A Florida Corporation (OTC Bulletin Board: ZLDV), (Xetra/Frankfurt Exchange: UZ8) and a leader in Pop Culture collectibles, comic books, memorabilia and auctions headquartered in Fort Lauderdale, Florida today announced that it will be introduced to StockPlaysOnline where many traders and investors frequent.

The company needs to constantly introduce itself and the overall game plan to a wide variety of people. The types of individuals that are involved with StockPlaysOnline can potentially help us in the rollup strategy. Everyone knows about rollups and their success. Now people need to know and understand why the industry of comics and online auctions is a compelling industry to get involved with. This is just one format of many to utilize.

"After many years and lots of hard work building and establishing another very well known site, I have decided to build an all new stock site composed of some of the most experienced and well known names on the web," states Chuck (chuck44l) Lane with StockPlaysOnline. "If you haven't joined us yet, please feel free to do so, I think that you will be pleasantly surprised and will recognize the very familiar faces of some of the finest traders/investors in the business. Here at StockPlaysOnline we take great pride in what we do and are committed to bringing only the best to our members where in the future you can expect a very clean, professional and well run site. Along with continued training for new members as well as the seasoned trader/investor, we will have CEO interviews, SPO Exclusive plays and more."

Please feel free to post on the forums and be sure to join in the chat room and take part with the familiar faces. Zaldiva, Inc. (OTCBB: ZLDV) and a spokes person for Zaldiva will be available for a live interview at http://www.stockplaysonline.com/visichat/ on Tuesday, September 15, 2009 at 10:30AM EDT to discuss the company's plans moving forward and will conclude with a short questions and answers session. Be there early as this session will be limited to approximately 20 to 30 minutes so have your questions prepared in advance.

More info on ZLDV can be found and shared here. http://www.stockplaysonline.com/showthread.php?t=81&highlight=zldv

About Zaldiva, Inc.

Zaldiva is a distribution system unique to the specialty retail industry, focusing its product orientation on the comics and collectibles genre. The company combines a highly visible brick and mortar location in Ft. Lauderdale, Florida with an e-commerce website and portal (www.Zaldiva.com) which operates in conjunction with a series of ancillary websites and online auctions.

Zaldiva podcasts can be found in the iTunes(TM) store by searching Zaldiva podcasts. The podcasts are also available on YouTube at http://www.youtube.com/watch?v=jrdA-IDXFR0 .

For Advertising, Sponsorship and Merger opportunities call 954-938-4133 or visit www.zaldiva.com.

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.

orycontent>

MONTREAL, Sept. 16 /PRNewswire-FirstCall/ - Global General Technologies' (GLGT:PK) (www.glgt-corporate.com) subsidiary Collagenna Skin Care Products is pleased announce the release of two new products which have been developed in order to offer a more complete product line.

Michael Arnkvarn President of Collagenna http://collagenna-usa.com/1_5 / Co-CEO of GLGT said "We have recently completed testing on a new Botanical Toner which combines marine minerals, essential proteins and botanicals to revive your skin, refine your pores and promote firmness. This product will be ready for release immediately."

Collagenna Skin Care Products is also pleased to announce an agreement in principle to develop and market a Natural Marine Clay Mask containing Marine Collagen with a Quebec Marine Clay Manufacturer.

Both Products were recently sent out to 100 existing commercial clients for evaluation complete with questionnaires. The feedback was very positive with over 85% of the respondents liking the products and feeling that they completed the line.

The products are scheduled for official release in their final packaging on September 25, 2009. Collagenna Skin Care Products is currently working on several other projects which will expand the product line. New products will be released as they become as they become available.

Collagenna Skin Care Products focuses on the development of Natural Source Products which contain active ingredients that nourish, repair and produce anti-aging effects. Our two main ingredients are 100 % Marine Collagen as well as proven Peptide Technology. Our Skin Care Line concept is also supported internally by the use of our supplements for optimal synergetic effects."

The company will, as per its prior announcement, its new policy of communications with its shareholders and its commitment to that task continue to provide its shareholders and followers with timely and frequent updates.

Safe Harbor Statement

Information in this news release may contain statements about future expectations, plans, prospects or performance of Global General Technologies, Inc. that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. Global General Technologies, Inc. cautions you that any forward-looking information provided by or on behalf of Global General Technologies, Inc. is not a guarantee of future performance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. Global General Technologies Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Global General Technologies Inc.'s control. In addition to those discussed in Global General Technologies Inc.'s press releases, public filings, and statements by Global General Technologies, Inc.'s management, including, but not limited to, Global General Technologies, Inc.'s estimate of the sufficiency of its existing capital resources, Global General Technologies Inc.'s ability to raise additional capital to fund future operations, Global General Technologies Inc.'s ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match Global General Technologies Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Global General Technologies, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

CONTACT: www.minamargroup.com/helpdesk

EQ Labs, Inc. (Pink Sheets: EQLB) announced today that on Saturday, August 29, 2009, the Company held its first public stockholders' meeting at its headquarters in Las Vegas, Nevada with Maurice "Mo" Owens, the Company's Chairman of the Board and CEO presiding. The Board of Directors of EQ Labs is pleased to announce that all of the recommendations of the Board and the resolutions placed before the shareholders were approved during the shareholder meeting.

Investors traveled from throughout the United States to attend the Company's first annual shareholder meeting and an equally significant number of investors were able to participate in the event online.

One of the most noteworthy highlights of the meeting was Owens' overview of the Company's research and development activities which have developed three new flavors of the EQ Smart Energy Drink tablets: Strawberry Dream, Mo Apple, and Lemon Lime. These new flavors, when combined with water or another beverage of choice, taste more like fruit drinks and are in no way similar in taste to other energy drinks already on the market.

"With a Manufacturers Suggested Retail Price (MSRP) of less than one dollar per tablet, we expect these exciting new flavors to fare very well with consumers," Owens commented. "The fact of the matter is, these new flavors came out over a month ago and were immediately marketed to our current distributors and wholesalers (collectively representing over 100,000 points of sale), who have responded very positively."

"The next phase of this marketing initiative will entail expanding the demand for these effervescent tablets with new consumer oriented retail organizations so that they too might 'think outside the can' and appreciate the impact, unique characteristics of this product, and income potential," Owens concluded.

About EQ Labs, Inc.

EQ Smart Energy Drink(R) is an effervescent tablet that provides instant energy in any beverage. Consisting of a blend of essential vitamins, Gingko Biloba, and less caffeine than a cup of coffee, EQ keeps you going any time - - day or night. Since one tablet of EQ Smart Energy Drink(R) is the equivalent of one can of any competing energy drink on the market, it is more economically efficient and convenient for consumer usage than most energy drink products in the marketplace. EQ is sold either in packets of one single tablet or three-inch tubes of six tablets. The product does not have to be kept cold to enjoy nor does it require a lot of space. As an example, a three-inch tube containing six tablets can be transported in a pocket or purse, and yet it is the equivalent of 6 cans of energy drink, when combined with eight - ten ounces of any beverage, at a significant cost savings. EQ is all about energy and living the All-American Lifestyle.

The Company presently distributes its products through national distributors, such as McLane Distributors, which distributes to the national convenience store chain, 7-Eleven, and numerous other regional distributors, and has been approved for consumer consumption by the Ministries of Health in Latin America countries such as Mexico and Brazil. Similar approval is pending in Brazil, where the largest nation-wide pharmacy chains have formally requested national distribution privileges.

The Company sponsors athletes from a diverse field to assist in promoting its products. EQ Labs, Inc. sponsored the off-track racing teams that won 1st Place (in Series 5) in the prestigious Baja 1000 in 2007, the LVDC team who won the 2008 Baja 1000 and has won 1st Place trophies in 15 of its last 17 races, with the EQ brand prominently displayed by the drivers and their crew.

Forward-Looking Statements

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by EQ Labs, Inc. are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

    Contact:

    Maurice "Mo" Owens, CEO
    EQ Labs, Inc.
    TEL: 702-445-7762 Email: mo@drinkeq.com; or
    Bob Fain, COO
    Email: patcoinc@cox.net, and bob@drinkeq.com
    Web Sites:
    www.drinkeq.com

b> Corporacion GEO, S.A.B. de C.V. (BMV: GEOB; CORPGEO MX, ADR Level I CUSIP: 21986V204; Latibex: XGEO), Casas GEO, Mexico's leading affordable entry-level housing developer, today announced that it has received the National Housing Mortgage Institute for Private Workers (INFONAVIT) "Sustainability Award" as the company receiving the most Green Mortgages in 2009.

This year, GEO has closed more than 5,000 Green Mortgages through INFONAVIT for its homes that include solar heating and water & gas conservation mechanisms. These technologies are important to environmental preservation while they also provide significant savings to the low-income families living in GEO's green homes.

Inigo Orvananos, GEO's Chief Marketing Officer, commented on the importance of sustainable cities: "GEO is the first homebuilder to offer Green Mortgages. We have always maintained the philosophy that the only way to correctly and sustainably develop Mexico is through efficient and careful use of non-renewable resources, such as water, while maintaining the utmost care for our environment."

About Corporacion GEO, S.A.B. de C.V.

Corporacion GEO is a leading housing developer in Mexico and one of the largest in Latin America. The Company is engaged in all aspects of design, development, construction, marketing, sales and delivery of mainly low-income housing developments in Mexico. With operations in 52 cities across 16 states, GEO is one of the most geographically diversified homebuilders in Mexico. Since its inception GEO has sold more than 450,000 homes which currently provide housing to 1,800,000 people. GEO's Solid Business Model focuses mainly in the Affordable Entry Level and Economic segments, which are supported by government policies and by the Mexican Housing Institutions INFONAVIT and FOVISSSTE. For more information, visit www.corporaciongeo.com

ActionView International, Inc. (Pink Sheets: AVEW) Chairman Gary Nerison today commented on the revenue model for the company's wholly owned MatchFights, LLC subsidiary and the revenue targets that the company plans to achieve with its upcoming pay-per-view events. The inaugural MatchFights event, which includes full contact fights, live music and ring girl contests, is scheduled for September 25, 2009 in Evanston, Wyoming and will be broadcast to a global audience in high definition over the Internet. Fight fans interested in watching the fight live via the Internet can pre-register for $9.95 at www.bkbfightclub.com.

Mr. Nerison highlighted the company's target of 100,000 pay-per-view buys for each event, which are scheduled to occur every 45 days. "Beyond our inaugural event, we are already looking forward to a number of additional venues for upcoming MatchFights events, including Indian casinos, as mentioned in a recent press release, and several international destinations, which are expected to significantly raise our profile in global markets. Full contact fighting has a more established history in certain foreign markets, and we expect to leverage this popularity with events staged in cities around the world."

"We are expecting the pay per view audience for our events to grow as awareness increases and comprehensive marketing programs for MatchFights events are implemented. 100,000 pay-per-view buys at the standard $14.95 will generate $1.5 million in revenues for each event and with 9 events planned per year, the company's annual revenues would be approximately $13.5 million. An advantage of our revenue model is that as viewership increases, our cost remain relatively fixed, allowing revenues to grow without a commensurate increase in cost for delivering the events. Using the Internet as the delivery vehicle for our live content allows us to reach a global market without increasing costs. In fact, our events become profitable with only a few thousand PPV buys.

"ActionView International is committed to supporting MatchFights as it delivers an exciting product with interactive elements that are not available in other boxing, MMA or martial arts events. We believe that our target of 100,000 is very realistic and achievable in the short term. These numbers would result in value being created for our shareholders, which is a core focus of ActionView International as a publicly traded company."

The company encourages shareholders and anyone interested in following the progress of ActionView International and its wholly owned MatchFights, LLC subsidiary to subscribe to the mailing list at www.matchfights.com.

About ActionView International, Inc.

ActionView International has completed its acquisition of MatchFights, LLC, which is now the focus of the company's operations. MatchFights, LLC and its BKB Fight Club property deliver live, high definition, pay-per-view events, including no-holds-barred, full contact fights, in an interactive venue over the Internet to a global audience. MatchFights intends to sanction events and ultimately create BKB champions that are recognized worldwide. The live events will have broad appeal and include elements of fighting, music, ring girl contests, and other live entertainment as part of the broadcast. The premier BKB Fight Club event will take place on September 25, 2009. For additional information about MatchFights and its BKB Fight Club, please visit www.matchfights.com or www.bkbfightclub.com.

Forward-Looking Statements

This release contains 'forward-looking statements' within the meaning of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be 'forward-looking statements.' Forward-looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated.

    Contact:
    ActionView International, Inc.
    Investor Relations
    888-528-0883
    media@matchfights.com

IntercontinentalExchange((R)) (NYSE: ICE), a leading operator of regulated global futures exchanges, clearing houses and over-the-counter (OTC) markets, announced that ICE Trust U.S. (ICE Trust(TM)) has surpassed the $2 trillion mark in notional value cleared for North American credit default swap (CDS) contracts. For the week ending September 11, ICE Trust cleared $41 billion in notional, bringing total cleared volume to just over $2 trillion since the March 2009 launch. Open interest at ICE Trust is $187 billion and 24,006 transactions have been cleared to date.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090727/CL51999LOGO )

"ICE's leadership in clearing CDS markets is helping to reduce systemic risk by increasing market transparency and security, and we appreciate the assistance we have received from regulators, clearing members and the buy-side community," said Dirk Pruis, President of ICE Trust. "As the one-year anniversaries of the Lehman and AIG crises approach, CDS clearing is playing a significant role in restoring safety and soundness to capital markets."

In July 2009, ICE Clear Europe((R)) began processing European CDS index transactions. Through September 11, ICE Clear Europe has cleared euro 313 billion ($447 billion) notional, resulting in open interest of euro 37 billion ($52 billion). On a global basis, ICE has cleared 30,147 transactions totaling nearly $2.5 trillion in gross notional value, resulting in open interest of $241 billion. Currently, ICE Trust and ICE Clear Europe are clearing 20 North American CDX index contracts and 12 European iTraxx contracts, respectively. ICE expects to begin clearing single-name CDS contracts later this month.

About IntercontinentalExchange

IntercontinentalExchange((R)) (NYSE: ICE) operates leading regulated exchanges, trading platforms and clearing houses serving the global markets for agricultural, credit, currency, emissions, energy and equity index markets. ICE Futures Europe((R)) hosts trade in half of the world's crude and refined oil futures. ICE Futures U.S.((R)) and ICE Futures Canada((R)) list agricultural, currency and Russell Index markets. ICE offers trade execution and processing for the credit derivatives markets through Creditex and ICE Link(TM) respectively, and CDS clearing through ICE Trust(TM) and ICE Clear Europe((R)). A component of the Russell 1000((R)) and S&P 500 indexes, ICE((R)) serves customers in more than 50 countries and is headquartered in Atlanta, with offices in New York, London, Chicago, Winnipeg, Calgary, Houston and Singapore. www.theice.com

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 - Statements in this press release regarding IntercontinentalExchange's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see ICE's Securities and Exchange Commission (SEC) filings, including, but not limited to, the risk factors in ICE's Annual Report on Form 10-K for the year ended December 31, 2008, as filed with the SEC on February 11, 2009.

PLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, today provided an update on its marketing activities at ESC Congress 2009, the annual meeting of the European Society of Cardiology, August 29 - September 2, 2009 in Barcelona, Spain. More than 30,000 clinicians and professionals attended this event, including representatives from potential partners and distributors for RenalGuard((R)).

Mark R. Tauscher, president and chief executive officer of PLC Systems, said, "In participating in ESC, we were focused on leveraging opportunities to broaden RenalGuard's distribution in the European Union. As we evaluate our progress, we are very pleased with the attention RenalGuard garnered at this conference, from both clinicians and potential partners. We are also very happy with the strong scientific results on RenalGuard's efficacy that were presented, and the interest that drew from attendees. We very much look forward to continuing to build momentum for RenalGuard as we move ahead on discussions with prospective partners and distributors. To that end, we look forward to additional opportunities to continue to raise visibility for RenalGuard and engage the thought leaders in our market at the upcoming TCT conference in San Francisco later this month."

At ESC, Dr. Giancarlo Marenzi, Chief, Intensive Cardiac Care Unit, Centro Cardiologico Monzino-University of Milan (CCM) presented preliminary results of the MYTHOS investigator-sponsored clinical trial of RenalGuard, attracting strong interest from attendees. These results indicate that patients who were at high risk for renal failure, treated with RenalGuard( )while undergoing certain imaging procedures, acquired contrast-induced nephropathy (CIN) at a significantly lower rate than those who were treated beforehand with overnight hydration. Acquiring CIN has been found to lead to a range of serious and potentially deadly outcomes in patients who already have compromised kidney function.

In the preliminary results presented at ESC, the trial had enrolled 90 chronic kidney disease (CKD) patients undergoing elective or urgent percutaneous coronary interventions (PCI). Approximately 14.9% of the patients in the control group were determined to have acquired CIN, whereas only 4.6% of those who were treated with RenalGuard acquired CIN. The MYTHOS trial anticipates enrolling a total of 120 patients, and is expected to be completed this year. More information about the trial is available at the company's website: http://www.plcmed.com/Products-Clinical-Investigations2.asp.

About PLC Systems Inc.

PLC Systems Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Headquartered in Franklin, Massachusetts, PLC pioneered the CO2 Heart Laser System, which cardiac surgeons use to perform CO2 transmyocardial revascularization (TMR) to alleviate symptoms of severe angina. PLC's newest product, RenalGuard, is approved for sale in the EU as a general fluid balancing device. Additional company information can be found at www.plcmed.com.

This press release contains "forward-looking" statements. For this purpose, any statements contained in this press release that relate to prospective events or developments are deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "will" and similar expressions are intended to identify forward-looking statements. Our statements of our objectives are also forward-looking statements. While we may elect to update forward-looking statements in the future, we specifically disclaim any obligation to do so, even if our estimates change, and you should not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release. Actual results could differ materially from those indicated by such forward-looking statements as a result of a variety of important factors, including that we may not receive necessary regulatory approvals to market our RenalGuard product or that such approvals may be withdrawn, we may be unable to raise sufficient funds in the future to implement our business plan and/or commence our planned U.S. clinical trial for RenalGuard, the current clinical trials in Italy and the planned future U.S. clinical trial for RenalGuard may not be completed in a timely fashion, if at all, or, if these clinical trials are completed, they may not produce clinically significant or meaningful results or future results from clinical trials may differ from results to date, the RenalGuard product may not be commercially accepted, operational changes, competitive developments may affect the market for our products, regulatory approval requirements may affect the market for our products, and additional risk factors described in the "Forward Looking Statements" section of our Annual Report on Form 10-K for the year ended December 31, 2008, and our other SEC reports.

PLC Systems, PLC Medical Systems, PLC and CO2 Heart Laser, RenalGuard and RenalGuard System are trademarks of PLC Systems Inc.

    Contact:  Mary T. Conway
    Conway Communications
    617-244-9682
    mtconway@att.net

ActionView International, Inc. (Pink Sheets: AVEW) and its wholly owned MatchFights, LLC subsidiary today announced that they have received final approval from the city of Evanston, Wyoming to move forward with MatchFights' inaugural event scheduled for September 25, 2009. The venue for the event, dubbed the BKB Break Out, is The Machine Shop, a renovated exhibition hall in historic downtown Evanston.

ActionView Director Tony "The Tiger" Lopez commented, "Getting the green light from the city of Evanston is an important milestone for us as we introduce a new fight product to the market. While we were confident that there would not be any problems with our event, it is reassuring to know that the last of the hurdles has been removed."

"The first live event, which will be delivered in an interactive venue over the Internet to a global audience, will feature fourteen fighters from broad fight backgrounds," Mr. Lopez continued. "We have several fighters lined up for this first event that I believe the fight fan will really get excited about. We have professional MMA fighters, boxers, street fighters, and Muy Thai fighters. This will be a fight event much more in line with what the sport was intended to be--a venue for fighters of all styles to meet and prove who the toughest is. We believe that the rule changes we have implemented; namely, the number and length of rounds, will create fights that are faster and more exciting than the conventional MMA product."

Fight fans interested in watching the fight live via the Internet can pre-register for $9.95 at www.bkbfightclub.com. Tickets for the event are available by contacting www.bkbfightclub.com and through several local retailers in Evanston. The pre-fight weigh in will be at 12:30 local time on September 25, 2009 at Suds Brothers Brewery located at 1400 Main Street, Evanston.

The company encourages shareholders and anyone interested in following the progress of ActionView International and its wholly owned MatchFights, LLC subsidiary to subscribe to the mailing list at www.matchfights.com.

About ActionView International, Inc.

ActionView International has completed its acquisition of MatchFights, LLC, which is now the focus of the company's operations. MatchFights, LLC and its BKB Fight Club property deliver live, high definition, pay-per-view events, including no-holds-barred, full contact fights, in an interactive venue over the Internet to a global audience. MatchFights intends to sanction events and ultimately create BKB champions that are recognized worldwide. The live events will have broad appeal and include elements of fighting, music, ring girl contests, and other live entertainment as part of the broadcast. The premier BKB Fight Club event will take place on September 25, 2009. For additional information about MatchFights and its BKB Fight Club, please visit www.matchfights.com or www.bkbfightclub.com.

Forward-Looking Statements

This release contains 'forward-looking statements' within the meaning of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be 'forward-looking statements.' Forward-looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated.

    Contact:
    ActionView International, Inc.
    Investor Relations
    888-528-0883
    media@matchfights.com

Mitek Systems, Inc. (OTC Bulletin Board: MITK) (www.miteksystems.com) today announced its Mobile Receipt (TM) application climbed all the way to the number one paid finance application in the App Store (SM) on September 8, 2009 and is consistently in the top five application in its category. Mobile Receipt converts the photo of a receipt taken with the iPhone camera into a high quality image and, with a single tap, converts the data into a professional looking expense report. Mobile Receipt saves time, enhances productivity and can help speed reimbursements.

(Logo: http://www.newscom.com/cgi-bin/prnh/20041117/LAW022LOGO)

"Mobile Receipt is the first product we introduced in our suite of OOMPH, Office On My Phone, applications in the App Store," said James DeBello, president and CEO, Mitek Systems. "The past few weeks watching Mobile Receipt climb the sales charts is confirmation that we are building products that people want to pay for and we can't wait to get more of these apps out there in the market."

Mobile Receipt is available for $4.99 from the App Store on the iPhone or at www.itunes.com/apps/mobilereceipt

To capture a receipt the user simply snaps a photo of it and assigns an expense category. In seconds, Mobile Receipt's patent pending IMagePROVE(TM) technology automatically crops, rotates and scales the image so it is easy to read and print.

With a touch to the iPhone screen, the application automatically creates an expense report and sends it to your email address complete with printed images of the receipts acceptable for reimbursement and tax reporting purposes. No stapling or pasting of receipts is required.

Mobile Receipt is part of Mitek's family of innovative OOMPH, Office On My Phone(TM), products that unlock the potential of the millions of mobile phones with cameras sold each year.

See Mobile Receipt in action at: http://www.miteksystems.com/OOMPH_webisodes.asp

About Mitek Systems

Mitek Systems (OTC Bulletin Board: MITK; www.miteksystems.com) is an innovator of advanced image analytics and mobile document capture applications for camera phones. For over twenty years, the company has developed the most comprehensive suite of intelligent character recognition software used to test, clean, authenticate and extract data from imaged checks, documents and objects, and its software is used to process more than ten billion transactions per year. For more information about Mitek Systems, contact the company at 858-503-7810 or visit www.miteksystems.com.

Mitek Systems, OOMPH and Mobile Receipt are owned by Mitek Systems, Inc, other names and trademarks may be names of their respective owners

    Media Contact:                     Investor Contact:
    Josh Morgan                        Fred Hutton
    Morgan/Dorado for Mitek            Mitek Systems, Inc.
    916.941.0901                       858.503.7810 ext. 332
    josh@morgandorado.com              fhutton@miteksystems.com

JAG Media Holdings, Inc. (OTC Bulletin Board: JAGH) has entered into an agreement with The Investor Relations Group, Inc. ("IRG"), pursuant to which IRG will provide various investor relations and public relations services for the Company in accordance with the terms of the agreement. As of Tuesday, September 15th, all stockholders should address any inquiries directly to IRG.

"We are very excited to begin working with IRG in connection with the Company's investor relations and public relations programs," said Dr. Yahia Gawad, Chief Executive Officer of JAG Media. "Dian Griesel, PhD, IRG's founder and CEO, has vast experience in the life sciences area and we are confident that her experience and the resources of IRG will be very effective in helping stockholders, media outlets and the general public alike better understand CardioGenics and the potential of its point-of-care diagnostic platform, related tests and products," continued Gawad.

"Dr. Gawad is a proven success in developing cardiac diagnostic test products. Over the past eighteen years, he has displayed noteworthy talent for taking products through development, regulatory approvals and commercialization. All of us at The Investor Relations Group are honored to have been chosen to help raise the awareness of the portfolio currently being developed by Dr. Gawad and his team," said Dian Griesel, founder and CEO of IRG.

A Current Report on Form 8-K containing further details regarding the IRG agreement will be filed by the Company and will be available on EDGAR.

About JAG Media Holdings, Inc. and its CardioGenics Subsidiaries

Through its CardioGenics subsidiaries, the Company develops technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. It has developed the QL Care Analyzer, a proprietary Point Of Care immuno-analyzer, which will run a number of diagnostic tests under development, the first of which will be a series of cardiovascular diagnostic tests. As part of its core proprietary technology, the Company has also developed a proprietary method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improve instrument sensitivity to light. The Company's principal offices are located in Mississauga, Ontario, Canada.

Through its Pixaya subsidiaries, the Company also provides Internet-based equities research and financial information that offers its subscribers a variety of stock market research, news and analysis, including "JAG Notes", the Company's flagship early morning consolidated research product.

ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) has entered into an agreement with a leading commercial manufacturer to produce its FDA-approved MuGard for North American distribution. One or more U.S. market seeding studies could begin as early as Q4 2009, the company says.

In a comparison of cancer patients receiving standard oral mucositis care with those patients receiving MuGard , MuGard has been shown to significantly reduce the incidence and severity of the debilitating side effect of radiation treatment and chemotherapy.

Access has contracted with Accupac, Inc. to serve as its commercial manufacturer of MuGard in North America. Accupac manufactures, fills and packages a wide range of consumer commodity, over-the-counter (OTC) and prescription (Rx) products for the world's largest pharmaceutical and consumer products companies.

"Access is moving forward with the development of MuGard in North America," said Jeffrey B. Davis, Access' President & CEO. "Establishing our relationship with Accupac, a leader in liquid contract manufacturing, is critical to our successful commercialization of MuGard. In addition, Access is currently evaluating potential eMarketing partners as well as potential co-promotion or other licensing opportunities."

Access intends to use the initial batches of MuGard in connection with one or more market seeding studies to be conducted in the U.S. pursuant to protocols that are currently being developed. Access hopes to finalize these protocols and begin one or more market seeding studies in Q4 2009.

MuGard is a novel, ready-to-use mucoadhesive oral wound rinse for the management of oral mucositis. MuGard forms a protective coating over the oral mucosa when swirled gently around the mouth. Up to 80% of all patients receiving radiotherapy and approximately 40% of all chemotherapy patients develop oral mucositis, and almost all patients receiving radiotherapy for head and neck cancer and those undergoing stem cell transplantation develop symptoms. MuGard is currently being marketed in the United Kingdom, Germany, Italy, Norway and Greece by Access' partner, SpePharm.

Updated clinical practice guidelines for the prevention and treatment of mucositis recommend the use of a preventive oral care regimen as part of routine supportive care along with a therapeutic oral care regimen if mucositis develops. The market for the treatment of oral mucositis, expanding to include all patients undergoing chemotherapy and radiotherapy, is estimated to be in excess of $5 billion worldwide.

About Access:

Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' products include MuGard(TM) for the management of patients with oral mucositis and ProLindac(TM), currently in Phase 2 clinical testing of patients with ovarian cancer. ProLindac(TM) is also under study for its potential role in combination with other pharmaceuticals in the treatment of hepatocellular carcinoma (a form of liver cancer), and pancreatic cancer. The Company's pipeline also includes: Cobalamin(TM)-mediated targeted delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine, a new generation nucleoside analog which has demonstrated both pre-clinical and clinical activity in certain cancers. For additional information on Access Pharmaceuticals, please visit our website at www.accesspharma.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: clinical trial plans and timelines and clinical results for ProLindac and product candidates acquired in the MacroChem transaction, our ability to execute licensing agreements in the future, Access' plans to continue and initiate clinical trials, the value of its products in the market (including MuGard and the size of the overall market for mucositis products), its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited Access' need to obtain additional financing in order to continue the clinical trial and operations and to the risks detailed in Access' Annual Reports on Form 10-K and other reports filed by Access with the Securities and Exchange Commission.

    Contact: Company
    Stephen B. Thompson
    Vice President, Chief Financial Officer
    Access Pharmaceuticals, Inc.
    (214) 905-5100

    Contact: Investor Relations
    Donald C. Weinberger/Diana Bittner(media)
    Wolfe Axelrod Weinberger Assoc. LLC
    (212) 370-4500

orycontent>

VANCOUVER, Sept. 10 /PRNewswire-FirstCall/ - Laburnum Ventures, Inc. (OTCBB:LBUV) is pleased to announce that it has received a consent to act as a director from Mr. David Chapman and has appointed Mr. Chapman to the company's board of directors. Shortly after Mr. Chapman's appointment, Mr. Tom Brown resigned as a director. Mr. Chapman is now the company's sole director and is committed to guiding the company through the closing of the business combination with AGR Stone Tools USA, Inc.

"It is a privilege to be able to be a part of the Laburnum/AGR team and work together with the management to finalize all of the steps involved in this business combination," said Mr. Chapman after his appointment.

Mr. Chapman has been a corporate executive for the past 25 years. Most recently licensed as a Real Estate Agent and Mortgage Broker. Mr. Chapman is the CEO and Chairman of Aris Mortgage Corporation, a private mortgage company specializing in all aspects of commercial, residential and project financing.

Since 1982 Mr. Chapman has had a successful history in banking, industrial equipment design, manufacturing and corporate finance. In 1987, Mr. Chapman was a founding partner and vice president of Pacific and Western Trust based in Saskatchewan. Following the sale of his interest in the trust company in 1989, Mr. Chapman bought a chain of Equipment Rental Stores and founded Semco Drilling Equipment Inc., which designed and manufactured equipment for the mining industry. In addition to his professional career Mr. Chapman was, in 1985, appointed by the British Columbia Government to be a member of the Kelowna Hospital Board of Trustees.

About AGR Stone Tools USA, Inc.

AGR is a manufacturer of diamond tools and adhesives. It specializes in producing consumable tools for the natural stone, engineered stone, concrete and masonry industries. Its goal is to provide its clients with superior quality products, excellent customer service and the most competitive prices in the diamond tool industry. The company has completed extensive research and testing, and uses the latest technologies to assure AGR Tools is at the forefront of the diamond tool industry. The company employs some of the world's top scientists, engineers and metallurgists to produce the highest quality diamond tools for the construction industry.

More information on AGR can be found at: http://www.agrtools.com/index.html

Forward-Looking Statements:

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See Laburnum Ventures Inc.'s filings with the United States Securities and Exchange Commission which identify specific factors that may cause actual results or events to differ materially -from those described in the forward-looking statements.

See Laburnum Ventures Inc.'s Current Report on Form 8-K regarding the share exchange agreement between AGR Stone Tools USA, Inc. for details on various conditions which must be met before the share exchange between the two companies closes. There can be no assurance that the share exchange will close.

JAG Media Holdings, Inc. (OTC Bulletin Board: JAGH) has entered into an agreement with The Investor Relations Group, Inc. ("IRG"), pursuant to which IRG will provide various investor relations and public relations services for the Company in accordance with the terms of the agreement. As of Tuesday, September 15th, all stockholders should address any inquiries directly to IRG.

"We are very excited to begin working with IRG in connection with the Company's investor relations and public relations programs," said Dr. Yahia Gawad, Chief Executive Officer of JAG Media. "Dian Griesel, PhD, IRG's founder and CEO, has vast experience in the life sciences area and we are confident that her experience and the resources of IRG will be very effective in helping stockholders, media outlets and the general public alike better understand CardioGenics and the potential of its point-of-care diagnostic platform, related tests and products," continued Gawad.

"Dr. Gawad is a proven success in developing cardiac diagnostic test products. Over the past eighteen years, he has displayed noteworthy talent for taking products through development, regulatory approvals and commercialization. All of us at The Investor Relations Group are honored to have been chosen to help raise the awareness of the portfolio currently being developed by Dr. Gawad and his team," said Dian Griesel, founder and CEO of IRG.

A Current Report on Form 8-K containing further details regarding the IRG agreement will be filed by the Company and will be available on EDGAR.

About JAG Media Holdings, Inc. and its CardioGenics Subsidiaries

Through its CardioGenics subsidiaries, the Company develops technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. It has developed the QL Care Analyzer, a proprietary Point Of Care immuno-analyzer, which will run a number of diagnostic tests under development, the first of which will be a series of cardiovascular diagnostic tests. As part of its core proprietary technology, the Company has also developed a proprietary method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improve instrument sensitivity to light. The Company's principal offices are located in Mississauga, Ontario, Canada.

Through its Pixaya subsidiaries, the Company also provides Internet-based equities research and financial information that offers its subscribers a variety of stock market research, news and analysis, including "JAG Notes", the Company's flagship early morning consolidated research product.

Cavitation Technologies, Inc. (CTI) (OTC Bulletin Board: CVAT; Berlin: WTC) commented today that it has entered into an agreement with Desmet Ballestra Group www.desmetballestra.com to evaluate CTI's Nano Cavitation Reactor technology and its potential benefits to the vegetable oil industry.

Desmet Ballestra is known for their specialized expertise and are the market leaders in the field of the extraction and refining of oils and fats from oleaginous materials and the conversion of crude oils and fats into value-added products such as edible oil, shortening, biodiesel, detergents, surfactants and soap.

Speaking on behalf of Cavitation Technologies, Mr. Roman Gordon, CEO said: "We are very pleased to be working with the Desmet Ballestra Group and look forward to our cooperation in the vegetable oil industry. We expect their knowledge, experience, expertise and leadership will help us realize the full worldwide potential of our technology."

CTI's new GPD system is based on its patented flow-through Nano Cavitation Reactor technology that promotes the formation, growth, and implosive collapse of gas or vapor-filled bubbles in liquids. The process involves the mixing of crude vegetable oil and water and exposing them to high-pressure impulses and micro explosions at the molecular level causing the gums to become denser thus allowing efficient separation and higher oil yields.

This environmentally friendly technology represents a significant advancement over current 40-year-old process techniques.

About Cavitation Technologies

Cavitation Technologies, Inc. (CTI); (OTC: CVAT); is a "Green-Tech" company, established in 2006 to become a world leader in the development of new cutting edge technologies for the vegetable oil refining, renewable fuel, petroleum, water treatment, wastewater sanitation, petroleum, food and beverage, chemical industries. For additional information please visit: www.cavitationtechnologies.com

Safe Harbor: Pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995, and within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, and goals, assumption of future events or performance are not statements of historical fact and may be "forward-looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this Release may be identified through the use of words such as "expects," "will," "anticipates," "estimates," "believes," or statements indicating certain actions "may," "could," or "might" occur. Such statements reflect the current views of CTI with respect to future events and are subject to certain assumptions, including those described in this release. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products, services, and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses, and other factors. The actual results that the Company achieves may differ materially from any forward-looking statements due to such risks and uncertainties. Cavitation Technologies, Inc. does not undertake any responsibility to update the "forward-looking" statements contained in this news release.

orycontent>

CARLSBAD, CA, Sept. 11 /PRNewswire-FirstCall/ - EcoBlu Products, Inc. (OTCBB: ECOB) today announced that it would like to correct a misstatement in its press release of September 8, 2009. EcoBlu inaccurately reported that it had provided coating services for Universal Forest Products, Inc. (UFPI), when in fact it had provided services to a subsidiary of UFPI, Universal Forest Products Western Division, Inc. (UFPWD).

EcoBlu would like to make it clear that neither UFPI nor any of its affiliates and subsidiaries (collectively, "Universal") is in any way affiliated with EcoBlu. Universal and EcoBlu have no other relationship except that of vendor and customer. Universal supplies wood coated with Bluwood technology solely at the customer's request. Universal does not warrant or endorse the use of Bluwood technology and makes no claims as to its performance or efficacy. EcoBlu regrets any confusion the release may have caused and remains committed to providing our customers with the highest quality of wood treated lumber.

ABOUT ECOBLU PRODUCTS, INC.

EcoBlu Products, Inc. is a manufacturer of proprietary wood products coated with an eco-friendly chemistry that protects against mold, rot, decay, termites and value added fire. EcoBlu products protected by BLUWOOD(TM) technology is the ultimate in wood protection, preservation, and fire safety to building components constructed of wood; from joists, beams and paneling, to floors and ceilings. The Company is committed to the development, marketing and sales of environmentally-responsible building materials. EcoBlu products are ready to deliver the winning edge to builders and the environment with its sustainable green product line.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: The statements in this release relating to completion of the acquisition and the positive direction are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include, but are not limited to, contractual difficulties which may arise, the failure to obtain necessary approvals, the future market price of EcoBlu Products, Inc. common stock and the ability to obtain the necessary financing.

Michigan Heritage Bancorp, Inc. (OTC Bulletin Board: MHBC) announced today that it has postponed until October 6, 2009 the previously announced special meeting of shareholders which was scheduled to be held on September 14, 2009 at 2:00 p.m. local time at the offices of Dykema Gossett PLLC, legal counsel for Michigan Heritage Bancorp, located at 39577 Woodward Avenue, Suite 300, Bloomfield Hills, Michigan for shareholders of record on August 7, 2009. The special meeting is now scheduled to be held on October 6, 2009 at 2:00 p.m. local time at the same location (the offices of Dykema Gossett PLLC in Bloomfield Hills). The purpose of this meeting is to seek approval of a proposal to dissolve Michigan Heritage Bancorp in accordance with relevant law and pursuant to a plan of dissolution.

Based on preliminary estimates of the vote count, the company believes that substantially more votes are in favor of the proposal to dissolve the company than against it; however, at this time, the number of votes cast does not constitute a quorum. The company has postponed the special meeting to provide an opportunity for additional stockholders to vote on the proposal. The company intends to continue to solicit votes and proxies in favor of the dissolution during the postponement. During this time, stockholders will continue to be able to vote their shares for or against the proposal, or to change previously cast votes.

The company has delivered to its shareholders a proxy statement in connection with the solicitation of proxies by the board of directors for the special meeting of shareholders to which this communication relates. The proxy statement contains important information that shareholders should read before making any voting decision including a copy of the plan of dissolution. The proxy statement and proxy may be obtained for free by contacting Dykema Gossett at (248) 203-0734.

As described in the company's proxy statement, approval of the proposal requires the affirmative vote of a majority of the outstanding shares of the company's common stock. The company's board of directors requests that all shareholders review the proxy statement and the attached Plan of Dissolution, vote on the proposal and return the proxy as instructed in the proxy statement.

orycontent>

SHENZHEN, China, Sept. 11 /PRNewswire-FirstCall/ - HTDS www.htdsmedical.com The company is pleased to announce that its China based operating subsidiary Mellow Hope www.mellowhope.com has successfully completed and delivered on its tender for Mevac-A for the country of Bangladesh.

In developing countries, over 11 million children aged less than five years die each year, and nearly three quarters of these deaths result from infectious diseases. The World Health Organization (WHO) estimates that the death of at least four million of these children is linked to their lack of access to vaccines. Vaccines are highly effective against childhood diseases preventing an estimated three million deaths a year.

http://www.hawaii.edu/hivandaids/Introducing_HBV_Vaccine_into_the_Expanded_Programme_on_Immunization_in_Bangladesh__A.pdf

Every year Mellow Hope attends the government tender business of Hepatitis A Vaccine in Bangladesh. By virtue of Mellow Hope's high quality and competitive price, Mellow Hope's Hepatitis A Vaccine (MEVAC-A) has won the tenders in the last three consecutive years.

For 2009, Mellow Hope scheduled, and secured, and shipped the order. Mellow Hope is now preparing to participate for the 2010 tender.

As Mellow Hope has established a very solid foundation, strong track record and brand recognition in this region it is confident that it will also be successful with its 2010 tender as well.

In other company news, the company has completed certain filings on Pink Sheets, and brings attention with this release to those matters. One of the filings is the engagement letter of an SEC auditor as the company gears to complete its audit and become a reporting issuer. The second filing deals with certain activities of "oversold" and "sell only" campaign which affected HTDS. These are just one of many steps the company intends to take to protect its and its shareholders' interests.

Shortly the company will provide its followers with an update of behind the scenes measures and steps it is taking to address this issue. The company remains optimistic that just some the steps and measures it took will start to take effect and start trickling down as the market correct itself and the short covering begins.

Numerous updates to follow shortly on IP progress, the joint venture with the North American pharmaceutical company and other previously announced business matters.

Safe Harbor Statement

Information in this filing may contain statements about future expectations, plans, prospects or performance of Hard to Treat Diseases, Inc. that constitute forward-looking statements for purposes of the safe harbor Provision's under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. HTDS Corporation cautions you that any forward-looking information provided by or on behalf of Hard to Treat Diseases, Inc. is not a guarantee of future performance. None of the information in this filing constitutes or is intended as an offer to sell securities or investment advice of any kind. Hard to Treat Diseases, Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Hard to Treat Diseases, Inc.'s control. In addition to those discussed in Hard to Treat Diseases, Inc.'s press releases, public filings, and statements by Hard to Treat Diseases, Inc.'s management, including, but not limited to, Hard to Treat Diseases, Inc.'s estimate of the sufficiency of its existing capital resources, Hard to Treat Diseases, Inc.'s ability to raise additional capital to fund future operations, HTDS Corporation's ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match Hard to Treat Diseases, Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Hard to Treat Diseases, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

CONTACT: For medical and scientific dialogue inquiry only, please contact medicalinfo@htdsmedical.com'>medicalinfo@htdsmedical.com; For any corporate matters, please contact www.minamargroup.com/helpdesk

orycontent>

MONTREAL, Sept. 10 /PRNewswire-FirstCall/ - Global General Technologies (GLGT:PK) (www.glgt-corporate.com) subsidiary Collagenna Skin Care is pleased to announce a three (3) year agreement with Dr Ebi Taebi ED.N.M. for the exclusive distribution of the Collagenna Skin Care Product Line in the Middle Eastern market.

Dr. Taebi D.N.M. is a registered Doctor of Natural Medicine and Traditional Chinese Medicine (TCM). He is a member of the World Organization of Natural Medicine Practitioners as well as the founder of the Organica Wellness Centre in Richmond Hill, Ontario.

Over the past few months, Collagenna has been testing the Middle Eastern Market via Dr. Taebi's local distribution contacts and the feedback has been very positive. Dr. Taebi has a weekly live Satellite Television Show (Tasvir Iran) via the American Farsi Network (AFN) which is broadcast on Tuesday Evenings at 8.30 PM (EST), with repeats 3 times weekly. His program is followed by viewers all over the world and his main focus is on Natural Health and Skin. He is actively marketing several Natural Health Products all over the World and he has identified the Collagenna Skin Care Line as a premier product to meet the needs of his clientele as well as his distribution network.

Collagenna Skin Care Products were presented on his weekly show this past Tuesday September 8, 2009 with two more features on September 15, and September 22, 2009. Collagenna's CEO, Michael Arnkvarn participates in each show via a live telephone presentation of the different products while Dr Taebi translates the information into Farsi. The shows will be run as repeats 3 times during the same weeks in order to be viewed by a larger audience.

The Middle East Cosmetic Market is estimated at $ 2.1 Billion USD with one of the World's most rapidly growing market at an estimated growth of 12% annually.

For more information on Dr. Taebi, please visit his website at www.drtaebi.com

Safe Harbor Statement

Information in this news release may contain statements about future expectations, plans, prospects or performance of Global General Technologies, Inc. that constitute forward-looking statements for purposes of the safe harbor Provision's under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. Global General Technologies, Inc. cautions you that any forward-looking information provided by or on behalf of Global General Technologies, Inc. is not a guarantee of future performance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. Global General Technologies Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Global General Technologies Inc.'s control. In addition to those discussed in Global General Technologies Inc.'s press releases, public filings, and statements by Global General Technologies, Inc.'s management, including, but not limited to, Global General Technologies, Inc.'s estimate of the sufficiency of its existing capital resources, Global General Technologies Inc.'s ability to raise additional capital to fund future operations, Global General Technologies Inc.'s ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match Global General Technologies Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Global General Technologies, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

CONTACT: www.minamargroup.com/helpdesk

Butler National Corporation (OTC Bulletin Board: BUKS), a leading manufacturer and provider of support systems for "Classic" commercial and military aircraft, announces its financial results for the first quarter fiscal 2010 for the period ended July 31, 2009. In conjunction with the release, the Company has scheduled a conference call Thursday, September 10, 2009 at 9:00 AM Central Daylight Time.

What: Butler National Corporation First Quarter Fiscal 2010 Financial Results Conference Call

When: Thursday, September 10, 2009 - 9:00 AM Central Daylight Time

How: Live via phone by dialing 800-624-7038. Code: Butler National Corporation. Participants to the conference call should call in at least 5 minutes prior to the start time.

Clark Stewart, President & CEO, Butler National Corp., will be leading the call and discussing results of the first quarter, the status of new and existing orders, gaming activities and an outlook on the balance of fiscal 2010.

Historical selected financial data related to all operations:

                       Quarter Ended July 31        Quarter Ended April 30
                       (In thousands except         (In thousands except
                          per share data)              per share data)
                       ---------------------        ----------------------
                       2009    2008    2007          2009    2008    2007
                       ----    ----    ----          ----    ----    ----
    Net Sales        $6,069   $5,204  $4,707        $4,288  $4,446  $3,906
    Operating
     Income             701      656     410           678   1,015     627
    Net Income          718      318     232           279     662     415
    Total Assets     24,263   32,464  19,878        25,798  27,104  20,445
    Long-term
     Obligations      5,875    6,276   2,426         6,345   6,416   2,521
    Shareholders'
     Equity          13,937   12,509  10,879        13,219  12,190  10,648
    New Product
     Research and
     Development
     Cost               495    1,061     570          (609)    520     439
        nr = not reported

Management Comments:

"Our sales for the fiscal quarter-ended July 31, 2009, increased 17% to $6.1 million as compared to $5.2 million for the same period in fiscal 2009. Net income increased 126% to $718,000 as compared to $318,000 for the same period in fiscal 2009. We continue our efforts to improve the profitability in the delivery of high-value 'Classic Aviation' products.

"Revenue from Aircraft Modifications segment for the three months ending July 31, 2009, were $2.3 million, a decrease of 33.8% from the three months ending July 31, 2008 with revenue of $3.4 million, and an increase of 20% from the three months ending July 31, 2007 with revenue of $1.9 million. The modifications segment had an operating profit of $48,000 in the three months ended July 31, 2009, an operating profit of $775,000 in the three months ending July 31, 2008, and $113,000 in the three months ending July 31, 2007. The revenue and operating profit decline was due primarily to lower RVSM sales and other Learjet modifications not related to special mission projects.

"Revenue from Avionics for the three months ending July 31, 2009, were $2.3 million, an increase of 161% from the three months ending July 31, 2008 with revenue of $871,000, and an increase of 37% from the three months ending July 31, 2007 with revenue of $1.7 million. The avionics segment had an operating profit of $946,000 in the three months ending July 31, 2009, an operating loss of $41,000 in the three months ending July 31, 2008, and an operating profit of $516,000 in the three months ending July 31, 2007. Management expects increased revenue for the fuel system protection devices, when certified, like the TSD, GFI, and other classic aviation and defense products.

"Revenue from Monitoring Services remained stable at $381,000 in the first quarter of fiscal 2010 as compared to the same three months of fiscal 2009. We anticipate increases in revenue from additional lift station rehabilitations over the next three to four years. Revenue fluctuates due to the introduction of new products and services and the related installations of these types of products.

"Operating profits from management services related to gaming decreased 59% from $254,000 for the three months ended July 31, 2008 to $104,000 for the three months ended July 31, 2009. Decreases in operating profit can be attributed to increased expenses towards gaming developments.

"We invested approximately $441,000 towards the purchase of land in Dodge City, Kansas. During the quarter we sold a portion of the land we purchased during fiscal year 2008 for a gain of 25% or $496,000.

"We expensed $495,000, 8% of our sales, on product development. We feel this expenditure for the design and development engineering, testing, and certification of new products may stabilize our long-term revenues and enhance our profits.

"As of August 28, 2009, our backlog totaled $10.8 million. The backlog includes firm, pending, and contract orders, which may not be completed within the next fiscal year. This is consistent with the industry in which modifications services and related contracts may take several months and sometimes years to complete. There can be no assurance that all orders will be completed or that some may ever commence.

"The Company remains well-positioned to grow and continue to increase revenue and income in the coming years. We continue into fiscal 2010 with the focus of serving our customers needs and enhancing shareholder value," commented Clark D. Stewart, President of the Company.

Our Business:

Butler National Corporation operates in the Aerospace and Services business segments. The Aerospace segment focuses on the manufacturing of support systems for "Classic" commercial and military aircraft including the Butler National TSD for the Boeing 737 and 747 Classic aircraft, switching equipment for Boeing McDonnell Douglas Aircraft, weapon control systems for Boeing Helicopter and performance enhancement structural modifications for Learjet, Cessna, Dassault and Beechcraft business aircraft. Services include electronic monitoring of water pumping stations, temporary employee services, gaming services and administrative management services.

Forward-Looking Information:

The information set forth above includes "forward-looking statements" as outlined in the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Words such as "anticipate," "estimate," "expect," "project," "intend," "may," "plan," "predict," "believe," "should" and similar words or expressions are intended to identify forward-looking statements. Investors should not place undue reliance on forward-looking statements, and the Company undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking statements reflect the present expectation of future events of our management and are subject to a number of important factors, risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements. These factors and risks include, but are not limited to the Cautionary Statements and Risk Factors, filed as Exhibit 99 and Section 1A to the Company's Annual Report on Form 10-K, incorporated herein by reference. Investors are specifically referred to such Cautionary Statements and Risk Factors for discussion of factors, which could affect the Company's operations, and forward-looking statements contained herein.

FOR MORE INFORMATION, CONTACT:

    Craig D. Stewart, Investor Relations    Ph  (214) 498-7775
    Butler National Corporation             Fax (913) 780-5088
    19920 W. 161st Street
    Olathe, KS  66062

    Jim Drewitz, Public Relations           Ph  (830) 669-2466
    jim@jdcreativeoptions.com

THE WORLDWIDE WEB:

Please review www.butlernational.com for pictures of our products and details about Butler National Corporation and its subsidiaries.

b> American DG Energy Inc. (OTC Bulletin Board: ADGE), a leading On-Site Utility, offering clean electricity, heat, hot water and cooling solutions to healthcare, hospitality, housing and athletic facilities, today announced an agreement to supply energy to Carleton-Willard Village, a not-for-profit continuing care retirement community (CCRC), located in Bedford, Massachusetts. Under the terms of the agreement, Carleton-Willard, will soon receive a sizable portion of its energy from an On-Site Utility energy system, which will be owned and operated by American DG Energy. Carleton-Willard will receive a discount on the energy produced by the On-Site Utility and reduce its carbon footprint by up to 660 tons of carbon dioxide per year. The value of the deal is $2.2 million, which reflects the recent drop in energy prices.

American DG Energy will produce clean energy in the form of electricity, space heat and hot water at Carleton-Willard's Nursing and Rehabilitation Center building and sell it to Carleton-Willard at a price lower than the local energy utility. Carleton-Willard will pay only for the energy they use and will avoid all capital, installation and operating costs. The energy will be produced with small-scale, combined heat and power (CHP) equipment, up to 150 kW, located at the property site but owned and operated by American DG Energy. Since the Company will also handle all service, maintenance and repair, Carleton-Willard will not need any manpower to support the equipment.

"I'm excited about the project and looking forward to its implementation," said Paul Lund, Director of Facilities Management. "The energy cost savings will free-up funds in the budget while the impact on our carbon footprint pleases us as well as our residents, many of whom are concerned about the environment and want to be part of a community that does what it can to reduce its carbon footprint."

On-Site Utility

American DG Energy sells the energy produced on-site from a combined heat and power (CHP) system to an individual property as an alternative to the outright sale of energy equipment. On-Site Utility customers only pay for the energy produced by the CHP system and receive a guaranteed discount rate on the price of the energy. All system capital, installation and operating expenses are paid by American DG Energy. All system installation, operation and support are handled by the Company as well.

About American DG Energy

American DG Energy supplies low-cost energy to its customers through distributed power generating systems. The Company is committed to providing institutional, commercial, and small industrial facilities with clean, reliable power, cooling, heat and hot water at lower costs than charged by local utilities - without any capital or start-up costs to the energy user. American DG Energy is headquartered in Waltham, Massachusetts. More information can be found at www.americandg.com.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements under the Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. Important factors could cause actual results to differ materially from those indicated by such forward-looking statements, as disclosed on the Company's website and in Securities and Exchange Commission filings. This press release does not constitute an offer to buy or sell securities by the Company, its subsidiaries or any associated party and is meant purely for informational purposes. The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

MyStarU.com, Inc. (OTC Bulletin Board: MYST), is a leading provider of video sharing services in the People's Republic of China. MyStarU.com, Inc.'s platform includes production, uploading, storage, sharing and publishing onto more than 30 main video sharing portal websites. MyStarU.com, Inc. also offers SaaS business solutions and is in the process of developing what MyStarU.com, Inc. believes is the first online shopping mall in the world that will utilize 3D imaging throughout the online interface. MyStarU.com, Inc. management is in the process of organizing the spin-off of its entertainment assets and its importing and exporting business and is committed to reorganizing each of these major business segments as a separate, fully reporting and U.S.-listed public company.

"MyStarU.com, Inc. is focused on the future. We believe fully in each of our business segments but we are committing today to the idea that each business segment will grow stronger and become more profitable over time by operating independently of each other rather than being dependent. We have big plans and we want to move fast. We are excited about the future and are intent on serving the shareholders' best interests," said James Crane, chief financial officer of MyStarU.com, Inc.

About MyStarU.com, Inc.

MyStarU.com, Inc. is a leading provider of video sharing services in the People's Republic of China. MyStarU.com, Inc.'s platform includes production, upload, storage, sharing and publishing onto more than 30 main video sharing portal websites. MyStarU.com, Inc. also offers SaaS business solutions and is in the process of developing what MyStarU.com, Inc. believes is the first online shopping mall in the world that will utilize 3D imaging throughout the online interface. MyStarU.com, Inc.'s platform consists of its websites, http://www.subaye.com , http://www.x381.com , http://www.goongreen.org , and http://www.goongood.com and the Subaye Alliance network, which is its network of third-party websites. The Company's http://www.subaye.com and http://www.x381.com websites are generating revenue, while its other web-based businesses are under development or offering free services to potential customers at this time. Subaye.com's services are designed to enable internet users to find and view videos online. As of August 31, 2009, the Company had approximately 42,000 members and the Company's video database consisted of over 80,000 profiles of corporate video showcases. These showcases offer a cost-effective venue for small to mid-size enterprises ("SMEs") to advertise their products and services and establish and enhance their corporate brands. The Company provides its users with easy access to an index of over three million video clips, images and web pages.

For further information on MyStarU.com, Inc., please visit http://www.subaye.com/english . You may also register to receive MyStarU.com, Inc.'s future press releases or request to be added to the Company's distribution list by contacting James Crane by email at jimc@mystaru.com'>jimc@mystaru.com.

Forward-Looking Statements

Certain statements contained herein constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations, estimates and projections about MyStarU.com's industry, management's beliefs and certain assumptions made by management. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Because such statements involve risks and uncertainties, the actual results and performance of the Company may differ materially from the results expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. MyStarU.com's operations are conducted in the People's Republic of China ("PRC") and, accordingly, are subject to special considerations and significant risks not typically associated with companies in North America. These include risks associated with, among others, the political, economic and legal environment and foreign currency exchange. The Company's results may be adversely affected by changes in the political and social conditions in the PRC and by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion, remittances abroad, and rates and methods of taxation. Other potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain and successfully complete projects, and changes in products and competition. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made here. Readers should review carefully reports or documents the Company files periodically with the Securities and Exchange Commission.

    For more information, please contact:

    At the Company:
     James Crane, Chief Financial Officer
     U.S. Office: +1-617-209-4199
     P.R.C. Cell: +86-152-0120-8012

Yanglin Soybean, Inc. (OTC Bulletin Board: YSYB) ("Yanglin" or the "Company"), one of the leading domestic processors of soybean products in China, today announced that it hosted a research group from the American Soybean Association at the Company's office in Harbin and conducted high-level discussions with members of the research group.

Mr. Shulin Liu, Chief Executive Officer of Yanglin Soybean and other senior members of the Company were on hand to receive their guests. The Company presented their view on the current operating environment, status of the production facilities, as well as conducted high-level discussions on strategies that can help the Company to continue to deliver the highest-quality soybean products to end customers.

"The visit allowed our guests an opportunity to gain a better understanding of our operations, production capabilities and quality control. The exchange of ideas will help us to develop and foster a deeper and more meaningful relationship with our American counterparts," said Mr. Shulin Liu, CEO of Yanglin Soybean, Inc. "Our soybean products have achieved global-quality standards, and our strategic location gives us cost advantages which will benefit our customers. Yanglin is one of the few non-state owned domestic soybean processors in China promoting integration, technological advancement, and superior quality. We intend to increase our production capacity over the next several years to meet the growing demand for our quality soybean products both domestically and abroad."

About Yanglin

Yanglin Soybean, Inc. is one of the leading domestic soybean processors in China. The Company manufactures soybean oil, salad oil and soybean meal with an annual processing capacity of 520,000 metric tons in 2008. The Company's products are sold directly to its customers or through distributors. Majority of Yanglin Soybean's customers are located in Northern China.

Forward Looking Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain statements in this press release and oral statements made by the Company constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. These statements include, without limitation, statements regarding our ability to prepare the company for growth, the Company's planned capacity expansion and predictions and guidance relating to the Company's future financial performance. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs but they involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, which may include, but are not limited to, such factors as unanticipated changes in product demand, pricing and demand trends for the Company's products, changes to government regulations, risk associated with operation of the Company's facilities, risk associated with large scale implementation of the company's business plan, the ability to attract new customers, ability to increase its product's acceptance, cost of raw materials, downturns in the Chinese economy, and other information detailed from time to time in the Company's filings and future filings with the United States Securities and Exchange Commission. Investors are urged to consider these factors carefully in evaluating the forward-looking statements herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by this cautionary statement. The forward-looking statements made herein speak only as of the date of this press release and the Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.

    For more information, please contact:

    Yanglin Soybean, Inc.
     Mr. Bode Xu
     Chief Financial Officer
     Email: cfo@yanglinsoybean.com

    Grayling
     Eddie Cheung / Valentine Ding
     Investor Relations
     Tel:   +1-646-284-9414
     Email: eddie.cheung@us.grayling.com
            valentine.ding@us.grayling.com

Consolidation Services, Inc. ("CNSV"), (OTC Bulletin Board: CNSV), announced today that Buckhorn Resources, LLC, "Buckhorn" which is 50% owned by CNSV, signed a five year coal mining lease agreement with ICG Hazard, LLC, "ICG", a subsidiary of International Coal Group, Inc. (NYSE: ICO), on approximately 1,765 acres. Buckhorn received $108,000 and approximately another $125,000 is due immediately, which pays surface royalties due on about 144,000 tons of previously mined coal and fee (surface and mineral) royalties on approximately 18,000 tons of previously mined coal from the leased portion of the Buckhorn property. Approximately 334,000 tons of coal have been previously mined on disputed areas, of which Buckhorn has a claim for mineral royalties on about 144,000 tons and a fee claim (surface and mineral) on about 190,000 tons. Buckhorn expects its share of these royalties should be in excess of $1,500,000; however, the exact amount will depend upon the outcome of negotiations with counter claimants.

ICG and Buckhorn resolved their overlapping title claims on approximately 391 acres. Dr. Johnny R. Thomas, CEO of CNSV and Managing Member of Buckhorn, confirms that management will be focused on negotiations with the various counter claimants using this negotiation as a model.

Royalties due from future mining on undisputed areas will be due on the 25th of the month following the mining activity. All royalties due from ongoing coal mining activities from disputed areas will be held in escrow until negotiations or judicial rulings resolve the conflicting title claims. Less than half the leased area has had any coal mining activity.

Dr. Thomas also anticipates issuance of the first coal mining permits on CNSV's, LeeCo property (about 840,000 tons of coal) in the next couple of months, with contract mining expected to commence in late 2009 or early 2010. Management anticipates but cannot guarantee, that coal mining royalty revenues will enable the Company to substantially reduce its debt during the next four or five quarters.

About Consolidation Services, Inc.

CNSV is engaged in the acquisition of land and the mineral rights in eastern Kentucky. The Company is focused on investing in and developing potential energy resources, primarily the ability to generate revenues from which coal exists on or under the Company's properties in eastern Kentucky.

Forward Looking Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and under the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release are forward-looking statements. Without limiting the foregoing, the words "believe," "anticipate," "plan," "expect," "seek," "potential", "estimate" and similar expressions are intended to identify forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements.

Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Dale Jarrett Racing Adventure, Inc. (OTC Bulletin Board: DJRT), a "Full Throttle" lifetime experience company, today commented on material mid-quarter accomplishments for the company. As of August 31st, the company has recorded a 14% increase in year-to-date sales over 2008. This report also gives the company the opportunity to highlight some related accomplishments. First, over the course of the past 8 months the company has been building an ongoing relationship with a new international corporate client. We can now report that total revenues from this growing relationship have surpassed $250,000 this year as we continue to plan new outings for this year and beyond. To respond to this growing vertical market, we have increased our sales staff and established a dedicated corporate marketing division. This team of experienced sales people will focus exclusively on expanding our growing list of satisfied corporate clients.

This kind of growth in sales has resulted in our last 6 Racing Adventure dates being completely sold out. We're equally please to report that the next 6 Adventure dates on our calendar are sold out as well. As a result, we have expanded our fleet and have developed two complete Racing Adventure Teams which are available for running simultaneous outings at different race tracks. We recently ran our first double outings date and look forward to adding more dual outings to our existing calendar as circumstances warrant. A Racing Adventure Team consists of a fleet of race ready and safety tested NASCAR style racing cars, racing essentials such as racing suits and Hans Devices(C) plus all the accessories necessary to assure customer satisfaction.

Commenting, Tim Shannon, CEO of Dale Jarrett Racing Adventure said, "We're pleased that, by remaining focused on moving our core business forward and by providing the best adventures available on the market today, we have continued to expand our retail customer base while attracting new major corporate clients. Our corporate packages provide participants with valuable team building and experiential exercises that reward and inspire employees and affiliates in a way that no ordinary entertainment outings possibly can.

"As we continue to build racing adventure revenues, where you can drive former NASCAR stock cars around some of the most famous NASCAR tracks in the country, at speeds of up to 170 mph, we're also working to develop new profit centers and to expand our brand. Our WW II Adventure and our newest Firefighter Adventure set new standards of excellence for both realism and innovation." These adventures can be visited at http://WWIIAdventure.com and http://www.FireFighterAdventure.com. The Dale Jarrett Racing Adventure can be visited at http://www.RacingAdventure.com.

Forward-Looking Statements

Certain of the statements contained in this press release contain forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Dale Jarrett Racing Adventure, Inc. has based these forward-looking statements on its current expectations and projections about future events, based on the information currently available to it. The forward-looking statements contained in this press release may also include statements relating to Dale Jarrett Racing Adventure's anticipated financial performance, business prospects, new developments, strategies and similar matters. Dale Jarrett Racing Adventure disclaims any obligation to update any of its forward-looking statements, except as may be required by law.

    Contact:
    Tim Shannon
    828-466-8837

orycontent>

SCOTTSDALE, AZ, Sept. 8 /PRNewswire-FirstCall/ - Health Enhancement Products, Inc. (HEPI-OTCBB) announced the appointment of Peter Vitulli, a seasoned corporate veteran with a combination of Fortune 500 corporate experience and small/medium growth company expertise, as interim CEO.

Mr. Vitulli's vast experience includes his current position as Chairman of Efficas, Inc., a venture backed leading developer and marketer of natural bioactive compounds utilized for nutritional management of health and wellness in humans and animals. The Efficas scientific platform and expertise focus on the immune system and the tools required in identifying, investigating and assessing effects of bioactives on immune function. Mr. Vitulli spent the first 16 years of his career at the Quaker Oats Company, most recently as President of the North American Gatorade business, one of the premier functional food products in the world.

Mr. Vitulli stated: "I believe Health Enhancement's Products' ProAlgaZyme(TM) represents a break-through technology which will have several health and wellness applications. My goal is to help the team continue its rigorous scientific study while simultaneously developing the business strategy to successfully position ProAlgaZyme as a safe and effective way to address multiple chronic conditions."

To view Mr. Vitulli's complete resume go to: http://www.heponline.com/PVitulliCV-May2009PDF.pdf

John Gorman, Director of Sales for HEPI stated: "Our company is currently undergoing the most extensive clinical trials and scientific studies in its history, which thus far are once again confirming the efficacy of ProAlgaZyme (PAZ). We need a CEO capable of understanding these results and having the expertise to bring PAZ to market and to properly prepare us for introduction to the functional food and pharmaceutical industries. Mr. Vitulli, with vast experience in both biotech research and product marketing, is the person that can take us to that next level."

About Health Enhancement Products, Inc.

Health Enhancement Products, Inc. is an innovative health and wellness company engaged in the development of dietary supplements, food additives and ingredients using only pure, all-natural compounds. The Company's premier product is ProAlgaZyme (PAZ), a liquid product drawn from living algae grown in purified water. The water in which the algae is grown is drawn off, filtered and bottled as ProAlgaZyme.

Safe Harbor Statement

Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the timing of completion of a trial, actual future clinical trial results being different than the results the company has obtained to date, and the company's ability to secure funding. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and those actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.

orycontent>

SHENZHEN, China, Sept. 3 /PRNewswire-FirstCall/ - Hard to Treat Diseases (the "Company") (HTDS.PK) announced today that it has closed its Regulation D, Rule 504 offering and is no longer selling shares of its common stock to accredited investors. A Form D will be filed with the Securities and Exchange Commission shortly, disclosing that the company has raised $990,000 in the offering over the past twelve months. The limit to any such offering is $1 million per year.

HTDS is a holding company for China-based Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Mellow Hope is the biggest exporter of biological vaccines in China. Based on the cooperation with Institutes of Medical Biology and pharmaceutical manufacturers, Mellow Hope provides a wide range of vaccines with high quality, safety and efficacy. HTDS' other controlling interests include an East European (Serbian) medical company, Slavica Biochem, whose experts are performing cutting edge research in the field of neurological impairments in Multiple Sclerosis (MS) and Traumatic Brain Injury (TBI). The primary focus of Slavica Biochem is to investigate novel therapeutic approaches in treatment of these disorders of the CNS (central nervous system), as well as to enhance and modify existing approved drugs such as VIRAZOLE(R).

Closing the 504 offering brings to an end the issuer's recent use of equity in financing operations. With the new increased pool of credit the issuer intends to cover a majority of its upfront costs associated with its increasing contract demands. The issuer is looking forward to releasing quite a bit of new information over the next few weeks, including the finalized contracts as well as outlining its revised business plan to shareholders and potential investors. The revised business plan under consideration includes an anti-aging and cancer treatment project through nutritional supplementation.

The equity in financing has also opened up an opportunity for HTDS management to explore a possible lucrative joint venture project with a North American-based pharmaceutical company.

The issuer does not foresee the need or reason to disturb its current share structure, through dilution or otherwise. Management now intends to recalibrate its focus to its previously announced plans of addressing its share price, and matters that will increase its shareholder value. The issuer remains very optimistic that a 0.03 cent price per share is within its reach.

The issuer intends to furnish its shareholders with forward guidance shortly.

Safe Harbor Statement:

Information in this filing may contain statements about future expectations, plans, prospects or performance of Hard to Treat Diseases, Inc. that constitute forward-looking statements for purposes of the safe harbor Provision's under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. HTDS Corporation cautions you that any forward-looking information provided by or on behalf of Hard to Treat Diseases, Inc. is not a guarantee of future performance. None of the information in this filing constitutes or is intended as an offer to sell securities or investment advice of any kind. Hard to Treat Diseases, Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Hard to Treat Diseases, Inc.'s control. In addition to those discussed in Hard to Treat Diseases, Inc.'s press releases, public filings, and statements by Hard to Treat Diseases, Inc.'s management, including, but not limited to, Hard to Treat Diseases, Inc.'s estimate of the sufficiency of its existing capital resources, Hard to Treat Diseases, Inc.'s ability to raise additional capital to fund future operations, HTDS Corporation's ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match Hard to Treat Diseases, Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Hard to Treat Diseases, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

CONTACT: For medical and scientific dialogue inquiry only, please contact medicalinfo@htdsmedical.com'>medicalinfo@htdsmedical.com; For any corporate matters, please contact www.minamargroup.com/helpdesk

orycontent>

SHENZHEN, China, Sept. 4 /PRNewswire-FirstCall/ - Hard to Treat Diseases (the "Company") (HTDS.PK) announced today, that its China based subsidiary Mellow Hope, has just finished (August 2009) the clinical trial of Cerebroprotein Hydrolysate for Injection (Brand name: NUTRIPROTEIN) in India.

This biological product is a unique nutriment for the brain. It helps CNS in multiple ways, regulating and improving nerve cell metabolism, promoting synapse generation, inducing nerve cell differentiation, protecting nerve cells against damages by ischemia and neurotoxins etc.

This clinical trial is a multicentre one, authorized by Mellow Hope and sponsored by our partner Lupin Limited which is one of the top 3 pharmaceutical companies in India. http://www.lupinworld.com. The aim of this trial is to evaluate the efficacy and safety of this product in the management of subjects with Dementia in an open labeled, prospective, phase-III clinical trial. Through this clinical trial, this product has been approved with very good efficacy and safety.

In other company news, the revised business plan under consideration as per the issuer's news announcement of yesterday September 3 2009 includes an anti-aging and cancer treatment project. More information about cancer treatment project will be shortly available with Slavica Bio Chem (Slavica) on the updated website www.Slavicabiochem.com. Slavica is a second operating subsidiary of HTDS in Serbia, Europe. The aforementioned Mellow Hope and Lupin World clinical trial and cooperation is in addition to research work of Slavica.

Mr. Terry Yuan CEO of HTDS said (sic) "With the completion of this clinical trial, we are expected to receive the registration approval for NUTRIPROTEIN within three months in India. As soon as we get the approval, we will launch this product in the local market. Without any competitors in India, we will win a large market shares."

The issuer intends to provide further updates to its shareholders from both Mellow Hope in China and Slavica Bio Chem in Serbia operations on a frequent basis including certain developments on the anti-aging and cancer treatment project which the issuer is hopeful will have a significant and positive impact on its share price and add value to its shareholders.

More details to follow shortly.

Safe Harbor Statement:

Information in this filing may contain statements about future expectations, plans, prospects or performance of Hard to Treat Diseases, Inc. that constitute forward-looking statements for purposes of the safe harbor Provision's under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. HTDS Corporation cautions you that any forward-looking information provided by or on behalf of Hard to Treat Diseases, Inc. is not a guarantee of future performance. None of the information in this filing constitutes or is intended as an offer to sell securities or investment advice of any kind. Hard to Treat Diseases, Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Hard to Treat Diseases, Inc.'s control. In addition to those discussed in Hard to Treat Diseases, Inc.'s press releases, public filings, and statements by Hard to Treat Diseases, Inc.'s management, including, but not limited to, Hard to Treat Diseases, Inc.'s estimate of the sufficiency of its existing capital resources, Hard to Treat Diseases, Inc.'s ability to raise additional capital to fund future operations, HTDS Corporation's ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match Hard to Treat Diseases, Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Hard to Treat Diseases, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

CONTACT: For medical and scientific dialogue inquiry only, please contact medicalinfo@htdsmedical.com'>medicalinfo@htdsmedical.com; For any corporate matters, please contact www.minamargroup.com/helpdesk

orycontent>

VANCOUVER, Sept. 3 /PRNewswire-FirstCall/ - Callinan is pleased to announce that it has recently entered into an option agreement to earn an interest in 32 mineral claims comprising 5,303 hectares in the Island Lake area of East-Central Manitoba. The Island Lake property hosts several known gold occurrences, including historical drill holes with values of up to 28.3 grams per tonne of gold. Other historic work includes a 70 ton bulk sample mined by Island Lake Gold Mines in 1934 from two pits on the property, from which 47.25 oz of gold was recovered. The property is located on the same system of shears, faults and splays as the previously producing Island Lake Gold Mine operated by Island Lake Gold Mines Limited, according to assessment work filed with the Manitoba government.

"Great gold mines are often found near or under old gold mines," said Callinan President Mike Muzylowski. "Our Island Lake property has a significant mineralized system that has produced gold with good grades. The work done by previous operators, including diamond drilling, trenching and bulk samples, consistently produced gold grades of multiple grams per ton and associated silver values. This gives us a good indication that, with modern geophysical and drilling techniques, we may be able to uncover value in this shear zone."

Induced polarization work done by previous operators has located anomalies as large as 100 by 50 meters, and 140 by 15 meters with coincident gold values. These anomalies remain un-tested.

All assay values and grades referenced at the Island Lake property have been sourced from records of work of previous operators filed with the Manitoba Government. As the work was conducted prior to the implementation of NI 43-101, and Callinan has not been able to verify the methods used and the quality assurance and controls, if any, these early results are disclosed for information purposes only, may not be relevant and should not be relied upon.

Callinan plans to drill test targets in the Island Lake area as part of a winter 2009-2010 drilling program and has budgeted $500,000 for the drilling program. Callinan currently has $11.8M in cash, and continues to receive income from its net profits and royalty interests in the 777 Mine in Flin Flon, Manitoba.

The Island Lake property has been optioned under an option agreement with W.S. Ferreira Ltd. and William Ferreira. The agreement gives Callinan the right to earn an 80% interest in and to the Island Lake claims for initial consideration of $20,000 and the issuance of 50,000 common shares in its capital to W.S .Ferreira Ltd., upon regulatory approval. Callinan will continue to make payments of cash and shares on the anniversary of regulatory approval of the agreement in each of the next three years if the company wishes to continue to earn its interest. Should Callinan elect to exercise the option and acquire the 80% interest, the Company will have issued a further 350,000 common shares and made further cash payments of $380,000 and expended $1,900,000 on the exploration of the property over the three year time period. Upon exercise of the option, the claims will be subject to a 2% net smelter return royalty to W.S. Ferreira Ltd., with 50% of this royalty purchasable by Callinan for a total payment of $1,000,000. The option agreement is subject to regulatory approval.

Callinan's exploration programs are being conducted under the supervision of P.J. DeVeaux, a qualified person as defined by National Instrument 43-101 who has reviewed and approved the contents of this news announcement.

    Mike Muzylowski

    Mike Muzylowski
    President and CEO

    Neither TSX Venture Exchange nor its Regulation Services Provider (as
    that term is defined in the policies of the TSX Venture Exchange) accepts
    responsibility for the adequacy or accuracy of this release.

Some statements in this news release contain forward-looking information. These statements include, but are not limited to, statements with respect to future expenditures. These statements address future events and conditions and, as such, involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the statements. Such factors include, among others, the ability to complete contemplated private placements and the timing and amount of expenditures. Callinan does not assume the obligation to update any forward-looking statement.

China Agritech, Inc. (OTC Bulletin Board: CAGE) ("China Agritech" or "the Company"), a leading national liquid and granular organic compound fertilizer manufacturer and distributor in China, today announced that it will implement a 1 for 4 reverse split of its common stock effective on Tuesday, September 8, 2009. As a result of the reverse split, the stock will begin trading under the symbol "CTEC" on the OTC Bulletin Board, commencing on Tuesday, September 8, 2009.

Each shareholder of record as of September 8, 2009, will have 1 new common share for every 4 common shares previously held. The effect of the reverse split will be to reduce the number of shares of common stock outstanding to approximately 7.0 million from the 28.2 million shares, based on the number of shares outstanding as of June 30, 2009.

Mr. Yu Chang, Chief Executive Officer of China Agritech, commented, "We have successfully implemented our strategic business plan by expanding our sales network, developing sales and distribution relationships, and building capacity for our new organic granular fertilizer products. Our record quarterly financial performance in the 2009 second quarter was a direct result of management's strategic actions to grow the Company. We are pleased with our results year to date and are very enthusiastic about 2010 which should include a full year results of granular and increased sales of liquid. In addition, our capacity expansion for granular fertilizer, which we have already paid for, remains on track for completion by the end of this year. We are also implementing a reverse split to better position China Agritech to meet the qualifying thresholds for a more senior trading exchange in the U.S., which we believe will increase the visibility and trading characteristics of our stock."

About China Agritech, Inc.

China Agritech, Inc. is engaged in the development, manufacture and distribution of liquid and granular organic compound fertilizers and related products in China. The Company has developed proprietary formulas that provide a continuous supply of high-quality agricultural products while maintaining soil fertility. The Company sells its products to farmers located in 28 provinces of China.

For more information about the Company, please visit http://www.chinaagritechinc.com .

Safe Harbor Statement

This release may contain certain "forward-looking statements" relating to the business of China Agritech and its subsidiary companies, which can be identified by the use of forward-looking terminology such as "believes," "expects," "anticipates," "estimates" or similar expressions, including, but not limited to, statements regarding the continued demand for China Agritech's products, China Agritech's ability to sustain growth for the balance of the year and China Agritech's ability to generally meet all of its objectives. Such forward-looking statements involve known and unknown risks and uncertainties, including all business uncertainties relating to product development, marketing, concentration in a single customer, raw material costs, market acceptance, future capital requirements, and competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the SEC. Except as required by law, China Agritech is under no obligation to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

    For more information, please contact:

    In China:
     Mr. Gareth Tang
     Chief Financial Officer
     China Agritech, Inc.
     Tel:   +86-10-5962-1220
     Email: gareth@chinaagritech.com

    In the U.S.:
     Mr. Kevin Theiss / Mr. Valentine Ding
     Investor Relations
     Grayling
     Tel:   +1-646-284-9409
     Email: kevin.theiss@us.grayling.com
            valentine.ding@us.grayling.com

INFINITE Software Corporation (Pink Sheets: IFSC), a leader in Legacy Extension, Business Intelligence and Enterprise Infrastructure, announced today that it has been awarded a contract to migrate and modernize legacy software that currently runs on IBM hardware. The successful proposal from INFINITE and HP will provide software, services and hardware to allow Valbruna Stainless Steel's IBM legacy software to run on 21st century HP servers via browser.

INFINITE is a global software services and infrastructure company that enjoys over 100,000 installations in 56 countries. Carol Conway, the company's president said, "This contract with Valbruna represents another significant win for INFINITE. We are positioned to serve customers, both domestic and international, as a result of our global alliances with HP, our multi-national presence, and decades of experience with legacy migration."

INFINITE is HP's exclusive worldwide partner for AS/400 software migration. INFINITE engages with HP's services, software and Business Critical Systems teams globally to assist IBM clients in transitioning to more modern and cost-effective platforms.

About INFINITE Software Corporation

INFINITE Software is a global provider of software and services for the legacy extension and financial services markets. The company is headquartered in Orange County, CA and operates globally from offices in Asia, North America, South America and Europe. The Company's products are marketed under the brand names INFINITE and LPS. INFINITE Software enjoys over 100,000 installations in 56 countries.

About Valbruna Stainless Steel

Valbruna Stainless Steel is a leader in the steel industry and both supplier and producer of stainless steel and special metal alloys. A privately owned company, Valbruna has over 1500 employees and produces more than 170,000 tons of special high quality steels. Founded in 1925, Valbruna Stainless Steel maintains its original business strategy of serving niche markets with high quality products and dedicated service to its clients.

Safe Harbor Statement

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as INFINITE Software or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

orycontent>

VANCOUVER, Sept. 3 /PRNewswire-FirstCall/ - Callinan is pleased to announce that it has recently entered into an option agreement to earn an interest in 32 mineral claims comprising 5,303 hectares in the Island Lake area of East-Central Manitoba. The Island Lake property hosts several known gold occurrences, including historical drill holes with values of up to 28.3 grams per tonne of gold. Other historic work includes a 70 ton bulk sample mined by Island Lake Gold Mines in 1934 from two pits on the property, from which 47.25 oz of gold was recovered. The property is located on the same system of shears, faults and splays as the previously producing Island Lake Gold Mine operated by Island Lake Gold Mines Limited, according to assessment work filed with the Manitoba government.

"Great gold mines are often found near or under old gold mines," said Callinan President Mike Muzylowski. "Our Island Lake property has a significant mineralized system that has produced gold with good grades. The work done by previous operators, including diamond drilling, trenching and bulk samples, consistently produced gold grades of multiple grams per ton and associated silver values. This gives us a good indication that, with modern geophysical and drilling techniques, we may be able to uncover value in this shear zone."

Induced polarization work done by previous operators has located anomalies as large as 100 by 50 meters, and 140 by 15 meters with coincident gold values. These anomalies remain un-tested.

All assay values and grades referenced at the Island Lake property have been sourced from records of work of previous operators filed with the Manitoba Government. As the work was conducted prior to the implementation of NI 43-101, and Callinan has not been able to verify the methods used and the quality assurance and controls, if any, these early results are disclosed for information purposes only, may not be relevant and should not be relied upon.

Callinan plans to drill test targets in the Island Lake area as part of a winter 2009-2010 drilling program and has budgeted $500,000 for the drilling program. Callinan currently has $11.8M in cash, and continues to receive income from its net profits and royalty interests in the 777 Mine in Flin Flon, Manitoba.

The Island Lake property has been optioned under an option agreement with W.S. Ferreira Ltd. and William Ferreira. The agreement gives Callinan the right to earn an 80% interest in and to the Island Lake claims for initial consideration of $20,000 and the issuance of 50,000 common shares in its capital to W.S .Ferreira Ltd., upon regulatory approval. Callinan will continue to make payments of cash and shares on the anniversary of regulatory approval of the agreement in each of the next three years if the company wishes to continue to earn its interest. Should Callinan elect to exercise the option and acquire the 80% interest, the Company will have issued a further 350,000 common shares and made further cash payments of $380,000 and expended $1,900,000 on the exploration of the property over the three year time period. Upon exercise of the option, the claims will be subject to a 2% net smelter return royalty to W.S. Ferreira Ltd., with 50% of this royalty purchasable by Callinan for a total payment of $1,000,000. The option agreement is subject to regulatory approval.

Callinan's exploration programs are being conducted under the supervision of P.J. DeVeaux, a qualified person as defined by National Instrument 43-101 who has reviewed and approved the contents of this news announcement.

    Mike Muzylowski

    Mike Muzylowski
    President and CEO

    Neither TSX Venture Exchange nor its Regulation Services Provider (as
    that term is defined in the policies of the TSX Venture Exchange) accepts
    responsibility for the adequacy or accuracy of this release.

Some statements in this news release contain forward-looking information. These statements include, but are not limited to, statements with respect to future expenditures. These statements address future events and conditions and, as such, involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the statements. Such factors include, among others, the ability to complete contemplated private placements and the timing and amount of expenditures. Callinan does not assume the obligation to update any forward-looking statement.

orycontent>

VANCOUVER, Sept. 3 /PRNewswire-FirstCall/ - Pacific North West Capital Corp. ("PFN") (TSX: PFN; OTCBB: PAWEF; Frankfurt: P7J.F) is pleased to announce the appointment of Christopher Davies, B.Sc., M.Sc., D.I.C., to its Technical Committee. Mr. Davies has extensive global experience in gold and Platinum Group Metal (PGM) operations, exploration and mine development, with particular emphasis on southern Africa. Mr. Davies spent nearly 20 years with Lonmin plc, serving as Technical Director in South Africa from 1991 to 1998, Group Technical Director in the London office from 1998 to 2004, and Vice President: Exploration and Business Development until the end of 2008. He was closely involved with the expansion of Lonmin's PGM production and rationalisation of its gold mines in Zimbabwe, as well as a number of evaluations of potential gold and PGM acquisition targets. Mr. Davies has negotiated, executed and managed exploration and development agreements with both the junior and major mining sectors, and with governments, in a number of countries. He has also served on the boards of public companies in South Africa and Australia.

Harry Barr, President and CEO stated: "Mr. Davies will add significantly to the technical and commercial capabilities of the Company, particularly with respect to those countries in Africa where PFN management believes there is excellent potential for new PGM discoveries. Specifically, we have asked Mr. Davies to assist us to locate and acquire high quality properties in South Africa, Zimbabwe and Tanzania. We believe this region has excellent mineral potential as well as the economic framework required for the successful development of new discoveries."

The addition of Mr. Davies adds a wealth of knowledge and experience, particularly in sub-Saharan Africa, to PFN's Technical Committee. Together with John Royal and John Londry, two highly experienced former officers of the Company, the Technical Committee will guide the Company in its new strategy of focussing on more advanced project acquisitions.

About Pacific North West Capital Corp:

Pacific North West Capital Corp. (TSX: PFN; OTCBB: PAWEF; Frankfurt: P7J.F) is a mineral exploration company focused on Platinum Group Metals (PGM), precious and base metals. Management's corporate philosophy is to be a Project Generator, Explorer and Project Operator with the objective of optioning/joint venturing projects with major and junior mining companies through to production. To that end, Pacific North West Capital's current option/joint venture agreements are with Anglo Platinum, First Nickel, Kinbauri Gold and Fire River Gold. Pacific North West Capital Corp. is well funded with an experienced management team and the ability to take advantage of the tremendous opportunities that are available in the mining sector today. Our focus will be to acquire advanced stage precious metals projects, continue to expand our PGM and base metals division and to look for special situations and under-funded projects in the resource sector.

Pacific North West Capital Corp. has approximately $4.6 million in working capital and securities.

    On behalf of the Board of Directors

    (signed)

    Harry Barr
    President and CEO

    The Toronto Stock Exchange has not reviewed and does not accept
    responsibility for the adequacy or accuracy of this release

Disclaimer: This news release may contain certain "Forward-Looking Statements" within the meaning of Section 21E of the United States Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, included herein are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time with The Toronto Stock Exchange, British Columbia Securities Commission and the United States Securities Exchange Commission.

Orient Paper, Inc. (OTC Bulletin Board: OPAI) ("Orient Paper" or the "Company"), which controls and operates Hebei Baoding Orient Paper Milling Co., Ltd. ("HBOP"), a leading manufacturer and distributor of diversified paper products in Hebei, China, today announced that the Company's management team will attend the upcoming Rodman & Renshaw Annual Global Investment Conference.

The date, time and location of Orient Paper's presentation at the conference are as follows:

    Date:       Thursday, September 10, 2009
    Time:       5:45 p.m. Eastern Time
    Venue:      Asia Track
                New York Palace Hotel
                New York, NY
    Webcast:   http://www.wsw.com/webcast/rrshq15/opai.ob

A replay of the presentation will be available for 90 days following the live presentation using the same link.

During the conference, the Company will be available to meet with analysts and portfolio managers. Interested parties and investors who wish to meet with Orient Paper's management may contact mwoodson@rodm.com'>mwoodson@rodm.com or call (212) 430-1782. Participation in the Rodman and Renshaw Annual Global Investment Conference is by invitation only.

About Rodman & Renshaw, LLC.

Rodman & Renshaw, LLC is a full service investment bank dedicated to providing investment banking services to companies that have significant capital needs, along with research and sales and trading services to investor clients. Rodman is a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets according to PrivateRaise a service of DealFlow Media Inc. and Sagient Research Systems, Inc.

About Orient Paper, Inc.

Orient Paper, Inc., through its wholly owned subsidiaries, Shengde Holdings, Inc. and Baoding Shengde Paper Co., Ltd., controls and operates Hebei Baoding Orient Paper Milling Co., Ltd ("HBOP"). Founded in 1996, HBOP is engaged in the production and distribution of products such as corrugated paper, offset paper, writing paper, and other paper and packaging-related products in China. The Company uses recycled paper as its primary raw material. As one of the largest paper producers in Hebei Province, China, the Company is strategically located in Baoding, a city in close proximity to Beijing where the majority of publishing houses are based. Orient Paper is led by an experienced management team committed to diversifying the Company's product offering and delivering tailored services to its customers. For more information, please visit http://www.orientalpapercorporation.com .

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact in this announcement are forward-looking statements, including but not limited to, the availability of funds and working capital to finance its activities; the actions and initiatives of current and potential competitors; the Company's ability to introduce new products; market acceptance of new products; general economic and business conditions; the ability to attract or retain qualified senior management personnel and research and development staff; and other risks detailed in the Company's filings with the Securities and Exchange Commission. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations, assumptions, estimates and projections about the companies and the industry. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or to changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward looking statements are reasonable, it cannot assure you that its expectations will turn out to be correct, and investors are cautioned that actual results may differ materially from the anticipated results.

    For more information, please contact:

    Orient Paper, Inc.
     Sally Yang, Director, Investor Relations
     Phone: +86-312-869-8215
     Email: info@orientalpapercorporation.com

    CCG Investor Relations Inc.
     Mr. Crocker Coulson, President
     Phone: +1-646-213-1915 (New York)
     Email: crocker.coulson@ccgir.com
     Web:  http://www.ccgirasia.com

Green Bridge Industries, Inc. (OTCPK: GRBG) is pleased to announce that the Company will be exhibiting in the Green Building (Building 5) in booth 5210 at this year's L.A. County Fair, which runs from September 5 through October 4. Green Bridge Industries will be marketing and selling their ZAP(TM) Stain Remover Pen to the approximately 1.3 Million fairgoers. All the proceeds from the sales of ZAP(TM) Stain Remover Pen will be donated to various charities. The LA County Fair is located at the Pomona Fairgrounds and will have various events throughout the month.

The L.A. County Fair will have concerts, rides, special promotions, shopping, and engaging entertainment and education activities for kids. The main attraction at the L.A. County Fair is the largest carnival midway in the nation, featuring more than 70 thrill rides and 40 challenging games. The award winning Ray Cammack Shows returns to the fair for their 25th consecutive year as well. The fair will also feature La Grande Wheel, which is the largest mobile Ferris wheel in the Western Hemisphere. The event will also feature live horse racing, an international wine and spirits marketplace, and concerts featuring artists such as Al Green, The Spinners, Good Charlotte, Peter Frampton, and the Beach Boys.

"We are excited to be a part of one of the largest fairs in the United States. We will not only have an opportunity to sell our products where the entire proceeds are going to charity, but we will be able to educate consumers about the benefits of using environmentally friendly cleaning products," stated William White, Chairman and CEO of Green Bridge Industries, Inc.

For more information on the L.A. County Fair, please visit http://www.lacountyfair.com/2009/index.asp.

About Green Bridge Industries, Inc.:

Green Bridge Industries, Inc. offers non-toxic, environmentally friendly cleaning products to fit the sanitation needs of the medical, agricultural, military, and retail markets. The Company, through its proprietary technology, has the ability to develop bio-renewable alternative cleaning products, which are superior to the synthetic products currently offered in the marketplace. The Company's products are safe for the surfaces it cleans, the environment, animals and humans.

Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

                                        Contact:
                              Green Bridge Industries, Inc.
                              www.greenbridgeindustries.com
                                   Investor Relations
                                      407-389-5900

Green Bridge Technologies International, Inc. (Pink Sheets: GRBT), is pleased to announce that the Company's Board of Directors has approved a reduction in the number of authorized common shares from 10 billion to 975 million common shares. The Board then submitted a resolution to the shareholders to amend the Articles of Incorporation to reflect this reduction and a majority of shareholders voted for this resolution. The Company is currently applying to the state of Florida to effect this change.

The Board of Directors believe the current share price is not in line with the value of the Company and that the reduction of authorized shares will help improve the share price and increase the overall value of the Company.

"The Board of Directors decided that a reduction in the number of authorized shares would have a positive effect on both our share price and shareholder confidence. We believe our shareholders will be more comfortable with a number of authorized shares that better reflects our current outstanding," stated Leonard Baxter, CEO and President of Green Bridge Technologies International, Inc.

About Green Bridge Technologies International, Inc.:

Green Bridge Technologies International, Inc. is a technology based company that concentrates on developing and marketing new energy efficient products and services. The Company operates an incubator facility and works with inventors and early stage development companies that have technologies that will help reduce US energy needs. Through its wholly owned subsidiary Ecologix, the Company provides solutions for vehicle and asset recovery and tracking. The tracking technology product line has applications for data and tracking functions across a variety of industries, utilizing CDMA, IDEN, and GSM technologies.

Statements contained in this news release, other than those identifying historical facts, constitute "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934 and the Safe Harbor provisions as contained in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relating to the Company's future expectations, including but not limited to revenues and earnings, technology efficacy, strategies and plans, are subject to safe harbors protection. Actual Company results and performance may be materially different from any future results, performance, strategies, plans, or achievements that may be expressed or implied by any such forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements.

.

Orient Paper, Inc. (OTC Bulletin Board: OPAI) ("Orient Paper" or the "Company"), which controls and operates Hebei Baoding Orient Paper Milling Co., Ltd. ("HBOP"), a leading manufacturer and distributor of diversified paper products in Hebei, China, today announced that the Company's management team will attend the upcoming Rodman & Renshaw Annual Global Investment Conference.

The date, time and location of Orient Paper's presentation at the conference are as follows:

    Date:       Thursday, September 10, 2009
    Time:       5:45 p.m. Eastern Time
    Venue:      Asia Track
                New York Palace Hotel
                New York, NY
    Webcast:   http://www.wsw.com/webcast/rrshq15/opai.ob

A replay of the presentation will be available for 90 days following the live presentation using the same link.

During the conference, the Company will be available to meet with analysts and portfolio managers. Interested parties and investors who wish to meet with Orient Paper's management may contact mwoodson@rodm.com'>mwoodson@rodm.com or call (212) 430-1782. Participation in the Rodman and Renshaw Annual Global Investment Conference is by invitation only.

About Rodman & Renshaw, LLC.

Rodman & Renshaw, LLC is a full service investment bank dedicated to providing investment banking services to companies that have significant capital needs, along with research and sales and trading services to investor clients. Rodman is a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets according to PrivateRaise a service of DealFlow Media Inc. and Sagient Research Systems, Inc.

About Orient Paper, Inc.

Orient Paper, Inc., through its wholly owned subsidiaries, Shengde Holdings, Inc. and Baoding Shengde Paper Co., Ltd., controls and operates Hebei Baoding Orient Paper Milling Co., Ltd ("HBOP"). Founded in 1996, HBOP is engaged in the production and distribution of products such as corrugated paper, offset paper, writing paper, and other paper and packaging-related products in China. The Company uses recycled paper as its primary raw material. As one of the largest paper producers in Hebei Province, China, the Company is strategically located in Baoding, a city in close proximity to Beijing where the majority of publishing houses are based. Orient Paper is led by an experienced management team committed to diversifying the Company's product offering and delivering tailored services to its customers. For more information, please visit http://www.orientalpapercorporation.com .

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact in this announcement are forward-looking statements, including but not limited to, the availability of funds and working capital to finance its activities; the actions and initiatives of current and potential competitors; the Company's ability to introduce new products; market acceptance of new products; general economic and business conditions; the ability to attract or retain qualified senior management personnel and research and development staff; and other risks detailed in the Company's filings with the Securities and Exchange Commission. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations, assumptions, estimates and projections about the companies and the industry. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or to changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward looking statements are reasonable, it cannot assure you that its expectations will turn out to be correct, and investors are cautioned that actual results may differ materially from the anticipated results.

    For more information, please contact:

    Orient Paper, Inc.
     Sally Yang, Director, Investor Relations
     Phone: +86-312-869-8215
     Email: info@orientalpapercorporation.com

    CCG Investor Relations Inc.
     Mr. Crocker Coulson, President
     Phone: +1-646-213-1915 (New York)
     Email: crocker.coulson@ccgir.com
     Web:  http://www.ccgirasia.com

China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), operating through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. ("Taibang") and Chongqing Dalin Biologic Technologies Co., Ltd. ("Dalin") and its equity investment in Xi'an Huitian Blood Products Co., Ltd. ("Huitian"), today announced that the Company's management team will attend the upcoming Rodman & Renshaw Annual Global Investment Conference.

The date, time and location of China Biologic's presentation at the conference are as follows:

    Date:           Thursday, September 10, 2009
    Time:           12.05 p.m. Eastern Time
    Venue:          Asia Track
                    New York Palace Hotel
                    New York, NY

During the conference, the Company will be available to meet with analysts and portfolio managers. Interested parties and investors who wish to meet with China Biologic's management may contact mwoodson@rodm.com'>mwoodson@rodm.com or call (212) 430-1782. Participation in the Rodman & Renshaw Annual Global Investment Conference is by invitation only.

About Rodman & Renshaw, LLC.

Rodman & Renshaw, LLC is a full service investment bank dedicated to providing investment banking services to companies that have significant capital needs, along with research and sales and trading services to investor clients. Rodman is a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets according to PrivateRaise a service of DealFlow Media Inc. and Sagient Research Systems, Inc.

About China Biologic Products, Inc.

China Biologic Products, Inc. (the "Company"), through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Chongqing Dalin Biologic Technologies Co., Ltd, and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is currently the largest non-state-owned plasma-based biopharmaceutical company in China. The Company is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies, and are used for the prevention and treatment of various diseases. It sells its products to hospitals and other healthcare facilities in China.

    For more information, please contact:

    Company Contact:
     Mr. Y. Tristan Kuo
     Chief Financial Officer
     China Biologic Products, Inc.
     Tel:   +86-538-6202206
     Email: IR@chinabiologic.com
     Web:  http://www.chinabiologic.com

    Investor Relations Contact:
     Mr. Crocker Coulson, President
     CCG Investor Relations
     Tel:   +1-646-213-1915 (NY office) or
     Mr. Gary Chin
     Tel:   +1-646-213-1909
     Email: crocker.coulson@ccgir.com
     Web:  http://www.ccgirasia.com

China Industrial Waste Management, Inc. (OTC Bulletin Board: CIWT) ("China Industrial Waste Management" or the "Company"), a PRC-based industrial waste processor and provider of environmental protection, pollution treatment and waste management design services, announced today that it attended the "Sino-German Workshop in Response to Climate Change Application of Sludge Treatment Technologies and Potential CDM Projects" on August 31st and September 1st in Dalian, China.

The Workshop was organized by the Ministry of Housing and Urban-Rural Development of the Peoples' Republic of China ("MOHURD") and the German Federal Environmental Department of Nature Conservation and Nuclear Safety. Experts from China and Germany introduced the current practice of sludge treatment in both countries and its further development in the context of Clean Development Mechanisms ("CDM").

Mr. Jun Liu, General Engineer of Dongtai Organic Waste Treatment Co., Ltd. ("Dongtai Organic"), the Company's subsidiary, introduced a sludge treatment project in Dalian, operated by Dongtai Organic. Participants of the seminar visited Dongtai Organic's sludge treatment facility. The initial six fermentation tanks are in trial production and are performing very well. Once completed, there will be 12 fermentation tanks in operation. The designed capacity of this project is 600 tons per day for sludge treatment, and 25,000-30,000 m3 per day for biogas generation.

The company's core technology of anaerobic digestion and its successful application was highly praised by representatives from MOHURD, and they recommended this technology and equipment be applied in other cities as well.

"We were pleased to have attended this seminar for an extensive discussion with experts in the sludge treatment industry," said Mr. Jinqing Dong, the Company's Chief Executive Officer. "The success of our sludge treatment project in Dalian has attracted increasing attention from domestic and overseas specialists."

Currently, a 12-km-long biogas pipe network is under construction. Management anticipates that this network will be completed by end of October 2009. The biogas generated by these 12 fermentation tanks will be distributed through the network to end-users in Dalian as a supplement to town gas.

About China Industrial Waste Management, Inc.

China Industrial Waste Management, Inc. is engaged in the collection, treatment, disposal and recycling of industrial wastes principally in Dalian and surrounding areas in Liaoning Province, People's Republic of China through its 90%-owned subsidiary Dalian Dongtai Industrial Waste Treatment Co., Ltd. ("Dongtai") and other indirect subsidiaries. Dongtai treats, disposes of and/or recycles many types of industrial wastes, and recycled waste products used by customers as raw material to produce chemical and metallurgy products. In addition, Dongtai treats or disposes of industrial waste through incineration, burial or water treatment, and provides environmental protection services, technology consultation, pollution treatment services, waste management design processing services, waste disposal solutions, waste transportation services, onsite waste management services, and environmental pollution remediation services. For more information, please visit: http://www.chinaciwt.com .

Cautionary Statement Regarding Forward-Looking Information

This release may include "forward-looking statements." You can identify these statements by the fact that they do not relate strictly to historical or current facts. These statements contain such words as "may," "project," "might," "expect," "believe," "anticipate," "intend," "could," "would," "estimate," or the negative or other variations thereof or comparable terminology. These forward-looking statements are based on current expectations and projections about future events. Investors are cautioned that forward-looking statements are not guarantees of future performance or results and involve risks and uncertainties that cannot be predicted or quantified and, consequently, our actual performance may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to, the following factors, as well as other factors described from time to time in our reports filed with the Securities and Exchange Commission: the timing and magnitude of technological advances; the prospects for future acquisitions; the effects of political, economic and social uncertainties regarding the governmental, economic and political circumstances in the People's Republic of China, the possibility that a current customer could be acquired or otherwise be affected by a future event that would diminish their waste management requirements; the competition in the waste management industry and the impact of such competition on pricing, revenues and margins; uncertainties surrounding budget reductions or changes in funding priorities of existing government programs and the cost of attracting and retaining highly skilled personnel; our projected sales, profitability, and cash flows; our growth strategies; anticipated trends in our industries; our future financing plans; and our anticipated needs for working capital. Forward-looking statements speak only as of the date on which they are made, and, except to the extent required by federal securities laws, we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events.

    For more information, please contact:

    Company Contact:
     Ms. Guo Xin, CFO
     Tel:   +86-411-8581-1229
     Email: hellenguo@chinaciwt.com
     Mr. Zhang Dazhi, Company Secretary
     Tel:   +86-411-8259-5339
     Email: darcy.zhang@chinaciwt.com
     Web:  http://www.chinaciwt.com

    CCG Investor Relations:
     Mr. Crocker Coulson, President
     Phone: +1-646-213-1915 (New York) or
     Mr. Gary Chin, Tel +1-646-213-1909
     Email: crocker.coulson@ccgir.com
     Web:  http://www.ccgirasia.com

Rahaxi, Inc. (OTC Bulletin Board: RHXI) an international card payments processor and technology company, today announces that its subsidiary Rahaxi Processing Oy, in Helsinki has increased the volume of transactions by 27% as compared for the same month in 2008.

Transaction numbers jumped from 1,554,548 to 1,981,106 for the month of June, whereas in July they increased from 1,745,120 to 2,238,416. These numbers reflect the steady increase in deployment of our POS Hardware and software solutions to the Finnish domestic market.

Paul Egan, Rahaxi, Inc CEO, explained, "As we move forward, each goal we achieve enables us to further extend our reach within the global processing community. It's a strategic and consistent trend we intend on continuing. This has resulted in an a significant increase in transactions over the same period last year."

About Rahaxi, Inc.

Rahaxi, Inc. provides mission-critical solutions to the financial industry worldwide. Working with merchants and acquirers in more than twenty countries, its product suite has empowered partners to focus on their core competencies, while its innovative driven approach has enabled them to benefit from first to market advantage and realize their true potential. Rahaxi Inc. has adopted a partnership strategy for growth. Its partners are market leaders in their respective industries. These include IKEA, Finnair and Stockmann. Its subsidiaries, Rahaxi Processing Oy., Finland, FreeStar Technologies Ireland, Ltd., and FreeStar Dominicana S.A. Dominican Republic, continue to develop and implement first class products and solutions that enhance the service level its partners can offer their customers.

For more information, please visit http://www.rahaxi.com

    Contact

    For more information, please contact:
    At Rahaxi, Inc.
    Fionn Stakelum
    Managing Director f.stakelum@rahaxi.com
    (09) 612 0730

Diguang International Development Co., Ltd. (OTC Bulletin Board: DGNG) ("Diguang" or "the Company") today announced that the Company will participate at the 2009 IFA Consumer Electronics Show in Berlin, Germany from September 4-9, 2009.

    (Logo:http://www.newscom.com/cgi-bin/prnh/20070830/CNTH005LOGO )

    Diguang's booth will be at the below location:

     IFA 2009
     Diguang International Development Co., Ltd,
     Hall 26
     Messedamm 22
     14055 Berlin

Diguang will present its newly-developed LED backlight integrated products, including 19 inch and 22 inch ultra-slim LED monitors, 19, 22, 26 inch and 32 inch LED TVs, 19 inch all-in-one PCs and other innovations at the IFA Consumer Electronics Show.

Diguang's CEO, Mr. Song Yi, will attend the show. Mr. Song commented, "Since March 2009, our LED backlight value-added products have been sold in China's major cities and attracted great interest from various domestic branded companies for further cooperation. Our products have also attracted a great deal of attention and accolades from consumers and the media. While we continue to develop new products, we remain dedicated and focused on our marketing efforts for our LED backlight products in the global market by promoting the concept of modern, energy saving, and environmentally friendly electronic products. We would like to welcome companies from all over the world to the visit our booth at the IFA Consumer Electronics Show."

For further details about the IAS Consumer Electronic Show, please visit http://tinyurl.com/nfz2q7 .

About Diguang International Development Co., Ltd.

Through its subsidiaries, Diguang International develops and produces CCFL and LED backlights for a wide range of TFT-LCD products. A backlight is the typical light source of a liquid crystal display (LCD), with applications spanning televisions, computer monitors, cellular phones, digital cameras, DVDs and other home appliances. Leveraging its LED expertise, the Company also creates and markets energy-saving technologies and solutions for rapidly growing markets such as LED backlight monitors and LED general lighting. For more information, contact CCG Investor Relations directly or go to Diguang's website at http://www.diguangintl.com .

Safe Harbor Statements

This press release contains forward-looking statements made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward looking statements are based upon the current plans, estimates and projections of Diguang's management and are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. Therefore, you should not place undue reliance on these forward-looking statements. The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: government support of LED products, prospective success of new and existing products, business conditions in China and globally; weather and natural disasters; legislative or regulatory environments, requirements or changes adversely affecting the businesses in which Diguang is engaged; fluctuations in customer demand; management of rapid growth; intensity of competition; timing approval and market acceptance of new product introductions; general economic conditions; geopolitical events and regulatory changes, as well as other relevant risks, including but not limited to risks outlined in the Company's periodic filings with the U.S. Securities and Exchange Commission. Diguang does not assume any obligation to update the information contained in this press release.

    For more information, please contact:

    Company Contact:
     Viola Tse
     Diguang International Development Co., Ltd.
     Tel:   +1-626-593-5486
     Email: viola@diguang.com
     Web:  http://www.diguangintl.com

    Investor Relations Contact:
     Elaine Ketchmere, Partner
     CCG Investor Relations
     Tel:   +1-310-954-1345
     Email: Elaine.ketchmere@ccgir.com
     Web:  http://www.ccgirasia.com

orycontent>

VANCOUVER, Sept. 3 /PRNewswire-FirstCall/ - Pacific North West Capital Corp. ("PFN") (TSX: PFN; OTCBB: PAWEF; Frankfurt: P7J.F) is pleased to announce the appointment of Christopher Davies, B.Sc., M.Sc., D.I.C., to its Technical Committee. Mr. Davies has extensive global experience in gold and Platinum Group Metal (PGM) operations, exploration and mine development, with particular emphasis on southern Africa. Mr. Davies spent nearly 20 years with Lonmin plc, serving as Technical Director in South Africa from 1991 to 1998, Group Technical Director in the London office from 1998 to 2004, and Vice President: Exploration and Business Development until the end of 2008. He was closely involved with the expansion of Lonmin's PGM production and rationalisation of its gold mines in Zimbabwe, as well as a number of evaluations of potential gold and PGM acquisition targets. Mr. Davies has negotiated, executed and managed exploration and development agreements with both the junior and major mining sectors, and with governments, in a number of countries. He has also served on the boards of public companies in South Africa and Australia.

Harry Barr, President and CEO stated: "Mr. Davies will add significantly to the technical and commercial capabilities of the Company, particularly with respect to those countries in Africa where PFN management believes there is excellent potential for new PGM discoveries. Specifically, we have asked Mr. Davies to assist us to locate and acquire high quality properties in South Africa, Zimbabwe and Tanzania. We believe this region has excellent mineral potential as well as the economic framework required for the successful development of new discoveries."

The addition of Mr. Davies adds a wealth of knowledge and experience, particularly in sub-Saharan Africa, to PFN's Technical Committee. Together with John Royal and John Londry, two highly experienced former officers of the Company, the Technical Committee will guide the Company in its new strategy of focussing on more advanced project acquisitions.

About Pacific North West Capital Corp:

Pacific North West Capital Corp. (TSX: PFN; OTCBB: PAWEF; Frankfurt: P7J.F) is a mineral exploration company focused on Platinum Group Metals (PGM), precious and base metals. Management's corporate philosophy is to be a Project Generator, Explorer and Project Operator with the objective of optioning/joint venturing projects with major and junior mining companies through to production. To that end, Pacific North West Capital's current option/joint venture agreements are with Anglo Platinum, First Nickel, Kinbauri Gold and Fire River Gold. Pacific North West Capital Corp. is well funded with an experienced management team and the ability to take advantage of the tremendous opportunities that are available in the mining sector today. Our focus will be to acquire advanced stage precious metals projects, continue to expand our PGM and base metals division and to look for special situations and under-funded projects in the resource sector.

Pacific North West Capital Corp. has approximately $4.6 million in working capital and securities.

    On behalf of the Board of Directors

    (signed)

    Harry Barr
    President and CEO

    The Toronto Stock Exchange has not reviewed and does not accept
    responsibility for the adequacy or accuracy of this release

Disclaimer: This news release may contain certain "Forward-Looking Statements" within the meaning of Section 21E of the United States Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, included herein are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time with The Toronto Stock Exchange, British Columbia Securities Commission and the United States Securities Exchange Commission.

Yuhe International Inc. (OTC Bulletin Board: YUII) ("Yuhe" or "the Company"), a leading supplier of day-old chickens raised for meat production, or broilers, in the People's Republic of China ("PRC"), today announced that the Company's management will present at the upcoming Rodman & Renshaw Annual Global Investment Conference and attend the Susquehanna Financial Group Third Annual Beijing Management Summit.

    Rodman & Renshaw Annual Global Investment Conference
    Date:      Thursday, September 10, 2009
    Time:      4:55 p.m. Eastern Time
    Presenter: Mr. Jason Wang, Director of Investor Relations
    Venue:     Asia Track
               New York Palace Hotel
               New York, NY

During the conference, the Company will be available to meet with analysts and portfolio managers. Interested parties and investors who wish to meet with Yuhe's management may contact mwoodson@rodm.com'>mwoodson@rodm.com or call (212) 430-1782. Participation in the Rodman & Renshaw Annual Global Investment Conference is by invitation only.

Susquehanna Financial Group Third Annual Beijing Management Summit

Mr. Zhentao Gao, chief executive officer, and Mr. Vincent Hu, chief financial officer, will participate in one-on-one meetings at the Susquehanna Financial Group Third Annual Beijing Management Summit to be held September 16-17, 2009 at the Grand Hyatt Beijing Hotel in Beijing, People's Republic of China.

About Yuhe International, Inc.

Founded in 1996, Yuhe is the second largest day-old broiler breeder in China. The Company's main operations involve breeding, as all broilers are sold within a day of hatching. With headquarters in Weifang, Shandong province, the Company has modern facilities and is led by an experienced team which includes experts in chicken breeding, disease prevention and animal husbandry science. Yuhe has two operational subsidiaries, Weifang Yuhe Poultry Co. Ltd. and Weifang Taihong Feed Co. Ltd. which largely supplies the Company's internal demand for chicken feed. Currently, 85% of the Company's sales are in Shandong province with a customer base of 27 local agents. The Company has imported state-of-the-art equipment from the United States, Germany and Japan and has passed ISO9001 certification, allowing it to adhere to international standards of operation. For more information on the Company and its products, please visit http://www.yuhepoultry.com .

    For more information, please contact:

    Yuhe International, Inc.

     Mr. Vincent Hu, CFO
     Phone: +86-536-7300-667
     Email: vincent.hu@yuhepoultry.com

     Mr. Jason Wang, Director of Investor Relations
     Phone: +1-765-409-1844
     Email: jason.wang@yuhepoultry.com
     Web:  http://www.yuhepoultry.com

    CCG Investor Relations Inc.

     Mr. Crocker Coulson, President
     Phone: +1-646-213-1915 (New York)
     Email: crocker.coulson@ccgir.com
     Web:  http://www.ccgirasia.com

ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board : ACCP) announced today that Access will present at the Rodman & Renshaw 11th Annual Healthcare Conference to be held September 9-11, 2009 at the New York Palace Hotel in New York City. Jeffrey B. Davis, President and CEO of Access is scheduled to speak on Friday, September 11, 2009 at 10:50 am EDT in the Fahnestock Salon (5th Floor) and will give a corporate overview and discuss the Company's product opportunities.

The presentation will be available via a webcast and can be accessed at: http://www.wsw.com/webcast/rrshq15/accp.ob .The replay can be obtained at the same link for up to 90 days after the live presentation.

About MuGard: MuGard is a novel, ready-to-use mucoadhesive oral wound rinse for the management of oral mucositis, a debilitating side effect of many anticancer treatments. Up to 40% of all patients receiving chemotherapy and/or radiotherapy develop moderate to severe mucositis, and almost all patients receiving radiotherapy for head and neck cancer and those undergoing stem cell transplantation develop mucositis. Updated clinical practice guidelines for the prevention and treatment of mucositis recommend the use of a preventive oral care regimen as part of routine supportive care along with a therapeutic oral care regimen if mucositis develops. The market for the treatment of oral mucositis, used prophylactically for patients undergoing chemotherapy and radiation therapy, is estimated to be in excess of $5 billion world-wide.

About ProLindac(TM): ProLindac is a novel DACH platinum prodrug which has been shown to be active in a wide variety of solid tumors in both preclinical models and in human trials. Access believes that ProLindac's unique molecular design potentially could eliminate some of the toxic side effects seen in the currently marketed DACH platinum, Eloxatin, which has sales in excess of $2 billion. Access has previously announced that it has licensed ProLindac to Aosaikang Medicinal Group ("ASK") for the Greater China Region and to JCOM, Ltd for South Korea. Under these agreements both of these partners will be conducting Phase 2 combination studies with ProLindac in specific tumor types at their expense based on these results.

About Access: Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' products include ProLindac(TM), currently in Phase 2 clinical testing of patients with ovarian cancer, and MuGard(TM) for the management of patients with mucositis. The company also has other advanced drug delivery technologies including Cobalamin(TM)-mediated targeted delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine, a new generation nucleoside analog which has demonstrated both pre-clinical and clinical activity in certain cancers. For additional information on Access Pharmaceuticals, please visit our website at www.accesspharma.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: clinical trial plans and timelines and clinical results for ProLindac and product candidates acquired in the MacroChem transaction, our ability to execute licensing agreements in the future, Access' plans to continue and initiate clinical trials, the value of its products in the market (including MuGard and the size of the overall market for mucositis products), its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited Access' need to obtain additional financing in order to continue the clinical trial and operations and to the risks detailed in Access' Annual Reports on Form 10-K and other reports filed by Access with the Securities and Exchange Commission.

    Contact: Company
    Stephen B. Thompson
    Vice President, Chief Financial Officer
    Access Pharmaceuticals, Inc.
    (214) 905-5100

    Contact: Investor Relations
    Donald C. Weinberger/Diana Bittner (media)
    Wolfe Axelrod Weinberger Assoc. LLC
    (212) 370-4500

Transgenomic, Inc. (OTC Bulletin Board: TBIO) and Power3 Medical Products, Inc. (OTC Bulletin Board: PWRM) today announced the advance on-line publication of a clinical research paper entitled "Abnormal Serum Concentrations of Proteins in Parkinson's Disease" in the scientific journal Biochemical and Biophysical Research Communications. The study demonstrates the usefulness of a protein biomarker panel to distinguish Parkinson's disease (PD) patients from age-matched normal controls independent of the severity of symptoms, using clinical blood serum samples.

The analytic technology forms the basis for the NuroPro(R)PD test for PD being commercialized by Transgenomic as per a licensing/collaboration agreement with Power3 Medical signed in early 2009. The publication of the peer-reviewed article is a significant validation milestone in the ongoing clinical development of the NuroProPD diagnostic assay.

The article describes the use of analytically validated quantitative 2D gel electrophoresis to identify protein biomarkers for diagnosing PD using serum from routinely collected blood samples. 57 protein biomarkers, which had been discovered using retrospective blood serum samples from various neurodegenerative diseases, were then applied specifically to PD in a prospective clinical investigation using freshly collected blood serum from PD patients and age-matched normal controls. A multi-variate statistical method, stepwise linear discriminant analysis, selected a combination of 21 of the biomarkers as optimal to distinguish PD patients from controls. When applied to the PD samples, the 21-protein set had sensitivity of 93.3% (52 of 56 PD correctly classified) and specificity of 92.9% (28 of 30 controls correctly classified); 15 of 15 patients with mild and 28 of 30 with moderate to severe symptoms were correctly classified, as were all 6 PD samples from an independent site.

"We are enthusiastic about the acceptance of our paper in this established peer-reviewed scientific journal. It represents independent external validation of the clinical data, and so increases the confidence that we have in NuroProPD to be a meaningful tool for the diagnosis of Parkinson's disease, especially early in its course," said Craig Tuttle, CEO of Transgenomic. "We are completing the clinical validation of the assay in our CLIA-certified molecular testing laboratory and will be launching the assay in the very near future."

"In the U.S., there are an estimated 1.5 million individuals with Parkinson's disease. Unfortunately, by the time patients are given a probable diagnosis, many have already suffered substantial and irreparable brain damage, rendering treatment less effective," said Dr. Ira Goldknopf, President and CSO of Power3 Medical and lead author on the paper. "The fact that these results were obtained using fresh blood serum, in the same way that the test will be performed in a clinical diagnostic setting, provides further support for their robustness and their commercial value."

Clinical investigators in the study were Dr. Katerina Markopoulou of the University of Thessaly, Greece, Drs. Marwan Sabbagh and Holly Shill of Banner Sun Health Research Institute, Sun City, Arizona, and Dr. Stanley Appel of the Texas Methodist Health System, Houston.

About Transgenomic, Inc.

Transgenomic, Inc. (OTC BB: TBIO.OB, www.transgenomic.com ) is a global biotechnology company specializing in high sensitivity genetic variation and mutation analysis, providing products and services in DNA mutation detection and discovery for clinical research, clinical molecular diagnostics and pharmacogenomics analyses. Its product offerings include the WAVE(R) Systems and associated consumables specifically designed for use in genetic variation detection and single- and double-strand DNA/RNA analysis and purification. With broad applicability to genetic research, over 1,450 systems have been shipped to customers in more than 30 countries. The SURVEYOR(R) Mutation Detection Kits and SURVEYOR Check-It Kit provide reagents and protocols for high sensitivity detection of mutations in DNA. In addition, HANABI automated chromosome harvesting systems improve laboratory productivity with consistent quality compared to manual methods for cytogenetic analyses. Service offerings include the Transgenomic Molecular Laboratory, which provides reference laboratory services specializing in molecular diagnostics including Mitochondrial Disorders, Oncology and Hematology, Molecular Pathology and Inherited Diseases. Transgenomic Pharmacogenomic Services is a CRO for pharmacogenomic, translational research and clinical trials.

About Power3 Medical Products, Inc.

Power3 Medical Products, Inc. (OTCBB: PWRM, www.power3medical.com ) is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3 Medical operates a state-of-the-art CLIA certified laboratory in The Woodlands (Houston), Texas.

Cautionary Statements

Certain statements in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Forward-looking statements include, but are not limited to, those with respect to management's current views and estimates of future economic circumstances, industry conditions, company performance and financial results, including the ability of the Company to grow its involvement in the diagnostic products and services markets. The known risks, uncertainties and other factors affecting these forward-looking statements are described from time to time in reports to the Securities and Exchange Commission. Any change in such factors, risks and uncertainties may cause the actual results, events and performance to differ materially from those referred to in such statements. Accordingly, the company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 with respect to all statements contained in this press release.

Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that Leslie Bernhard, an independent director, has been named Chairman of the Board, succeeding Leonard Osser who had previously led the Company as Chairman since 1991. Osser, who has also served as the interim Chief Executive Officer since February 2009 and was formerly Milestone's CEO from 1991 through 2007, will again lead the Company as its CEO effective immediately.

"In view of Leonard's passion, vision and well defined strategy for optimizing Milestone's future growth, having him resume the full duties and responsibilities of the CEO post is without question in the best interests of the Company, its dedicated workforce and its shareholders," stated new Chairman Bernhard. "Moreover, by my assuming the Chairmanship, the Board can take advantage of enhancing our corporate governance and oversight, while freeing Leonard to concentrate on achieving the Company's mission critical goals and objectives."

Commenting on the leadership changes, Osser noted, "We are now seeing a number of promising growth opportunities in the international markets related to the expansion of our global dental distribution network and worldwide marketing of our award winning STA Single Tooth Anesthesia System((TM)). We are also gaining meaningful traction in our negotiations in collaborating on the development of new medical products utilizing our patented CompuFlo((R)) technology. Consequently, the Board determined that my time and effort was best utilized focused on fully capitalizing on these promising opportunities. As such, I'm very pleased that Leslie has agreed to assume leadership of the Board. In my capacity as a director and CEO, I look forward to working closely with her to help guide and manage our Company's long term growth and anticipated success."

About Milestone Scientific Inc.

Headquartered in Piscataway, New Jersey, Milestone Scientific is engaged in pioneering proprietary, highly innovative technological solutions for the medical and dental markets. Central to the Company's IP platform and product development strategy is its patented CompuFlo((R)) technology for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids. The STA Single Tooth Anesthesia System((TM)), a computer-controlled local anesthesia delivery system, uses this technology to provide dentists with audible and visual signals as to in-tissue pressure. Milestone's existing painless injection systems are currently sold in 25 countries. For more information on these and other innovative Milestone products, please visit the Company's web site found at www.milestonescientific.com and www.STAis4U.com.

Safe Harbor Statement

This press release contains forward-looking statements regarding the timing and financial impact of the Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2008. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

FOR MORE INFORMATION, PLEASE CONTACT:

Elite Financial Communications Group

Dodi Handy, President and CEO (Twitter: @dodihandy)

For Media Inquiries: Kathy Addison, Director, Elite Media Group (Twitter: @kathyaddison)

407-585-1080 or via email at mlss@efcg.net'>mlss@efcg.net

China Valves Technology, Inc. (OTC Bulletin Board: CVVZ) ("China Valves" or the "Company"), a leading metal valve manufacturer with operations in the People's Republic of China (the "PRC"), today announced that the Company's new production facility at its Henan Kaifeng High Pressure Valve Co., Ltd. ("Kaifeng Valve") subsidiary will begin formal production in mid September 2009.

The new production facility at Kaifeng Valve will mainly focus on the production of high-end large diameter metal valves used in thermal and nuclear power plants, as well as by the oil petrochemical and water supply and drainage industries. Additionally, the new facility will produce high-quality forged steel valves for use in supercritical thermal power generating units. The Company believes it is the only company in China capable of manufacturing this advanced product. The new facility will also produce conventional islands valves of nuclear power stations. The facility covers 13,000 square meters (approximately 140,000 square feet) and is equipped with state-of-the-art, fully automated machines supported by a new power transformer station. The construction was completed in the first quarter of 2009 and the facility began trial production in June 2009.

"Our new facility will focus on production of high-end valve products, and we plan to quickly ramp up production to reach 100% utilization by the end of 2009. Based on feedback from end valve users in the power generation and oil and petrochemical industries, demand for large diameter valves and forged steel valves will remain strong due to the shortage of production capacity for valve products used in more critical applications, such as supercritical thermal power generating units. This conscious and ongoing shift in our product portfolio towards technologically advanced valves should significantly improve our competitive position in the high-end valve market in China," said Mr. Siping Fang, Chairman and Chief Executive Officer of China Valves. "We expect the new facility to contribute $9.8 million in revenue and $3 million in net income in 2009. On a full year basis when at full capacity and accounting for seasonality we expect the new facility will contribute approximately $29.4 million in revenue and approximately $9 million in net income. These estimates assume that the facility's product mix remains in line with current backlog. However, annualized revenue and net margin may change as our product offerings evolve."

About China Valves Technology, Inc.

China Valves Technology, Inc., through its subsidiaries, Zhengzhou Zhengdie Valve Co, Ltd., Henan Kaifeng High Pressure Valve Co., Ltd., and Tai Zhou Tai De Valve Co., Ltd., is engaged in development, manufacture and sale of high-quality metal valves for the electricity, petroleum, chemical, water, gas and metallurgy industries. The Company has one of the best-known brand names in China's valve industry, and its history can be traced back to 1959 when it was formed as a state-owned enterprise. The Company develops valve products by extensive research and development and owns a number of patents. It enjoys significant domestic market shares and exports to Asia and Europe. For more information, visit http://www.cvalve.com .

Safe Harbor Statements

Any statements set forth above that are not historical facts are forward- looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such factors include, but are not limited to, the Company's ability to increase utilization at the new facility to targeted levels, develop and market new products, the ability to acquire other companies, changes from anticipated levels of sales, changes in national or regional economic and competitive conditions, changes in relationships with customers, changes in principal product profits and other factors detailed from time to time in the Company's filings with the United States Securities and Exchange Commission and other regulatory authorities. The Company undertakes no obligation to update or revise to the public any forward-looking statements, whether as a result of new information, future events or otherwise. This press release was developed by China Valves, and is intended solely for informational purposes and is not to be construed as an offer or solicitation of an offer to buy or sell the Company's stock. This press release is based upon information available to the public, as well as other information from sources which management believes to be reliable, but it is not guaranteed by China Valves to be accurate, nor does China Valves purport it to be complete. Opinions expressed herein are those of management as of the date of publication and are subject to change without notice.

    For more information, please contact:

    China Valves Technology, Inc.
     Ray Chen, VP of Investor Relations
     Tel:   +1-650-281-8375
            +86-139-2527-9478
     Email: raychen@cvalve.net
     Web:  http://www.cvalve.com

    CCG Investor Relations
     Crocker Coulson, President
     Tel:   +1-646-213-1915
     Email: crocker.coulson@ccgir.com
     Web:  http://www.ccgirasia.com

ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board : ACCP) announced today that Access will present at the Rodman & Renshaw 11th Annual Healthcare Conference to be held September 9-11, 2009 at the New York Palace Hotel in New York City. Jeffrey B. Davis, President and CEO of Access is scheduled to speak on Friday, September 11, 2009 at 10:50 am EDT in the Fahnestock Salon (5th Floor) and will give a corporate overview and discuss the Company's product opportunities.

The presentation will be available via a webcast and can be accessed at: http://www.wsw.com/webcast/rrshq15/accp.ob .The replay can be obtained at the same link for up to 90 days after the live presentation.

About MuGard: MuGard is a novel, ready-to-use mucoadhesive oral wound rinse for the management of oral mucositis, a debilitating side effect of many anticancer treatments. Up to 40% of all patients receiving chemotherapy and/or radiotherapy develop moderate to severe mucositis, and almost all patients receiving radiotherapy for head and neck cancer and those undergoing stem cell transplantation develop mucositis. Updated clinical practice guidelines for the prevention and treatment of mucositis recommend the use of a preventive oral care regimen as part of routine supportive care along with a therapeutic oral care regimen if mucositis develops. The market for the treatment of oral mucositis, used prophylactically for patients undergoing chemotherapy and radiation therapy, is estimated to be in excess of $5 billion world-wide.

About ProLindac(TM): ProLindac is a novel DACH platinum prodrug which has been shown to be active in a wide variety of solid tumors in both preclinical models and in human trials. Access believes that ProLindac's unique molecular design potentially could eliminate some of the toxic side effects seen in the currently marketed DACH platinum, Eloxatin, which has sales in excess of $2 billion. Access has previously announced that it has licensed ProLindac to Aosaikang Medicinal Group ("ASK") for the Greater China Region and to JCOM, Ltd for South Korea. Under these agreements both of these partners will be conducting Phase 2 combination studies with ProLindac in specific tumor types at their expense based on these results.

About Access: Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' products include ProLindac(TM), currently in Phase 2 clinical testing of patients with ovarian cancer, and MuGard(TM) for the management of patients with mucositis. The company also has other advanced drug delivery technologies including Cobalamin(TM)-mediated targeted delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine, a new generation nucleoside analog which has demonstrated both pre-clinical and clinical activity in certain cancers. For additional information on Access Pharmaceuticals, please visit our website at www.accesspharma.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: clinical trial plans and timelines and clinical results for ProLindac and product candidates acquired in the MacroChem transaction, our ability to execute licensing agreements in the future, Access' plans to continue and initiate clinical trials, the value of its products in the market (including MuGard and the size of the overall market for mucositis products), its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited Access' need to obtain additional financing in order to continue the clinical trial and operations and to the risks detailed in Access' Annual Reports on Form 10-K and other reports filed by Access with the Securities and Exchange Commission.

    Contact: Company
    Stephen B. Thompson
    Vice President, Chief Financial Officer
    Access Pharmaceuticals, Inc.
    (214) 905-5100

    Contact: Investor Relations
    Donald C. Weinberger/Diana Bittner (media)
    Wolfe Axelrod Weinberger Assoc. LLC
    (212) 370-4500